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Abstract 
The structural core of DNA, a continuous stack of aromatic heterocycles—the 
base pairs—that extends down the helical axis, gives rise to the fascinating electronic 
properties of this molecule that is so critical for life.  This π-stacked structure facilitates a 
unique form of charge conduction, termed DNA-mediated charge transport (DNA CT).  
Experiments with diverse platforms, in solution, on surfaces, and with single molecules, 
collectively provide a broad and consistent perspective on the essential characteristics of 
this chemistry.  Notably, DNA CT can proceed over long molecular distances, but is 
remarkably sensitive to perturbations in base pair stacking.  These characteristics suggest 
that DNA CT may be used for long-range sensing both in nature and in nanoelectronic 
applications.  Here, measurements of DNA CT with surface and single molecule 
platforms are used to (i) determine how ground state DNA CT varies over regimes of 
increasing distance and (ii) apply this chemistry to the electrical detection of DNA-
binding proteins.   
First, the design and fabrication of multiplexed, DNA-modified electrodes on 
silicon chips is reported.  These lithographically patterned chips with 16 individually 
addressable gold electrodes allow for the measurement of DNA CT with four different 
types of DNA, side by side on the same surface, with four-fold redundancy.  
Discrimination of DNA with a single base mismatch and detection of sequence-specific 
restriction enzyme activity are both achieved with these chips.  Scaling of these devices 
to microelectrode dimensions is also demonstrated.  Importantly, these chips show 
greater reproducibility and consistency than commercially available rod electrodes.  This 
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greater signal quality, combined with the capacity to examine different samples side by 
side, opens the door for more complex applications of this platform.  
The fully developed, multiplexed chips are first used to compare DNA CT over 
short and long distance regimes.  DNA is evaluated in this context because the efficacy of 
a long-range sensor, in either nature or nanoelectronics, is determined largely by its 
capacity to facilitate CT in a manner that is minimally affected by the CT distance.  DNA 
CT over 34 nm in 100-mer monolayers is found to yield electrochemical signals that are 
comparable in size to shorter 17-mer DNA.  Signal attenuation from a single base-pair 
mismatch in the 100-mer is also comparable to that for 17-mers, and confirms that CT in 
these 100-mer films is DNA-mediated.  Efficient cleavage by a restriction enzyme 
indicates that the 100-mer DNA adopts a native, upright conformation.  The alkanethiol 
linker used to anchor the DNA to the electrode is found to limit the electron-transfer rate 
for both DNA lengths.  Thus the impact of increasing the CT distance on DNA CT is too 
small to be resolved by this platform, even over 34 nm.  These measurements put DNA 
among the longest and most conductive molecular wires reported to date.   
 Next, DNA CT with multiplexed chips is extended to the electrochemical 
detection of methyltransferases, proteins that are attractive targets because of their 
prominent role in the initial stages of many types of cancer.  Electrochemical detection of 
binding and activity by these proteins is achieved by two different methods.  First, DNA-
binding and base-flipping by these proteins disrupts the DNA π-stack and may be used 
for direct “signal OFF” detection.  Using this method, the concentration- and cofactor- 
dependence of SssI methyltransferase, the bacterial analog of human methyltransferases, 
are examined.  Second, methylation-conferred protection of DNA against cutting by a 
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restriction enzyme may be used for “signal ON” detection of methyltransferase activity.  
With this approach, the use of both unmethylated and hemimethylated DNA substrates is 
demonstrated for the sensitive detection of both bacterial (SssI) and human (Dnmt1) 
methyltransferase activity.  Importantly, the electrochemical format of these assays 
requires minimal equipment, is low cost, and may be easily applied to high throughput 
studies, making it an accessible option for a variety of research and clinical settings.    
 Alongside work with this surface, electrochemical platform, a single molecule, 
carbon nanotube-DNA (CNT-DNA) platform is also used to evaluate DNA CT over 
increasing distances and to detect protein binding.  CNT-DNA devices consist of a single 
molecule of DNA that is made to bridge a gap cut in a CNT covalently, such that current 
flow through the device is DNA-mediated.  Upon introduction of DNA bridges of 
varying length (15-mer, 60-mer, and 100-mer), the device resistance is minimally 
affected, echoing the result of long distance electrochemistry experiments.  These devices 
are also used to detect SssI methyltransferase binding by the direct “signal OFF” method 
used with multiplexed chips; DNA-binding and base-flipping disrupts DNA CT and shuts 
off current flow through the device.  CNT-DNA devices are used to electronically 
measure the sequence-specific, cofactor-dependent, and reversible binding of SssI.  DNA 
methylation catalyzed by SssI is also detected based on its alteration of the protein-
binding affinity of the device.  This detection approach, which relies on DNA as both a 
recognition element and electrical transducer, represents a unique strategy for the 
specific, single molecule detection of protein binding and activity.  
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Introduction 
The structure of double helical DNA, with two dynamic strands of 
complementary bases that encode a meaningful sequence, has long been conceptualized 
as an elegant construct for the storage, expression, and transmission of the genetic 
instructions of life.  Beyond the capacity to manage information, though, this structure 
also imparts DNA with the capacity to conduct charge; the continuous π-stacked array of 
heterocyclic aromatic base pairs that extends down the helical axis forms an efficient path 
for long-range charge transport (1, 2).  The importance of DNA-mediated charge 
transport (DNA CT) in directing biological processes is just now being illuminated, and 
this property shows great promise for use in nanoelectronics and biosensing applications. 
Since the initial postulate of DNA conductivity by D. Eley and D. Spivey in 1962 
(3),
 
numerous studies, using multiple techniques, have confirmed and expanded our 
understanding of DNA CT.  Data from experiments in solution, on surfaces, and with 
single molecules, collectively provide a broad and consistent perspective on the essential 
characteristics of this chemistry (1, 2).  For systems in which donors and acceptors are 
electronically well coupled to the π-stack, DNA CT can proceed over long molecular 
distances.  However, this process is remarkably sensitive to perturbations in base pair 
stacking.   
This thesis encompasses work on both fundamental measurements of DNA CT 
over long distances and the use of this sensitive chemistry for protein biosensing.  These 
exciting branches of study are only possible because of the strong foundation from which 
they extend.  Our thorough understanding of the defining attributes of DNA CT, built 
with experimental data from diverse platforms, is outlined in this first chapter.  Specific 
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focus is given to ground state electronic platforms, including DNA-modified electrodes 
and carbon nanotube-DNA (CNT-DNA) devices, as research for this thesis was 
performed with these platforms.  Subsequent chapters describe work that builds up and 
out from this strong foundation, toward a broader understanding and practical 
applications of DNA CT. 
 
Diverse Platforms Reveal the Characteristics of DNA CT 
Just like the characteristics of gene expression and inheritance, the characteristics 
of DNA CT originate from the unique structure of DNA.  At the most basic level, DNA 
CT is mediated by the overlapping π orbitals of the stacked nucleotide bases.  In fact, the 
first proposal that DNA might conduct charge was based mainly on structural 
observations.  Eley and Spivey noted that the aromatic bases of DNA, the very bases that 
encode genetic information, stack next to each other with an interplanar spacing similar 
to graphite and thus, like sheets of graphite, can form a conductive path of overlapping π 
orbitals that extends down the helical axis (3) (Figure 1.1).  A critical feature that 
distinguishes the DNA duplex from solid π-stacked materials, though, is that DNA is a 
macromolecular array in solution, with dynamical changes in π-stacking that occur on the 
picosecond to millisecond time scales (4).   
Several solution, surface, and single molecule platforms that have been developed 
to probe DNA CT are illustrated in Figure 1.2.  DNA CT has been investigated with 
photophysical methods, appending donors and acceptors to either end of the DNA 
duplex.  Long-range oxidative damage by DNA CT has been examined using DNA-
binding photooxidants to promote oxidation of guanines in the duplex from a distance.   
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Figure 1.1 The structure of DNA facilitates charge transport.  The aromatic bases (grey) 
of DNA stack with each other like a pile of coins and are wrapped by a sugar phosphate 
backbone (purple ribbon).  The overlapping π orbitals of these stacked bases form a 
conductive core down the helical axis that mediates the flow of charge.  This structure 
resembles that of stacked graphite sheets and, indeed, undamaged, well stacked DNA is 
found to have the same conductivity as that measured perpendicular to graphite.  
Importantly, the conformation of this structure is not static; dynamic motions within this 
macromolecular array contribute to the mechanistic complexity of DNA CT. 
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Figure 1.2 Platforms for the study of DNA CT.  Top row, spectroscopic solution 
platforms: (left)   photoactivated luminescence and quenching between covalent 
metallointercalators and (right) photoactivated fluorescence of base analog 2-
aminopurine and quenching by guanine.  Second row, biochemical solution platform: 
photoactivated oxidation of guanine doublets by a covalent metallointercalator.  Third 
row, electrochemical surface platforms: DNA-modified electrodes with (left) a covalent 
redox probe and (right) a bound protein with a redox-active cofactor.  Fourth row, single 
molecule platform: DNA covalently bridges the gap in a carbon nanotube device.    
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Additionally, DNA CT in the ground state has been probed both in electrochemical 
studies and in single molecule nanoscale devices.  
Remarkably, despite the diversity of techniques employed, a conserved set of 
characteristics for this process are observed: a) efficient DNA CT is heavily dependent on 
the proper electronic coupling of the donor and acceptor to the π-stack and between the 
bases of the DNA bridge, b) DNA CT is highly sensitive to the structural integrity of the 
stacked path of bases between the donor and acceptor, c) the distance dependence of 
DNA CT is very shallow, and this parameter is often limited by the platform used to 
make measurements rather than by the length of the DNA itself, and d) DNA CT is 
conformationally gated by the dynamic motions of the donor/bridge/acceptor system as 
they move in and out of CT-active configurations and form domains over which charge 
can delocalize. 
 
Coupling to the DNA π-Stack  
A first, critical feature of DNA CT was identified during initial work to build 
functional solution platforms to probe this process: DNA CT requires effective electronic 
coupling of the donor and acceptor to the base pair π-stack.  A variety of small molecule 
donors and acceptors that have been used for the study of DNA CT in both solution and 
surface platforms are illustrated in Figure 1.3.  The first platform to measure DNA CT 
utilized metallointercalators that were covalently attached to 15-mer DNA duplexes in 
solution (5).  The donor and acceptor, Ru(phen)2dppz
2+
 and Rh(phi)2phen
3+
 respectively, 
both have aromatic ligands that allow them to intercalate and interact directly with the 
DNA π-stack.  When the donor is photoexcited, complete quenching occurs due to rapid  
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Figure 1.3  Small molecule probes used for the study of DNA CT. 
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CT to the acceptor.  This quenching occurs only when the donor and acceptor are bound 
to the same duplex and does not occur when Ru(phen)2(phenʹ)
2+
, a poor intercalator, is 
substituted for the donor.  This result illustrates that DNA CT is necessarily an 
intraduplex process, which donors and acceptors must access through effective electronic 
coupling into the base pair π-stack.   
In a later variation on this platform, the pendant donors and acceptors were 
completely eliminated by using modified bases to examine photoinduced DNA CT in the 
duplex (6).  The base analogs 2-aminopurine (2-Ap) or 1,N
6
-ethenoadenine (Aε) were 
incorporated into 12-mer DNA duplexes in solution, and used to promote photooxidation 
of guanine.  In these experiments, quenching of 2-Ap occurred far more rapidly and with 
a far more shallow distance dependence, than did quenching of Aε. This result is 
consistent with the different structures of these analogs that allow for well integrated 
stacking of 2-Ap into the DNA helix and poor stacking of Aε.  Clearly, for effective DNA 
CT, coupling with the π-stack is key. 
 
Sensitivity to Perturbations of the DNA π-stack  
Studies with solution-based platforms also revealed a second important 
characteristic:  DNA CT is highly sensitive to the integrity of the π-stack of the bases 
between the donor and the acceptor.  The sensitivity of DNA CT to single base 
mismatches was first demonstrated in studies of photoinduced quenching of ethidium 
tethered to DNA by a rhodium complex intercalatively bound and tethered at the other 
terminus (7).  In addition to the loss of quenching by this pair that is observed when the 
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double helix is melted apart, the introduction of a single base mismatch between the 
donor and acceptor severely decreases the quenching yield (7).   
This exquisite sensitivity to such a subtle structural perturbation as a single base 
mismatch has been observed across experimental platforms, including surface (8-10) and 
single molecule (11) platforms which are described in greater detail later in this chapter.  
These ground state platforms have allowed for the identification of a variety of other 
distortions to the structure of the DNA π-stack that attenuate DNA CT (Figure 1.4) 
including a variety of base lesions (12) and protein binding events (13-15).  Importantly, 
it is specifically perturbations to the stacked bases that inhibit the flow of charge; the 
addition of methyl groups to the DNA bases (15) or the introduction of breaks (nicks) in 
the sugar phosphate backbone (16) do not affect DNA CT as these modifications do not 
alter the structure of the π-stack.  This sensitivity to perturbations in stacking forms the 
basis of DNA CT-based electrical biosensors.   
 
Shallow Distance Dependence 
As the limits of these experimental platforms were pushed to try to understand the 
limits of DNA CT itself, another critical characteristic of this chemistry emerged: the 
distance dependence of DNA CT is very shallow. To probe the distance dependence of 
DNA CT, experiments were performed in solution to measure long-range guanine 
oxidation from a distal, covalent metallointercalator photooxidant; after irradiation, the 
location of DNA-mediated photooxidation in the duplex is determined by biochemical 
sequencing (17, 18).  Irrespective of the DNA-bound photooxidant, significant oxidative 
damage is observed at the 5-guanine of guanine doublets, the site of lowest oxidation  
10 
 
 
 
 
 
Figure 1.4 Structural perturbations to the base pair π-stack inhibit DNA CT.  For 
efficient DNA CT, bases in the duplex must be well stacked with each other to achieve 
proper π-orbital overlap and electronic coupling.  This occurs naturally in the case of 
fully matched DNA (top row, left).  Nicks in the sugar phosphate backbone (top row, 
center) and and methylation of the DNA bases (top row, right) do not interfere with the π-
stack and thus do not inhibit DNA CT.  However, attenuation of DNA CT is observed for 
perturbations that disrupt the π-stack including single base mismatches (bottom row, left), 
single base bulges (bottom row, center), and bound proteins that severely kink the DNA 
(bottom row, right).  The attenuation in DNA CT caused by these structural perturbations, 
and others, has been measured with solution, surface, and single molecule platforms.   
 
 
 
 
11 
 
potential in the DNA.  Indeed, in an oligonucleotide duplex with a Rh intercalator 
tethered to one end, oxidation is observed not only at the 5-guanine of the guanine 
doublet in the center of the duplex, but also at the 5-guanine of the guanine doublet 
located near the distal end of the duplex.  With this platform, photooxidation that is 
insensitive to the separation distance up to the longest distance measured, 20 nm (60 bp), 
was observed (18).  Moreover, the integrity of the intervening stack of DNA is critical for 
the generation of oxidative damage to DNA from a distance, independent of the DNA-
bound photooxidant employed. 
More recently, the distance dependence of ground state DNA CT was examined 
electrochemically on a multiplexed electrode surface, as detailed in chapter 3 (10).  Using 
this platform DNA CT was measured to a distal redox probe over 34 nm (100 bp).  
Remarkably, the redox signal size and the degree of signal attenuation from the 
incorporation of a mismatched base is the same as that observed for much smaller (17 bp) 
duplexes (10).  Also, like the shorter duplexes (19), the rate of DNA CT through the 100-
mer is still limited by the tunneling rate through the alkane-thiol linker.  Even with this 
limit, these measurements indicate that DNA is competitive with the longest and most 
conductive molecular wires reported to date.  Clearly, as indicated by both of these 
solution and surface experiments, DNA CT occurs at rates and over distances that stretch 
beyond the physical limits of the platforms that have been designed thus far to make such 
measurements.  Indeed a fundamental shift is necessary to imagine the scale on which 
DNA can rapidly and sensitively transport charge and understand the implications of this 
vast capacity for biology.  
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Conformational Gating and Charge Delocalization 
In work to understand a mechanism for DNA CT, evidence for a fourth key 
feature of this chemistry was observed:  DNA CT is conformationally gated by the 
alignment of CT-active domains over which charge can delocalize.  The important role of 
structural dynamics in mediating DNA CT became clear in early observations on the 
effect of sequence-dependent flexibilities on DNA CT, and from this work it was 
proposed that long distance CT might occur through hopping between delocalized 
domains (20).  The extent of delocalization, and the resulting physical definition of a 
domain, would clearly depend heavily on the dynamic motions that allow segments of the 
assembly to achieve CT-active conformations.  Femtosecond spectroscopy experiments 
in solution provided strong support that dynamic motions within the DNA structure 
actually gate DNA CT; the CT rate is determined not by individual bases but by the 
simultaneous alignment of multiple components of the assembly, including the bases, the 
donor, and the acceptor, into CT-active conformations (21). 
The formation of discrete domains of delocalized charge was illustrated in greater 
detail by solution fluorescence studies in which a periodic length dependence was 
observed for the quenching yield of photoexcited 2-Ap by guanine across adenine tracts 
(22).  That CT through the DNA duplex essentially encounters a gate at each sequential 
length of 3–4 base pairs indicates that this length is ideal for the formation of a CT-
active, delocalized domain (22).  A similar periodic length dependence was measured for 
CT between photoexcited [Rh(phi)2(bpyʹ)]
3+
 and N
2
-cyclopropyldeoxyguanine (
CP
G) 
(23).  Recently, it was observed that the mechanism of DNA CT is actually dictated by 
the capacity of different lengths of DNA to form delocalized domains (24).  For this 
13 
 
work, 
CP
G oxidation by photoexcited 2-Ap across adenine-tracts was measured.  For 
DNA CT over a full turn of the DNA helix, a coherent CT mechanism is favored.  For 
segments that are not integer multiples of the 3–4 base pair length that is ideal for the 
formation of a delocalized domain, the 
CP
G oxidation yield decreases, indicating that CT 
must switch from a coherent to incoherent mechanism (24). 
Consideration of conformational gating and charge delocalization is critical for a 
viable mechanistic description of DNA CT.  However, the two most prominent models 
used to describe DNA CT, superexchange and localized hopping, do not account for the 
impact of these structural dynamics.  Not surprisingly, significant inconsistencies exist 
between the experimentally observed characteristics of DNA CT and these models (25).  
In the superexchange model, the orbitals of the DNA bridge are higher in energy than the 
donor and acceptor such that charge must tunnel through and only virtually occupy the 
DNA bridge (26).  Thus, the probability of tunneling and virtual occupation of the bridge 
becomes less and less favorable with increasing distance between the donor and acceptor, 
and an exponential distance dependence is expected (26).  The shallow distance 
dependence observed for DNA CT over long distances is wholly incompatible with 
superexchange in DNA (10, 25).  
In localized hopping, the orbitals of the DNA bridge are close in energy to the 
donor and acceptor and thus short hops between low-potential guanine sites in DNA that 
actually occupy the bridge are predicted to result in a much more shallow distance 
dependence (26-28).  However, this mechanism is not sufficient to explain DNA CT 
through adenine tracts (29).  Also, in experiments involving guanine oxidation over 
various lengths of T, A, and mixed A/T bridges, it is the flexibility of the intervening 
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sequence, not the length of the tract, that is the dominant factor in determining the 
oxidation yield; the introduction of a GC segment within TA tracts actually decreases the 
yield of DNA CT (20).  The exquisite sensitivity of DNA CT to single base mismatches 
that has been observed for all platforms is also poorly explained by a hopping 
mechanism.  The suggestion that guanine-containing mismatches interrupt DNA CT by 
proton abstraction (30) is inconsistent with experimental observations in which the 
degree of CT attenuation correlates with the thermodynamic destabilization of the 
mismatch (8).   
Another inconsistency with the localized hopping mechanism is routinely 
observed in electrochemistry experiments where the  potentials that are applied for 
reduction of the small molecule redox probe are far below the reduction potentials of the 
bases (up to 1 V difference) (31).  Given this discrepancy, charge injection to an isolated 
base for localized hopping would be extraordinarily slow, at least 4–5 orders of 
magnitude slower (25) than the linker-limited rate of 30 s
–1
 that is measured through our 
DNA-modified electrodes (10, 32, 33).  Thus, to account for the observed DNA CT on 
electrochemical platforms, the CT mechanism must necessarily involve a decrease in the 
energy gap between the Fermi level of the electrode surface and the oxidation potential of 
the individual bases; this cannot be explained within the bounds of the localized hopping 
mechanism.
 
The inclusion of conformational gating and charge delocalization in a mechanistic 
description of DNA CT helps to reconcile these inconsistencies.  While allowing the 
shallow distance dependence that comes with hopping between discrete domains, these 
phenomena provide reason for the impact of base dynamics and sequence flexibility.  
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Conformational gating and charge delocalization also help to explain why such severe 
attenuation of DNA CT is observed when the structure of the DNA π-stack is distorted.  
Structural perturbations to the π-stack cause the affected bases to preferentially adopt un-
stacked conformations.  When it comes to the formation of delocalized domains that 
facilitate CT, a primarily un-stacked base functions like a rotating disc in a multi-disk 
combination lock that is stuck on the wrong number.  Although the other disks might turn 
fluidly to the correct combination the disk that is stuck in the wrong orientation will still 
prevent the lock from opening.  Likewise, the bases surrounding a lesion, mismatch, or 
bound protein may be free to move into CT-active conformations, but the un-stacked base 
disrupts the formation of a domain over which charge could delocalize, dramatically 
shutting off DNA CT.  Charge delocalization additionally accounts for the fast CT rates 
that are measured electrochemically: states in which the charge is delocalized over large 
domains would necessarily be lower in energy than a state in which the charge is 
localized on an individual base, thus enabling charge injection at the applied potentials 
used in electrochemistry experiments.  
 
Ground State Platforms for DNA CT 
In contrast to solution-based strategies for the study of electron transfer, surface 
and single molecule platforms provide a solid handle to anchor study molecules into 
defined conformations (34).  In the case of DNA-modified electrodes, this handle is the 
electrode surface which replaces the donor and allows for the controlled application of a 
potential (31, 35, 36)  In the case of carbon nanotube-DNA (CNT-DNA) devices, this 
handle is the carbon nanotube, which isolates a single DNA molecule within a defined 
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electrical circuit (11, 15).  While solution studies necessarily involve excited-state 
measurements, DNA-modified electrodes and CNT-DNA devices allow for the study of 
ground-state electron transfer processes.  Importantly, these platforms are highly 
compatible with the aqueous, buffered environments that biomolecules require to 
maintain their native, biologically relevant structure.  The isolation of a DNA-mediated 
path as the only route for CT in these platforms has allowed for the study of fundamental 
characteristics of DNA CT as well the application of this sensitive chemistry for 
electrical biosensing.  Significantly, the characteristics of DNA CT, identified first in 
solution studies and outlined in previous sections, are consistently observed for these 
ground state platforms.    
 
DNA-Modified Electrodes 
 To form DNA-modified electrodes, DNA duplexes are modified with a linker on 
one end that allows for their self-assembly into monolayers on an electrode surface.  
Most commonly, alkanethiol linkers (37) are used for the attachment to gold electrodes, 
but for experiments that require a wider potential window pyrene linkers (38) allow for 
attachment to graphite electrodes.  The Barton laboratory has thoroughly characterized 
the structure of these assemblies with a variety of techniques including radioactive 
labeling (13, 37, 38), atomic force microscopy (13, 38–40), and scanning tunneling 
microscopy (41).  These studies have confirmed that film density can be controlled by 
Mg
2+
, which promotes dense packing (13, 37, 38).  Additionally, the duplexes adopt an 
upright orientation with an angle relative to the surface that can be modulated by the 
applied potential; in the absence of a potential, duplexes are oriented at a ~45° angle to 
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the surface and with the application of positive or negative potentials, the anchored 
duplexes are attracted to or repelled by the surface, respectively, from this set point (38, 
39).  Thus, the DNA duplexes function as highly sensitive extensions of the electrode 
surface into solution.   
In order to study CT that is mediated by these DNA extensions, a redox-active 
probe moiety is incorporated at or near the end of the DNA that is distal from the surface.  
For this purpose, noncovalent (8, 12, 37, 38, 42-45) and covalent (9, 10, 13, 14, 16, 19, 
32, 33, 46, 47) redox probes have been employed as well as DNA-binding proteins that 
are redox-active (48-53).  After assembly of the DNA monolayer, the modified electrode 
is treated with a backfilling agent, such as mercaptohexanol, to passivate the surface 
against direct reduction of the redox probe and to remove nonspecifically adsorbed DNA.  
In the completed DNA-modified electrode, CT is mediated from the electrode surface to 
the redox probe via the intervening path of well stacked DNA bases.  Importantly, 
experiments with this platform are all performed in aqueous, buffered solution such that 
the DNA maintains a native, CT-active conformation.  
 
Noncovalent Redox Probes 
 In the development of this platform, noncovalent, redox-active small molecules 
were initially used as probes for DNA CT.  For these experiments, electrodes with 
densely packed DNA films are required in order to prevent access of the freely diffusing 
probe molecules to the surface.  In these dense films, the probe is restricted to binding at 
the top of the duplex, thereby allowing for the interrogation of DNA CT in duplexes 
containing a single base mismatch (37, 42).  The mismatch sensitivity of a variety of 
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small molecule redox probes was investigated including the DNA groove binder 
[Ru(NH3)6]
3+
 and the DNA intercalators methylene blue (MB), [Ir(bpy)(phen)(phi)]
3+
, 
and daunomycin (42).  As in solution studies, it was observed that a close interaction 
between the probe and the DNA π-stack is essential for reduction that is sensitive to a 
mismatch and thus DNA-mediated; reduction of the DNA intercalators was significantly 
inhibited by the presence of a mismatch while reduction of the DNA groove binder 
[Ru(NH3)6]
3+
 
 
was unaffected (42). 
A more in-depth look at the behavior of [Ru(NH3)6]
3+ 
 as compared to MB in this 
platform clearly illustrates how the DNA functions as an extension of the electrode 
surface for molecules that can properly access the DNA CT pathway of the π-stacked 
bases (43).  For both [Ru(NH3)6]
3+
 and MB, high salt conditions decrease the number of 
molecules that are reduced, reflecting the inhibition of electrostatic and intercalative 
DNA binding modes, respectively.  This result indicates that the reduction of both probes 
is dependent on their tight binding to DNA.  However, polymerization of 2-naphthol to 
completely passivate the electrode surface against direct probe interaction reveals 
fundamental differences in the pathways by which these probes are reduced.  While 
reduction of MB is minimally affected by this total passivation (~3% signal reduction), 
reduction of [Ru(NH3)6]
3+
 
 
is decreased significantly (~70% signal reduction) (43).  Thus, 
while [Ru(NH3)6]
3+
 
 
is reduced directly at the electrode surface and the DNA functions 
simply as a charged guiderail that helps to facilitate its diffusion toward the surface, MB 
does not require access to the surface for its reduction.  Instead, the ability of MB to 
intercalate into the DNA duplex and interact directly with the π-stacked bases allows it to 
access a DNA-mediated pathway for reduction that extends through the DNA, above the 
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passivated surface; here the DNA functions as an electrical conduit through which charge 
is conducted from the surface directly to the distally bound probe. 
Additional work with this platform showed that not only must the redox probe be 
well coupled into the DNA π-stack, but the proper stacking of the bases themselves is 
also critical for DNA CT to occur.  Further work with the MB probe showed that its 
DNA-mediated signal may be amplified in an electrocatalytic cycle with ferricyanide 
(42) and used to sensitively detect all base mismatches (8) and a variety of DNA lesions 
(12) by an attenuation of DNA CT to the MB redox probe.  Electrochemical 
measurements of DNA CT through A-form DNA (DNA/RNA hybrid duplexes) showed 
that, like B-form DNA, this conformation can efficiently mediate charge through stacked 
bases, and mismatches within its sequence are readily detected (44).  In contrast, Z-form 
DNA, which is more rigid and has significantly less intrastrand base stacking than B- and 
A-form, shows significantly attenuated DNA CT (44).  Incorporation of a 3ʹ-endo-locked 
nucleotide into B-form DNA, which is known to disrupt base stacking, causes signal 
attenuation similar to that caused by the incorporation of a mismatch (45).  However, 
incorporation of this modified nucleotide into A-form DNA, which can better 
accommodate its structure into the base stack, does not show attenuation in DNA CT. 
 
Covalent Redox Probes 
 The development of covalent redox probes for the DNA-modified electrode 
platform opened the door for more precise characterization of DNA CT, as the location of 
the probe in the duplex could be defined.  Initial work made it clear that, like noncovalent 
probes, electronic coupling to the π-stack is absolutely required for the DNA-mediated 
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reduction of covalent probes.  For MB that is covalently attached by a flexible alkane 
linkage to the distal end of the DNA, a redox signal is observed for low ionic strength 
conditions that permit intercalation of the tethered MB into the duplex (43).  However, in 
a high salt environment that discourages intercalation, no redox signal for MB is 
observed despite its attachment to the DNA (43).  This result mirrors the ionic 
dependence of the DNA-mediated reduction of freely diffusing MB and again highlights 
the importance of the direct electronic connection between the redox probe and the π-
orbitals of the stacked DNA bases for DNA CT to occur; intercalation is still required for 
reduction of the covalent MB probe as the σ-bonds of the alkane linkage alone do not 
provide this electronic connection.     
Intercalation is not the only mechanism by which to establish this electronic 
coupling to the π-stack.  In a study that investigated different linkages to covalently 
attach the redox probes anthraquinone (AQ) or 2,2,6,6-tetramethylpiperidine 1-oxyl 
(TEMPO) directly to a modified uridine base, rigid acetylene linkages allowed for the 
DNA-mediated reduction of both probes that was sensitive to the incorporation of 
mismatches (32).  In contrast, alkane linkages for both probes resulted in significantly 
weaker redox signals that were not influenced by mismatches.  In these cases, although 
the acetylene holds the probe rigidly away from the DNA and prevents interaction 
directly with the base stack, this conjugated linkage still provides a connective path that 
electronically couples the probe to the base stack.  The alkane linkages do not create this 
electronic conjugation and, in contrast to the previous example with MB, do not 
structurally allow for direct interaction between the redox probe and DNA π-stack.  These 
examples illustrate an added level of complexity to the use of noncovalent probes in 
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measuring DNA CT processes: the covalent linkage now functions as the critical 
gatekeeper that can either promote or prevent the redox probe from achieving a CT-active 
conformation.  In addition to MB, AQ, and TEMPO, the linkages and conditions 
necessary for the DNA-mediated reduction of a variety of other covalent redox-active 
moieties have been described including daunomycin (13, 16, 19, 33), disulfide bonds 
(46), Redmond Red (47), and Nile Blue (9, 10, 14) (Scheme 1.1).   
 Covalent tethering of the redox probe makes it possible to use this platform for 
more detailed, fundamental characterization studies of DNA CT.  The directionality of 
the mismatch effect on DNA CT was clearly established; incorporation of a C∙A 
mismatch in the DNA between the gold surface and a covalent daunomycin probe causes 
significant signal attenuation, while the reverse case, in which the mismatch is located 
above the daunomycin relative to the surface, shows no signal attenuation (33).  The 
incorporation of nicks in the sugar-phosphate backbone of the duplexes that make up the 
DNA-modified electrodes causes no signal attenuation of a covalent daunomycin probe 
(16).  In contrast, the incorporation of a single base mismatch causes significant signal 
attenuation for both intact and nick-containing DNA, again illustrating that DNA CT 
propagates through the stacked base pairs, not the sugar-phosphate backbone (16). 
 Additionally, covalent tethering opens the door for ground state distance 
dependence studies of DNA CT that are not possible in solution platforms or with 
noncovalent electrochemistry.  Initial experiments in this area demonstrated that the 
covalent placement of daunomycin at different positions along a 15-mer duplex (50 Å) 
does not influence the signal intensity or splitting of the cathodic and anodic peaks as 
measured by cyclic voltammetry (33).  For DNA CT over similar DNA distances, the 
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contribution of the alkanethiol tether that attaches the DNA to the gold electrode on the 
rate of DNA CT was investigated and it was determined that the number of methylene 
units in the tether absolutely dominates the observed CT rate (19).  These results echoed 
the shallow distance dependence that had been observed in solution experiments.  
Extension of DNA-modified electrodes from single electrodes to multiplexed chips 
(chapter 2) allowed for the more complex experiments and precise side-by-side controls 
that are needed for reliable measurements of DNA CT over very long distances (9).  
Using this multiplexed platform, a shallow distance dependence for DNA CT over 100 
base pairs (340 Å) to a covalent Nile Blue redox probe was measured (chapter 3) (10). 
The use of covalent probes eliminates concern about direct surface reduction of 
freely diffusing probes, making it possible to use low density DNA films and expand this 
platform to biosensing applications, such as the detection of nucleic acid hybridization 
and protein binding, which require spatial access to the surface-tethered DNA duplexes.  
In developing this technology for the electrochemical detection of DNA-binding proteins 
and their activity, proteins that perturb the DNA π-stack upon binding were found to 
cause a dramatic attenuation in the DNA-mediated signal of the distally attached redox 
probe (13, 14).  This effect was sensitively measured for the DNA methyltransferase 
HhaI and uracil-DNA glycosylase (UDG), which both flip a base out of the DNA base 
stack upon binding, as well as the TATA-binding protein (TBP), which kinks the DNA 
by 90°.
  
  Proteins that do not bind DNA, such as BSA, or proteins that bind but do not 
distort the DNA, such as the PvuII restriction enzyme bound to its methyl-protected 
restriction site, do not cause this signal attenuation.   
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As an important and informative control, the effect of binding by wild-type HhaI 
and the mutant Q237W of HhaI was compared (13).  Wild-type HhaI inserts glutamine 
237 into the DNA base stack to flip out the target base, and this disruption of the DNA 
CT path results in significant signal attenuation of the redox probe.  However, binding by 
the Q237W mutant of HhaI results in only minimal attenuation of the redox signal.  In 
this case, the Q237W mutant inserts tryptophan into the base stack instead of glutamine, 
and this aromatic, heterocyclic amino acid fills the place of the flipped base in the π-
stack, restoring the DNA-mediated flow of charge to the probe (13).  This control 
underscores the central role of the stacked DNA bases in forming a conduit for DNA CT.  
Building on these initial studies, work toward the multiplexed, electrochemical detection 
of human methyltransferases has been performed (chapters 5 and 6).  This work is aimed 
at the development of clinical assays for methyltransferase activity that may be used for 
cancer screening and drug development. 
 
Proteins as Redox Probes 
 Small molecules are not the only redox-active players that can participate in DNA 
CT.  The DNA-bound potentials of numerous proteins with redox-active cofactors, such 
as [Fe-S] clusters, may be measured with the DNA-modified electrode platform.  For 
these experiments, electrodes are assembled with DNA that is modified only with a thiol 
tether; upon protein binding, redox-active cofactors within the protein that are well 
coupled to the DNA π-stack serve to report a DNA-mediated CT signal (48).  Like small 
molecule redox probes, the integrity of the DNA π-stack is critical for strong 
electrochemical signals from these proteins; the incorporation of intervening abasic sites, 
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lesions, or mismatches in the DNA-modified electrode significantly attenuate the redox 
signal (48-50). 
Such biologically integrated redox probes can be used to monitor protein activity 
that involves the coupling of the redox cofactor to the π-stack.  For example, the flavin 
cofactor of the light-activated DNA repair enzyme photolyase can be used to 
electrochemically monitor this protein as it binds and repairs pyrimidine dimer lesions 
(49).  Upon initial binding of photolyase to thymine dimer-containing DNA, a weak 
signal from the flavin cofactor is observed due to the destacked lesion that disrupts DNA 
CT and inhibits proper coupling of the flavin cofactor to the π-stack.  Upon 
photoactivation, the redox signal gradually increases as photolyase repairs the thymine 
dimer and restores efficient DNA CT to the flavin cofactor.  Following this, the redox 
signal gradually disappears as the protein dissociates from the now repaired DNA. 
The profound ramifications of strong coupling to the DNA π-stack are perhaps 
best illustrated by extensive work with the [4Fe-4S] cluster-containing base excision 
repair enzymes MutY, EndoIII, and AfUDG (48, 50-53).  In electrochemical studies of 
these proteins, DNA-modified electrodes are essential for measuring relevant DNA-
bound potentials (51).  Electrochemical studies of EndoIII on bare graphite electrodes 
and DNA-modified graphite electrodes reveal that DNA binding shifts the redox potential 
of the [4Fe-4S]
2+/3+
 couple by >200 mV and stabilizes the [4Fe-4S]
3+
 state, thereby 
converting the cluster into a form that is redox-active under physiologically relevant 
conditions (51).  Importantly, the redox state of the cluster influences the binding affinity 
of EndoIII for DNA, and in this way, long-distance, DNA-mediated redox of the cluster 
can influence protein binding and localization (52). 
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 Multiple experiments following this observation support a model in which this 
coupling and DNA-mediated redox activity is essential for the search process that these 
proteins undertake to efficiently locate and repair damage in the genome (52).  Proteins 
that are well coupled to the DNA π-stack and thus can access DNA CT have the capacity 
to participate in long distance, DNA-mediated signaling to coordinate search efforts and 
promote the localization of repair proteins around sites of DNA damage.  An 
electrochemical study of EndoIII variants with mutations around the [4Fe-4S] cluster 
clearly illustrates this model (53).  Mutants that exhibit large electrochemical signals and 
are thus well coupled to the DNA are also proficient at localizing near DNA damage, as 
observed by atomic force microscopy.  On the other hand, EndoIII mutants that exhibit 
small electrochemical signals, and thus poor coupling to the DNA, do not localize near 
mismatches.  Thus, the degree of coupling of the [4Fe-4S] cluster to the π-stack relates 
directly to the ability of the protein to utilize DNA CT for long-distance signaling to 
locate and respond to DNA damage.  These exciting experiments are just the beginning 
of work that suggests a critically important role for DNA CT as a signaling mechanism to 
coordinate complex biological processes.   
 
Carbon Nanotube-DNA Devices  
Conductivity measurements of single molecules allow for an understanding of the 
fundamental electronic properties of these molecules that cannot be achieved through 
bulk platforms (54).  However, the study of single molecule, ground state, DNA 
conductivity presents a significant challenge that is clearly foreshadowed by observations 
from bulk solution and electrochemical experiments; the nature of the electrical 
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connection to the DNA and the integrity of the π-stacked duplex structure are critical to 
make meaningful conductivity measurements.  Most initial experiments of single or few 
molecules of DNA by others utilized platforms with inconsistent or poorly defined 
electrical connections, and the DNA was not maintained in an aqueous, undamaged state.  
Not surprisingly, these experiments measured a full range of electrical behavior for DNA 
from insulating to semiconducting to conducting (55-58). 
Experiments using AFM (59) and STM (41, 60, 61) of DNA films provided more 
consistent measurements as these methods involve better defined electrical connections 
for the DNA duplexes and allow measurements to be taken under aqueous conditions.  
Measurements from these experiments included low resistances for well matched DNA 
and increased resistance with a single base mismatch.  However, since at least dozens of 
molecules can make contact with the probing tip in these experiments, these platforms 
did not allow for truly single molecule measurements of DNA conductivity.   
Carbon nanotube (CNT)-based devices provide a platform that has well defined 
electrical contacts and has previously been used to measure the electrical properties of a 
variety of small molecule molecular bridges (54, 62).  To fabricate CNT-DNA devices, 
CNTs are grown on silicon wafers and metal source and drain electrodes are patterned 
over them to incorporate them into electrical circuits.  Ultra high resolution electron beam 
lithography is then used to cut gaps of defined width in the CNTs.  This method of 
cutting results in carboxylic acid functionalization at each terminus of the CNT gap, such 
that amine-modified DNA can be reacted to bridge the gap covalently.  The width of the 
gap can be tuned to fit different lengths of DNA precisely.  Importantly, these devices are 
compatible with an aqueous environment for DNA, and the similar diameter of the CNT 
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and DNA duplex restricts covalent attachment to a single duplex within the gap.  The 
source-drain current of these DNA-bridged devices can then be measured as a function of 
gating voltage to characterize the conductivity of the DNA relative to the un-cut device.   
 
Single Molecule Measurements of DNA Conductivity 
 Using these DNA-CNT devices, the resistance of DNA duplexes 6 nm in length 
was measured as 0.1–5 MΩ (11).  Importantly, this range encompasses the resistance 
value (~ 1 MΩ) that would be expected through layered sheets of graphite of similar 
dimensions (11).  Thus, this platform makes it possible to validate the initial postulate of 
DNA conductivity by Eley and Spivey, that the π-stacked bases of DNA might conduct 
charge in the same way as the structurally similar stacked π orbitals of graphite sheets (3).  
The covalent attachment of both 5ʹ and 3ʹ ends of one strand of the duplex within 
the CNT gap yields a robust device to which different, noncovalent, complementary 
strands may be hybridized.  In this way it is possible to cycle between resistance 
measurements of matched and mismatched duplexes on the same device (Figure 1.5).  
Such experiments show that charge flow through these devices is exquisitely sensitive to 
the introduction of a variety of single base mismatches, with resistances increasing ~300-
fold upon hybridization of a mismatched strand (11).  These devices are also readily 
recognized and cut by a restriction enzyme, which also shuts off the conductivity of the 
device.  This sensitivity to mismatches and restriction activity, which mirror results seen 
with solution and electrochemical platforms, shows that resistance measurements are 
indeed from DNA CT through single duplexes that adopt biologically relevant 
conformations.  
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Figure 1.5  Single molecule experiments illustrate the sensitivity of DNA CT to 
mismatches.  Left illustration: DNA CT is measured in a single DNA duplex that 
covalently bridges a gap in a carbon nanotube device.  One strand (blue) is covalently 
attached by its 3ʹ and 5ʹ ends while the other strand can be freely exchanged between well 
matched complements (orange) and strands that introduce a single base mismatch (green, 
purple).  Right plot: the source-drain current (ISD) measured at the gating voltage VG = -3 
V is shown for the series of well matched and mismatched strands in the device.  The 
colors and numbers of the points in the series correspond to the different strands in the 
left illustration.  Clearly, current through the device is cut off in duplexes that contain a 
single base mismatch and restored when the bridging DNA strand is re-hybridized with 
its well matched complement.   
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Building on these studies, this single molecule platform has now been used to 
measure the distance dependence of DNA CT as well as detect the binding and activity of 
SssI methyltransferase (chapter 4) (15).  Initial resistance measurements of single DNA 
molecules of varying length suggest agreement with the shallow distance dependence 
measured in solution and on electrochemical surface platforms.  Experiments with SssI 
methyltransferase also mirror results from electrochemical surface platforms: the binding 
and base-flipping action of SssI shuts off current flow through the device in a manner that 
is sequence-specific, cofactor-dependent, and reversible (15). 
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Summary 
 Studies of DNA CT with photooxidation, spectroscopy, and electrochemistry, in 
solution, on surfaces, and with single molecule techniques, and using a variety of donors 
and acceptors have established a solid, experimentally-based foundation to understand 
this chemistry.  These complementary vantage points are collectively valuable as they 
serve to validate shared characteristics and cast light on pieces of the DNA CT puzzle 
that are only visible from a particular experimental platform.  Despite the diversity of 
platforms employed, a common set of characteristics for CT processes that are mediated 
by DNA have been consistently observed.  Namely, the electronic coupling of the donor 
and acceptor to the π-stack of DNA is required to access DNA CT.  The CT itself is 
highly sensitive to the structural integrity of the stack of bases between the donor and 
acceptor pair.  For donors and acceptors that are well coupled to structurally undisturbed, 
undamaged DNA duplexes, the DNA can mediate CT that is rapid and has an extremely 
shallow distance dependence which allows this process to efficiently occur over very 
long distances.  Additionally, this rapid rate is gated by the dynamic motions of the bases, 
donor, and acceptor as they move in and out of CT-active conformations. 
 Despite these consistent observables, a mechanism for DNA CT is still not well 
defined.  DNA CT clearly does not fit within the bounds of either superexchange or 
hopping models.  Experiments suggest that transient delocalization of charge across 
multi-base domains must necessarily play an important role.  Given the dynamic and 
structural complexity of the DNA molecule and the variability introduced by different 
sequences, donors, and acceptors, it is likely overly restrictive to confine this process to a 
single mechanistic description.  Instead, as we continue to shed light on DNA CT from 
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diverse experimental viewpoints it will be important to validate known characteristics 
and integrate new observations into a mechanistic understanding that is consistent with 
the complexity of this process. 
 The thesis work described here utilizes DNA CT chemistry and builds upon the 
strong foundation that has been established by these solution, surface, and single 
molecule platforms.  Chapter 2 describes the extension of the DNA-modified electrode 
platform to a multiplexed format that opens the door for more complex experiments with 
side-by-side controls.  This multiplexed platform is put to use in Chapter 3 for the ground 
state measurement of DNA CT over 34 nm (100 base pairs).  Chapter 4 describes single 
molecule work with CNT-DNA devices to also evaluate DNA CT over increasing 
distances, as well as detect SssI methyltransferase binding and activity.  Finally, Chapters 
5 and 6 describe the development of the multiplexed, DNA-modified electrode platform 
for biosensing, both for the general detection of DNA-binding proteins and specific 
detection of methyltransferase activity.   
 This body of work reflects the current direction of studies on DNA CT chemistry 
that extends from a fundamental, multifaceted understanding of this complex process.  
This exciting trajectory is propelled by what was learned from the question “How does 
DNA CT work?” toward new lines of inquiry: How does biology utilize DNA CT to 
coordinate proteins in their efforts to meet complex cellular challenges?  How can we 
utilize the unique conductive properties of DNA CT in the development of nanoelectronic 
and biosensing devices?  What we have already learned about DNA CT indicates that the 
pursuit of these questions is a promising investment for the further elucidation and 
application of this exquisitely sensitive chemistry. 
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Multiplexed DNA-Modified Electrodes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from Slinker, J. D., Muren, N. B., Gorodetsky, A. A., and Barton J. K. (2010)  
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J.D. Slinker and N.B. Muren developed and fabricated multiplexed chips, prepared DNA, 
and performed multiplexed electrochemistry experiments.  A.A. Gorodetsky assisted with 
chip development and performed electrochemistry on conventional rod electrodes. 
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Introduction 
Multiplexed detection of biomarkers, such as DNA, RNA, and proteins, is of 
utility for laboratory assays as well as clinical and point-of-care disease diagnostics (1–
4).  Toward these ends, electrical and electrochemical devices are under development for 
biosensing applications, offering low cost, portability, and multiplexed capability (5–7).  
Carbon nanotubes (8, 9), functionalized nanowires (10–12) and nanoparticles (13), 
aptamers (14, 15), and redox or impedance schemes involving DNA (16–25) or other 
mediators (26) have all served as electrical and electrochemical biosensing platforms. 
However, despite this proliferation of electrical biosensors, few examples of multiplexed 
molecular diagnostics have been reported (12, 16, 18–21).  Furthermore, still fewer 
electrical sensors have the sensitivity to distinguish single base mismatches within 
nucleic acid targets, and many are not suitable for sensing DNA-binding proteins.  The 
electrochemical format we describe here offers robust, label-free, and sensitive detection 
in these applications, and is now multiplexed.   
Electrochemical detection by DNA-mediated charge transport (DNA CT) is an 
emerging technology for clinical diagnostics and laboratory assays, showing great 
promise for sensitive and selective recognition of DNA and protein targets (27–41).  
Numerous studies have established that well-ordered, fully base-paired DNA facilitates 
electronic charge transport through the DNA π-stack over long distances, but that 
disruption of the base pair stack, such as by mismatched bases or bending of the duplex 
by proteins, greatly attenuates charge transport (27–29, 41–45).  Due to this sensitivity to 
perturbation, DNA CT electrochemistry can be used to distinguish between targets with 
single base mismatches (27, 28) and subtle base lesions (35).  Additionally, 
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electrochemistry through DNA monolayers and molecular junctions has been utilized for 
sensitive and selective detection of DNA (27, 28, 34–36, 41) and DNA binding proteins 
(29, 30, 32, 33, 38, 40, 41).  Since DNA serves as a natural and specific recognition 
element for DNA-binding proteins, protein sensing by DNA CT makes use of DNA as 
both the recognition element and transducer.  The result is a rational, sensitive, and 
selective platform that can be easily modulated to specifically detect a variety of 
unlabeled proteins.     
Here we describe the fabrication and application of 16-electrode silicon chips 
with DNA-modified electrodes (DME chips) employing DNA-mediated electrochemistry 
for multiplexed detection of DNA and DNA-binding protein targets (Figure 2.1).  Four 
DNA sequences may be interrogated simultaneously on one DME chip with four-fold 
redundancy, allowing for more meaningful comparisons and controls to be run side by 
side on the same gold surface.   DME chips were used to demonstrate sensitivity to single 
base mismatches and electrochemically monitor sequence-specific DNA cleavage by the 
restriction enzyme AluI.  The quality of monolayer formation was investigated by 
statistical comparison of DME chips to commercially available rod electrodes, and the 
sizes of the working electrodes on the DME chips were scaled to investigate 
microelectrode effects.  These experiments show that DME chips facilitate sensitive and 
selective detection of DNA and DNA-binding protein targets, and make it possible to 
utilize DNA CT in more complex experiments and applications. 
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Figure 2.1 Design of the DME chip.  Top left: a DME chip with sixteen 2 mm
2
 gold 
working electrodes shown with a conventional 2 mm
2
 gold rod electrode.  Top right: the 
DME chip in a testing mount with a clamp that splits the chip into four quadrants of four 
electrodes and forms a well for a common buffer solution.  Electrical contact is made to 
the chip with spring contact probe pins that are secured into contact with the chip by the 
thumb screws.  Bottom center: side-view illustration of one electrode in a fully-
assembled DME chip. The working electrode area is defined and separated from the 
contact area by the SU-8 insulating layer. The solution of interest is confined over the 
chip by the well, and external reference and counter electrodes complete the circuit. 
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Materials and Methods 
Materials 
All standard and modified phosphoramidites were purchased from Glen Research.  
Nile Blue perchlorate (laser grade) was purchased from Acros.  All other chemicals for 
the preparation of buffers and DNA-modified electrodes were purchased from Sigma-
Aldrich and used as recieved.  Silicon wafers were purchased from Silicon Quest and 
reagents for DME chip fabrication were purchased from Microchem.  AluI was purchased 
from New England Biolabs and stored at -20°C.  Prior to use, aliquots were exchanged 
into tris buffer containing 50 mM Tris-HCl, 10 mM EDTA, and 10 mM MgCl2, pH 7.8, 
using a Pierce Slide-A-Lyzer mini dialysis kit at 4°C with overnight stirring. 
 
DNA Sequences 
For experiments on the isolation of DNA with different probes, electrodes were 
modified with the sequence 5ʹ-HS-(CH2)6-ACTTCAGCTGAGACGCA-3′ with a 
Redmond Red-modified, Nile Blue-modified, or unmodified complement.  Redmond Red 
complements were modified on the 3′ terminus while Nile Blue complements were 
modified on the 5ʹ terminus.  To introduce a single base mismatch, a Nile Blue 
complement was prepared with an A opposite the italicized C in the sequence above.  
Well matched Nile Blue-modified DNA of this sequence was also used for 
microelectrode experiments and in AluI restriction experiments as the DNA substrate 
with the AluI restriction site (5ʹ-AGCT-3′), which is underlined in the above sequence.  
For the DNA substrate without the AluI restriction site, the sequence 5ʹ-HS-(CH2)6-
GAGATATAAAGCACGCA-3′ was utilized.  Although this sequence does not contain 
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the specific AluI restriction site, it does contain a pseudosite that differs by one base (5ʹ-
AGAT-3′) which is underlined.  This Nile Blue-modified 17-mer without the AluI site 
was also used for the comparison of DME chips and conventional rod electrodes.        
 
DNA Synthesis 
DNA was synthesized by standard methods on solid supports using an Applied 
Biosystems 3400 DNA synthesizer.  For thiolated strands, the 5′ end was modified with a 
Thiol Modifier C6 S-S phosphoramidite.  DNA modified with Redmond Red on the 3′ 
terminus was prepared on Epoch Redmond Red CPG columns with ultramild 
phosphoramidites and reagents.  DNA for Nile Blue coupling was prepared with 
ultramild phosphoramidites and a NHS-carboxy dT phosphoramidite at the 5ʹ terminus.  
To prepare the Nile Blue-coupled DNA, the DNA on the solid support was reacted with a 
10 mg/mL solution of Nile Blue perchlorate in 9:1 dichloromethane/DIEA solution for 
approximately 24 hrs. Excess reagents were then removed by washing with 
dichloromethane, methanol, and acetonitrile.  Unmodified and thiolated DNA was 
cleaved from the solid support and deprotected by treating with concentrated ammonium 
hydroxide for 8 hrs. at 60 °C.  Redmond Red- and Nile Blue- modified DNA strands 
were cleaved from the support and deprotected according to ultramild conditions with 
0.05 M potassium carbonate in methanol at ambient temperature for 8 hrs. 
 
DNA Purification 
Oligonucleotides were purified by high performance liquid chromatography 
(HPLC) on a reversed phase C-18 column (Agilent).  Following HPLC purification of the 
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products, the DNA was treated to remove the dimethoxytrityl (DMT) protecting group.  
For thiolated DNA, the disulfide of the thiolated linker was reduced to the free thiol in 
100 mM dithiothreitol in 100 mM Tris-HCl buffer pH 8.3 at room temperature for 45 
minutes.  The DMT group was removed from the unmodified, Nile Blue, and Redmond 
Red DNA strands by treating with an 80% solution of glacial acetic acid for 20 min, 
followed by quenching of the reaction with an excess of ethanol. All oligonucleotides 
were then dried and purified with a second round of HPLC.  The products were 
characterized by HPLC, matrix assisted laser desorption ionization time-of-flight mass 
spectrometry, and UV-visible (UV-vis) spectrophotometry.   
All DNA was subsequently desalted and quantified by UV-vis spectrophotometry 
according to their extinction coefficients (IDT Oligo Analyzer). Duplexes were formed 
by thermally annealing equimolar amounts (50 µM) of complementary oligonucleotides 
at 90 °C for 5 min in deoxygenated phosphate buffer (5 mM phosphate, 50 mM NaCl, pH 
7) followed by slow cooling to ambient temperature. 
 
DME Chip Fabrication 
One millimeter thick Si wafers with a 10,000 Å thick oxide layer were used for 
DME chip fabrication.  Chips were patterned in a two-layer process. In the first layer, the 
gold electrodes were deposited by a lift-off technique. For the second layer, SU-8 
photoresist was patterned as an insulator isolating the gold working electrode areas from 
the contact pads.  First, wafers were cleaned thoroughly in 1165 Remover and vapor 
primed with hexamethyldisilizane (HMDS).  SPR 220 3.0 photoresist was spin-cast at 
4000 rpm and baked.  The photoresist was patterned with a Karl Suss MA6 contact 
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aligner and a chrome photomask.  Following postexposure baking, wafers were 
developed in AZ 300 MIF developer for 1 min and rinsed thoroughly with deionized 
water.  A 15 Å Ti adhesion layer and a 1000 Å Au layer were deposited on the chips with 
a CHA Mark 50 electron beam evaporator.  Wafers were then immersed in 1165 
Remover overnight and sonicated as needed to complete metal lift-off.  Subsequently, the 
wafers were thoroughly baked and cleaned by UV ozone treatment.  SU-8 2002 was spin-
cast at 3000 rpm, baked, and photopatterned as above.  Wafers were developed in SU-8 
Developer for 1 min and baked for a permanent set of the photoresist.  The wafers were 
subsequently diced into 1-in. by 1-in. chips by hand with a diamond scribe and stored 
under vacuum until use. 
 
Preparation of DNA Monolayers  
Immediately prior to DNA monolayer assembly, gold surfaces were cleaned by 
sonication for 15 min in acetone and 5 min in 2-propanol, followed by treatment with UV 
ozone for 3 min. Multilevel wells were placed over the chip, defined by a custom-made 
Viton rubber gasket and a polypropylene clamp secured by screws to a test mount, 
providing a compression seal over the chip (Figure 2.1).  This allowed for application of 
up to four distinct sequences of 25 μM duplex DNA solutions in phosphate buffer with 
100 mM MgCl2 added. Monolayer formation was allowed to proceed in a humidified 
environment for a period of 16-20 hrs.  Upon completion of film formation, the cell was 
backfilled with 0.5 mM 1-mercaptohexanol in a 5% glycerol solution in phosphate buffer 
for 60 min. The electrodes and cells were rinsed thoroughly prior to electrochemistry 
experiments to ensure removal of residual 1-mercaptohexanol. 
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Electrochemical Analysis 
Cyclic voltammetry (CV) experiments were performed by automated 
measurement with a CH760B Electrochemical Analyzer and a 16-channel multiplexer 
module (CH Instruments).  The chips were interfaced with these instruments with a 
custom-built device mount bearing springloaded probe pins.  Chips were tested with a 
common Pt auxiliary electrode and a common silver/silver chloride (Ag/AgCl) reference 
electrode.  Alternatively, reference and counter electrodes can be patterned on the chip 
surface, though including other metals for a stable reference would increase the 
complexity of chip fabrication.  Electrochemistry was recorded at ambient temperature in 
either phosphate buffer supplemented with 4 mM MgCl2, 4 mM spermidine, 50 μM 
ethylenediaminetetraacetic acid (EDTA) and 10% glycerol at pH 7.0 or Tris buffer 
containing 50 mM Tris-HCl, 10 mM EDTA, and 10 mM MgCl2, at pH 7.8. Electron 
transfer kinetics were obtained by Laviron analysis (46). 
 
 
Electrochemical Measurement of Restriction Activity 
For the preparation of DME chips to measure restriction activity, MgCl2 was 
excluded from the DNA assembly solution in order to produce a lower density monolayer 
and grant greater access to the restriction enzyme.  Dialyzed AluI in Tris buffer was 
titrated onto the chip with test concentrations ranging from 0–50 nM (0–2000 units/mL).  
The reaction was allowed to equilibrate at each point of the titration for approximately 30 
min. before scanning the chip.  The integrated CV peak areas were recorded at each 
concentration  
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Results and Discussion 
Design of DME Chip and Testing Assembly  
Figure 2.1 shows a DME chip with 16 macroscale, 2 mm
2
 gold working 
electrodes for multiplexed analysis.  The DME chips are designed as a multiplexed 
extension of a conventional 2 mm
2
 commercially available rod electrode, which is also 
shown for comparison in Figure 2.1.  Each chip is patterned with four quadrants of four 
electrodes each so that four distinct DNA sequences can be simultaneously tested with 
four-fold redundancy.  Isolation of the quadrants is accomplished with a gasket and 
clamp assembly having four shallow wells surrounded by a larger well. The shallow 
wells, each with a maximum volume of approximately 25 μL, are used for deposition of 
different DNA solutions to form distinct monolayers, while the larger well, with 
minimum and maximum working volumes of 150 and 600 μL, respectively, enables all 
16 electrodes to share a common analyte solution as well as common reference and 
counter electrodes.   
The active area of each working electrode of the DME chip is defined by the SU-
8 layer.  Each working electrode is connected to a square contact pad on the periphery of 
the DME chip.  These contact pads are connected to a computer-controlled multiplexer 
module and electrochemical analyzer through spring contact probe pins on a testing 
mount secured with thumb screws.  This allows for rapid electrical connection and 
interchange of each DME chip.  In this configuration, multiplexed electrochemical testing 
of all 16 electrodes could be performed sequentially with common reference and counter 
electrodes. 
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Multiplexed Detection of Diverse DNA Types 
Multiplexed electrochemical analysis of four types of DNA with different redox 
signatures was accomplished with the DME chip.  The analyzed 17-mers share the same 
sequence but are distinct in either the choice of redox probe or the inclusion of a 
mismatch.  The redox probes Nile Blue and Redmond Red were used as they have been 
previously demonstrated for sensitive detection of proteins (40) and abasic sites (47), 
respectively.  As illustrated (Figure 2.2), these DNA substrates include (i) a well matched 
duplex with a proximal 3′ Redmond Red redox probe (48), (ii) a well matched duplex 
with no redox probe, (iii) a well matched duplex with a distal 5′ Nile Blue redox probe, 
and (iv) a duplex modified with a 5′ Nile Blue redox probe and containing a single base-
pair (CA) mismatch. The choice of these four diverse DNA types illustrates the versatility 
of the detection technique, the generality of redox probes used, the selectivity to specific 
DNA sequences, and the ability to isolate four monolayers with fidelity on the chip. 
The CV data resulting from these four DNA monolayers are shown in Figure 2.2. 
The monolayer prepared with well matched, Nile Blue-modified DNA gives a large CV 
peak area of 5.2 nC at -320 mV versus an Ag/AgCl reference (cathodic wave). Similarly, 
the well matched monolayer with a Redmond Red redox probe exhibits a large CV peak 
area of 6.2 nC located at the distinct potential of -340 mV (cathodic wave). These results 
reveal that high density DNA monolayers can be prepared on DME chips. In contrast, the 
monolayer prepared with a well matched complementary strand containing no redox 
probe shows no discernible CV peak, highlighting that no cross-contamination of the 
monolayers occurs between DME chip quadrants.   
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Figure 2.2 Multiplexed measurement of four different DNA types on a DME chip.  Left: 
illustration of a DME chip modified with four DNA types with distinct redox signatures 
including (clockwise from top left): a well matched strand with a proximal 3′ Redmond 
Red probe, a well matched strand with no redox probe, a 5′ Nile Blue-labeled strand 
containing a single base-pair (CA) mismatch, and a well matched strand with a distal 5′ 
Nile Blue redox probe.   All DNA was composed of the same thiolated strand: 5ʹ-HS-
(CH2)6-ACTTCAGCTGAGACGCA-3′, where the italicized C is the location of the CA 
mismatch.  Right: CV data for each DNA type with plot orientation corresponding to the 
chip illustration.  The potentials are reported versus Ag/AgCl with a CV scan rate of 100 
mV/s, and each curve represents an average over the four electrodes in each chip 
quadrant. 
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It has previously been demonstrated that DNA-modified electrodes which report 
DNA CT redox processes can be used to distinguish single base mismatches and other 
subtle lesions due to distortion imposed on the DNA base pair π-stack (27, 28, 35).  
Notably, the CV signals on DME chips are significantly attenuated for electrodes 
modified with the Nile Blue 17-mer that contains a single CA mismatch.  The CV peak 
area from these mismatched duplexes was 1.9 nC (cathodic wave), a factor of 2.7 lower 
than that found for the well matched complement.  Thus, DME chips support probe 
reduction by a DNA CT pathway and can thus be used for precise discernment of specific 
DNA and RNA targets, even distinguishing single base mismatches.  Note that here DME 
chips provide a direct measurement of mismatch discrimination, as both well matched 
and mismatched films are formed under identical experimental conditions and the 
comparison may be made side-by-side within the same experiment. 
Overall, three DME chips were prepared identically to that of Figure 2.2.  The 
ratios of integrated charge for well matched to mismatched Nile Blue strands across these 
three chips were 2.8 and 3.1 for the anodic and cathodic sweeps, respectively.  The 
variation in signal size (integrated cathodic peak ± standard deviation) among electrodes 
modified with the same type of DNA within a chip was 5.1 ± 1.6 nC for the well matched 
Nile Blue monolayer, 2.1 ± 0.1 nC for the mismatched Nile Blue monolayer, and 6.3 ± 
0.4 nC for the well matched Redmond Red monolayer.  Alternatively, the variation in the 
average integrated cathodic CV peak charge among three chips was 1.5, 1.0, and 3.0 nC 
for well matched Nile Blue, mismatched Nile Blue, and well matched Redmond Red 
monolayers, respectively. Thus, in general, the variation across a chip was smaller than 
that between chips.  DNA films on DME chips were found to be relatively stable under 
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storage at 4 °C.  For example, a chip stored for 24 days at 4 °C retained over 80% of the 
initial integrated charge, corresponding to an average signal loss of < 1% per day.   
Electron transfer kinetics from these monolayers were also estimated from the 
scan rate dependence of the cyclic voltammetry by Laviron analysis (46).  The electronic 
transfer rates were 4.2, 1.0, and 2.4 s
-1
, for well matched Redmond Red, well matched 
Nile Blue, and mismatched Nile Blue monolayers, respectively.  These values are 
comparable to estimates on similarly prepared monolayers on rod electrodes (49).  
Notably, there is little difference in the transfer kinetics between matched and 
mismatched DNA, suggesting the same CT mechanism for both sequences.   
It should be noted that our platform can be used for detection of unlabeled single-
stranded DNA targets.  To accomplish this, single-stranded DNA bearing the sequence 
complementary to the target is modified with a redox probe on one end and a thiol linker 
on the other end for assembly on the electrode.  Hybridization with the unlabeled target 
will complete the base pair π-stack and turn on the DNA-mediated redox signal. 
 
Monitoring Sequence-Specific Enzymatic Activity 
A major advantage of the multiplexed chip format over individual electrodes is 
the ability to measure protein-DNA binding activity with different DNA sequences on the 
same chip, thus exploring site-specific activity while preserving identical experimental 
conditions.  We demonstrate this capability by measuring the sequence-specific activity 
of the AluI restriction endonuclease, which cleaves at the restriction site 5′-AGCT-3′, 
leaving blunt ends between the G and C bases (Figure 2.3).  A DME chip was prepared 
with 17-mer Nile Blue modified DNA, where half of the electrodes were assembled with 
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Figure 2.3 Detection of sequence-specific restriction activity on a DME chip.  Top: 
Chips were modified on one half with the Nile Blue-modified 17-mer that lacks the AluI 
restriction site (left, blue) and the other half with the Nile Blue-modified 17-mer that 
contains the AluI restriction site (right, red).  AluI was titrated onto the chip and the 
restriction activity was monitored electrochemically.  Bottom: plot of measured signal 
size (normalized against the initial signal) versus AluI concentration for a DME chip 
modified with DNA with (Red) and without (Blue) the AluI restriction site.  Charge was 
obtained by integrating the cathodic Nile Blue CV peaks obtained at a 50 mV/s scan rate 
after equilibration of AluI activity at each concentration. 
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a sequence containing the AluI recognition site and the other half with a sequence lacking 
this site.  The AluI restriction enzyme was titrated onto the chip, and the integrated CV 
peak areas were recorded at each concentration.  The resulting plot of charge (normalized 
against the initial signal) versus AluI concentration is given in Figure 2.3.   
At low concentrations, there is a definitive drop in the integrated charge at the 
electrodes bearing the restriction site, while the charge from the electrodes without the 
site remains stable.  In contrast, for the DNA-modified electrode lacking the target site, 
there is virtually no drop in signal over this concentration range.  The threshold of AluI 
restriction activity for the sequence containing the restriction site was 400 units/mL, 
corresponding to a concentration of approximately 10 nM (50).  As the total sample 
volume was 250 μL, this corresponds to 2.5 pmol of enzyme per chip, or 160 fmol of 
enzyme per electrode.  At concentrations greater than 1600 units/mL (51) the charge at 
the electrodes lacking the restriction site decreases due to nonspecific restriction activity, 
also known as star activity.  In this case, the DNA without the consensus restriction site 
contains a pseudosite differing by only one base (5′-ATCT-3).  Thus, as expected at 
higher enzyme concentrations, restriction cleavage at this pseudosite is apparent.   
Several important implications arise from these observations.  Cleavage by the 
AluI restriction endonuclease requires that the DNA on these chips is in its native 
conformation and accessible to the protein.  The observation of sequence-specific 
cleavage indicates that protein detection with DNA-mediated electrochemistry is highly 
selective.  Also, by extension, incorporation of multiple DNA sequences with different 
protein binding characteristics on a single chip indicates that DME chips can serve as a 
robust platform to simultaneously monitor reactions on different oligonucleotides. 
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Finally, this assay requires only microliter volumes of low protein concentrations, 
making it competitive with alternative detection methods. 
 
Statistical Comparison of DME Chips to Rod Electrodes 
We have found that electrodes from DME chips exhibit performances superior to 
those of conventional, commercially available rod electrodes.  This is clearly revealed in 
the histogram of Figure 2.4, which compares the total charge obtained by integrating the 
cathodic CV peaks from Nile Blue-modified, 17-mer DNA monolayers prepared on DME 
chips and rod electrodes.  The average integrated charge value of 3.5 nC from the DME 
chips is nearly twice that of the 1.8 nC average obtained from rod electrodes, and the 
relative deviation is significantly lower, 0.5 versus 0.7.  This higher average integrated 
charge is indicative of higher surface density of DNA at the DME electrodes.  In 
addition, on average, fewer electrode failures (charge < 0.5 nC) were observed on the 
DME chips (6%) versus rod electrodes (25%).  Background noise is also much smaller 
for the DME chips, as they display a lower capacitive current (data not shown).  The 
higher overall signals, lower standard deviation, and better signal-to-noise ratio of the 
DME chips are clearly preferred for sensing and diagnostic applications. 
 
Microelectrodes 
In addition to macroelectrodes, we demonstrate that DME chips can be easily 
prepared with microelectrodes.  Microelectrodes exhibit a number of benefits for DNA 
and protein sensing such as high sensitivity, rapid kinetics, and lower sample volumes 
(18-20, 40, 52, 53).  By reducing the diameter of the SU-8 layer opening over each  
53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Statistical comparison of signal size on DME chips and conventional rod 
electrodes.  A histogram of the integrated charge from DNA monolayers on the 
electrodes of 9 DME chips (blue) and 15 rod electrodes (red). Both types of electrodes 
were modified with the same well matched Nile Blue-modified 17-mer: 5ʹ-HS-(CH2)6-
GAGATATAAAGCACGCA-3′.  The integrated charge was obtained by integrating the 
cathodic peak of the CV taken at a 50 mV/s scan rate.  For ease of comparison, integrated 
charges have been sorted according to the nearest half coulomb. Note that, on average, 
much higher signals and fewer failures (signals < 0.5 nC) are found for gold electrodes on 
DME chips. 
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electrode, DME chips with the gold layout of Figure 2.1 were patterned with circular 
working electrodes of 300, 56, and 10 μm diameters.  These electrodes were modified 
with the well matched 17-mer with a distally bound Nile Blue redox probe, and the CV 
curves for these electrodes at a 50 mV/s scan rate are given in Figure 2.5.   
For the 300 μm diameter working electrodes, the conventional macroelectrode 
surface-bound redox peaks associated with Nile Blue are visible at a midpoint potential 
of -220 mV vs Ag/AgCl.  However, for the 56 and 10 μm diameter electrodes, the CV 
curves are significantly altered from this conventional shape.  The 10 μm diameter 
electrodes exhibit the sigmoidal curves characteristic of microelectrode effects (52, 53).  
This result is similar to our previous work with individual microelectrodes, where 
microelectrode effects were observed for devices of 25 μm diameter or less (40).  This 
shape arises because ionic equilibration is achieved virtually instantaneously with the 
sweep of the voltage due to the small size of the electrode relative to the abundance of 
ions in the surrounding solution (52, 53).  As seen previously, the midpoint potential is 
shifted negatively by over 100 mV, while the limiting current and capacitive current are 
each higher by a factor of 5–6.  These increases may be due to more dense DNA 
monolayers and/or the presence of oxygen.  Alternatively, the 56 μm diameter electrodes 
yield a CV curve that is intermediate to the macroelectrode and microelectrode regimes. 
Microelectrode effects can thus be observed on DME chips, combining the benefits of 
high sensitivity and rapid equilibration to this multiplexed platform. 
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Figure 2.5 Electrochemistry of microelectrodes on DME chips.  Electrodes of 300 μm 
(top), 56 μm (center), and 10 μm (bottom) diameter were modified with a Nile Blue-
modified 17-mer on the same chip and averaged CV scans are shown for each.  The 
sequence for all DNA was: 5ʹ-HS-(CH2)6-ACTTCAGCTGAGACGCA-3′.  The potentials 
are reported versus Ag/AgCl with a CV scan rate of 50 mV/s, and each curve represents 
an average over four electrodes.  The 300 μm electrodes show the conventional surface-
bound macroelectrode redox peak, while the 10 μm electrodes show a sigmoidal CV 
curve, reflecting microelectrode effects.  
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Summary and Conclusions 
We have developed a multiplexed DME chip platform that employs DNA CT 
chemistry for the sensitive, electrochemical detection of DNA and DNA-binding protein 
targets.  Four electrochemically distinct types of DNA were simultaneously distinguished 
on a single DME chip with 4-fold redundancy, demonstrating the capacity of this 
platform isolate DNA monolayers for complex comparisons and controls on the same 
electrode surface.  Side-by-side analysis of well matched DNA and DNA with a single 
base mismatch showed significant signal attenuation of the mismatched DNA.  Thus 
DME chips support probe reduction by a DNA CT mechanism and as such, are highly 
sensitive and selective detection devices.   
DME chips also allow for the study of DNA-protein interactions and specifically 
here, sequence-specific restriction activity by AluI was measured on a single chip surface.  
Uniform signal sizes were measured among electrodes on the same chip, and in general 
these chips display larger, more consistent signals with less electrode failures than 
commercially available rod electrodes.  In addition to studies with macroelectrodes on 
DME chips, the working electrode areas on the chips were reduced to 10 μm to achieve 
microelectrode behavior that is useful for high sensitivity and rapid kinetic detection. 
DME chips thus offer a new and sensitive platform for the multiplexed, electrochemical 
detection of DNA and DNA-binding protein targets. 
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Introduction 
Extensive research has focused on charge transport (CT) through conjugated 
molecules in an effort to use these molecules as components in the construction of 
nanoscale circuits (1, 2).  Molecular wires provide a unique opportunity to study CT in 
one and two dimensions and are promising materials for electronic applications, such as 
optoelectronics, energy storage devices, logic circuits and sensors (3).  Thus, many 
efforts have been directed toward the fabrication of long, linear conjugated molecules for 
these purposes (1–9).  However, the synthesis of functional molecular wires is 
challenging, as these wires must have precisely defined, uniform lengths and 
functionalized terminal groups to bond to electrodes or electroactive moieties.  These 
requirements limit the effective length of the conjugated molecules to ~10–20 nm (1–9).  
Alternatively, DNA satisfies easily the synthetic requirements of molecular wires (2, 10, 
11).  Unlike other conjugated bridges and molecular monolayer assemblies, DNA 
synthesis is mastered to the point of automation.  The unique structure and directionality 
of DNA mean that modification of both the 3′- and 5′-DNA termini can be executed 
selectively and with high yield to endow it with a variety of functionalities.  Reaction 
products may be characterized precisely using mass spectrometry, measurements of 
melting behavior, and spectroscopy.   
The challenge that surrounds the use of DNA as a molecular wire, in contrast, 
arises not in the synthesis, but in obtaining consistent electrical properties from DNA.  A 
wide range of conductivities are reported, from insulating to superconducting (12–22).  
However, for those studies that utilized well characterized connections to the DNA and 
preserved the duplex conformation in buffered solution without damaging the bases, high 
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conductivities were achieved consistently (14, 19–22).  In our laboratory, recently we 
measured single molecule conductivities for 15-mer DNA duplexes that bridged a carbon 
nanotube gap, and we observed resistances through the stacked DNA bases comparable 
to those expected perpendicular to graphite planes (19).  Also, in these experiments 
attenuation in conductivity was seen in duplexes that contained a single base-pair 
mismatch, as expected from photophysical studies (23).  These studies and work by other 
groups have established that well ordered, fully base-paired DNA facilitates electronic 
CT through the DNA π-stack (19–30).   
Beyond the basic questions of conductivity, achieving long-range CT in DNA is 
particularly attractive because of its inherent biological recognition capabilities (10, 11) 
and its unmatched capacity to be patterned into precise, nanoscale shapes (31, 32), ideal 
for nanoelectronics such as integrated circuits and sensors.  The characterization of 
factors that govern DNA conductivity on scales of increasing length would not only 
facilitate the incorporation of DNA into complex nanoscale devices, but also its 
utilization for applications in biotechnology.  Solution-based photooxidation studies 
showed long-range oxidative DNA damage through DNA CT over 20 nm (26).  DNA 
electrochemistry provides a direct measure of ground-state CT through a well-ordered 
molecular assembly and is of great utility for electrical device applications (10, 33).  
However, efficient DNA CT through molecular assemblies over long distances has not 
been demonstrated, and electrochemical observation of DNA CT is limited typically to a 
range of 5 nm (15 base pairs) (10).  Here we probe CT through 34 nm DNA monolayers 
(100 base pairs) electrochemically. 
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Materials and Methods 
Materials 
All standard and modified phosphoramidites were purchased from Glen Research.  
Nile Blue perchlorate (laser grade) for coupling was purchased from Acros.  All other 
chemicals for the preparation of buffers and DNA-modified electrodes were purchased 
from Sigma-Aldrich and used as recieved.  The restriction enzyme RsaI was purchased 
from New England Biolabs and stored at -20°C.  Prior to use, an aliquot of RsaI was 
exchanged into Tris buffer containing 10 mM Tris, 50 mM NaCl and 4 mM spermidine, 
pH 8.0, using a Pierce Slide-A-Lyzer mini dialysis kit at 4°C with overnight stirring.  
Multiplexed chips were fabricated at Caltech as described previously (34). 
 
DNA Sequences 
Each 100-mer duplex was assembled from five single-stranded segments that 
were annealed to form the complete sequence 5ʹ-HS-(CH2)6-AGT ACT GCA GTA GCG 
ACG TCA TAG GAC ATC AGT CTG CGC CAT TCA TGA CAT ACG TAC GCA 
GTA GGT GAA TCG TGG CAG GTC AGT CAT GTA TAC TGC ACT A-3′.  The 5ʹ 
terminus opposite the thiol linker was modified with a covalent Nile Blue redox probe.  
For experiments with mismatched 100-mer duplexes, a single base-pair mismatch (CA) 
was incorporated primarily at the bold A in the sequence above.  For analysis of different 
mismatch locations, experiments were also carried out with a CA mismatch generated at 
the underlined bases.  The italicized bases 5′-GTAC-3′ mark the location of the RsaI 
restriction site.  The Nile Blue-modified 17-mer duplexes were prepared with the 
sequences 5ʹ-HS-(CH2)6-GA GAT ATA AAG CAC GCA-3′ for the 17-mer without the 
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Figure 3.1 Assembly of the well matched 100-mer DNA duplex.  The overall duplex is 
composed of five single stranded DNA segments.  The 73-mer (green) and 39-mer 
(brown) help to stabilize the duplex by pairing at a 12 base overlap region.  The positions 
of the RsaI restriction site and CA mismatch, both within the central 36-mer, are 
indicated. 
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Figure 3.2 Illustration of the DNA, with redox probe and linker structures, used to 
modify the electrodes.  Shown are (top to bottom) a well matched 17-mer, a well matched 
100-mer, a 100-mer with a single mismatched base pair, the six carbon alkanethiol linker, 
and the Nile Blue redox probe coupled through a uracil.  The green sections of the 100-
mer mark the approximate location of the RsaI restriction enzyme binding site, and the X 
notes the approximate location of the single CA mismatch, 69 bases from the thiolated 
end of the duplex. The asterisks on the sugar phosphate backbone of the 100-mers 
indicate the location of nicks. The specific sequences are given in the methods section. 
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RsaI binding site and 5ʹ-HS-(CH2)6-GA GAT ATA AAG TAC GCA-3′ for the 17-mer 
with the RsaI binding site (shown in italics).   
 
DNA Synthesis and Purification 
Oligonucleotides were synthesized on an Applied Biosystems 3400 DNA 
Synthesizer.  For thiolated strands, the 5′ end was modified with a Thiol Modifier C6 S-S 
phosphoramidite.  Thiolated DNA was cleaved from the solid support and deprotected by 
treating with concentrated ammonium hydroxide for 8 hrs. at 60 °C.  DNA for Nile Blue 
coupling was prepared with ultramild phosphoramidites and a NHS-carboxy dT 
phosphoramidite at the 5ʹ terminus.  Covalent Nile Blue coupling was carried out as 
described previously (34, 35).  Briefly, DNA on the solid support was reacted with a 10 
mg/mL solution of Nile Blue perchlorate in 9:1 dichloromethane/DIEA for approximately 
24 hrs, followed by washing with dichloromethane, methanol, and acetonitrile.  Nile 
Blue- modified DNA strands were cleaved from the support and deprotected according to 
ultramild conditions with 0.05 M potassium carbonate in methanol at ambient 
temperature for 8 hrs. 
Each single strand was purified by high-performance liquid chromatography 
(HPLC) on a reversed phase C-18 column (Agilent) with a 50 mM ammonium acetate 
buffer/acetonitrile gradient according to the reported protocol (34).  For the 73-mer 
strand, the HPLC column was heated to 40 °C to discourage the formation of a secondary 
structure.  Subsequently, the purified oligonucleotides were desalted and quantified by 
ultraviolet-visible spectrophotometry according to their extinction coefficients (IDT 
Oligo Analyzer).  Duplexes were formed by thermally annealing equimolar (50 μM) 
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amounts of oligonucleotides at 90 °C for five minutes in deoxygenated phosphate buffer 
(5 mM phosphate, 50 mM NaCl, pH 7) followed by slow cooling to ambient temperature.  
The integrity of each strand was verified by HPLC, matrix-assisted laser 
desorption/ionization time of flight mass spectrometry and ultraviolet-visible 
spectroscopy, and full hybridization and stoichiometry of double-stranded DNA solutions 
were confirmed through ultraviolet analysis of melting temperature. 
 
Preparation of DNA Monolayers and Electrochemical Analysis 
DNA monolayers were formed by assembly on chips bearing 16 gold electrodes 
described previously (34).  Each chip was prepared with up to four sequences of 25 mM 
duplex DNA solutions in phosphate buffer that contained 100 mM MgCl2.  Typically, 
monolayer formation was allowed to proceed in a humidified environment for a period of 
16–20 hours.  Upon completion of film formation, the cell was backfilled with 0.5 mM 1- 
mercaptohexanol in a 5% glycerol in phosphate buffer for 60 minutes.  The electrodes 
were rinsed thoroughly prior to the electrochemistry experiments to ensure removal of 
residual 1-mercaptohexanol.  Cyclic voltammetry (CV) scans were performed by 
automated measurement with a CH760B Electrochemical Analyzer and a 16-channel 
multiplexer module (CH Instruments).  Chips were tested with a common Ag/AgCl 
reference electrode and Pt auxiliary electrode.  Unless otherwise noted, electrochemistry 
was recorded at ambient temperature in Tris buffer containing 10 mM Tris, 50 mM NaCl, 
10 mM MgCl2 and 4 mM spermidine at pH 7.1.  Electron transfer kinetics were estimated 
by Laviron analysis (40). 
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Electrochemistry of Partial DNA Assemblies 
To demonstrate that probe reduction is DNA-mediated and not due to direct 
surface contact, the electrochemistry of partial DNA assemblies was compared to that of 
the 17-mer and 100-mer duplexes.  In addition to annealing the Nile Blue-modified, well 
matched 100-mer and well-matched 17-mer (without the RsaI binding site) as described 
in previous sections, an aliquot of the 100-mer without the 36-mer segment added was 
also annealed.  These samples (diluted to 25 μM) and a 25 μM sample of the ssNB-25-
mer directly from the stock were assembled with 100 mM Mg
2+
 in separate quadrants on 
chips using the same conditions described in the previous section.  After thorough 
rinsing, the chip was backfilled with 1 mM 1-mercaptohexanol for 45 min.  CV scans 
were performed at a scan rate of 100 mV s
-1
 in buffer containing 5 mM phosphate, 50 
mM NaCl, 4 mM MgCl2, 4 mM spermidine, 50 µM EDTA, 10% glycerol, pH 7.   
 
RsaI Restriction Assays  
For the analysis RsaI restriction activity on partial DNA assemblies, chips were 
treated with 1,500 units/mL RsaI in 10 mM Tris-HCl, 50 mM NaCl, 4 mM spermidine, 
pH 8.0 with 10 mM MgCl2 added.  Restriction activity was allowed to occur for 15 min. 
at room temperature.  CV scans were performed before and after the addition of RsaI in 
buffer containing 5 mM phosphate, 50 mM NaCl, 4 mM MgCl2, 4 mM spermidine, 50 
µM EDTA, 10% glycerol, pH 7.  For analysis of the 100-mer over time with and without 
RsaI treatment, chips were also treated with 1,500 units/mL RsaI in the described buffer 
but 10 mM MgCl2, which is necessary to activate RsaI was not added until after the RsaI 
solution had been added to the chip and allowed to fully equilibrate (~1 hr.).  
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Measurements were carried out on chips with the standard, single-well set up as well as 
with a custom-built well clamp bearing a control quadrant with a separate well to 
maintain one quadrant free of enzyme.  For this clamp, the reference and counter 
electrodes were thoroughly rinsed with deionized water when transferring between wells. 
 
Results and Discussion 
Preparation of DNA Monolayers  
Figures 3.1 and 3.2 show the various features of double-stranded DNA used in 
monolayers for DNA electrochemistry.  To make the 100-mer, five single-stranded 
oligonucleotides were synthesized and purified (34).  Duplexes were prepared by 
annealing a 27-mer strand with a six carbon thiol linker at its 5′-terminus and a 73-mer 
strand to complementary strands that included a 39-mer, a 36-mer and a 25-mer with a 
Nile Blue redox probe covalently attached through a uracil at its 5′-terminus.  This 
piecewise synthesis, which involves assembly of the double-stranded 100-mer from these 
overlapping single-stranded DNA segments, was employed to improve synthetic yield.  
Although duplexes prepared in this manner contain nicks in the sugar-phosphate 
backbone, DNA-mediated CT occurs through the π-stack and not through the backbone 
(36), so these duplexes remain fully functional for DNA CT.  The fully assembled 100-
mer duplexes were designed such that the Nile Blue redox probe was positioned at one 
5′-terminus of the duplex and the thiol linker extended from the other 5′-end.   
To investigate restriction-enzyme activity, 100-mers were designed with the 
binding site of the RsaI restriction enzyme near the center of the DNA duplex.  Likewise, 
those 100-mers that contained a single CA mismatch also had the mismatch located near 
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the center of the duplex.  Well matched 17-mer strands were prepared with the same 
modifications, the Nile Blue redox probe at one 5′-end and thiol linker at the other 5′-end.  
The DNA monolayers were assembled on silicon chips bearing sixteen 2 mm
2
 gold 
electrodes, which enabled simultaneous comparison of up to four distinct monolayers on 
a single chip with fourfold redundancy (34).  All monolayers were assembled as duplex 
DNA and, prior to testing, the electrodes were backfilled with mercaptohexanol to 
passivate against direct electrochemistry with the gold surface.  Previously, the 
morphology of DNA monolayers on gold electrodes was investigated with atomic force 
microscopy (37, 38); at negative potentials the duplexes were repelled from the surface to 
a near-vertical orientation.   
 
Electrochemistry of Well Matched and Mismatched 100-mers 
 First, we explored the general electrochemical characteristics of DNA as a 34 nm 
molecular bridge between the gold electrode and Nile Blue redox probe.  Cyclic 
voltammetric (CV) signals from these monolayers are given in Figure 3.3.  The CV 
measurements from well matched 100-mer monolayers exhibit large peaks associated 
with the Nile Blue redox probe, indicative of effective CT at a midpoint potential of –240 
mV versus an Ag/AgCl reference.  The integrated cathodic and anodic peak areas for 
these well matched monolayers were 1.7 ± 0.1 nC and 3.6 ± 0.1 nC, respectively, which 
correlate with a surface coverage of approximately 1 pmol cm
-2
; some variations arose 
with buffer and adventitious oxygen.  The surface coverage and the CV peak areas were 
comparable to those observed with 17-mers.   For instance, the average CT signal size 
through well-matched 17-mers modified by Nile Blue was 3.5 ± 0.5 nC, as averaged  
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Figure 3.3 Electrochemistry from 100-mer well matched and mismatched monolayers.  
a, The chip layout used to compare monolayer electrochemistry between well matched 
100-mers and 100-mers with a single base-pair mismatch.  A mismatch (CA) is generated 
in the 36-mer segment by substitution of a C for a T at the position 69 bases from the 
thiolated end of the duplex.  b, Average CV curves from well matched (blue) and 
mismatched (red) 100-mer DNA, each modified with a Nile Blue redox probe.  Data were 
obtained at a 50 mV/s scan rate in Tris buffer (10 mM Tris-HCl, 50 mM NaCl, 10 mM 
MgCl2 and 4 mM spermidine, pH 7) and averaged over the similar electrodes on the chip.   
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over 100 electrodes (34).  Therefore, the 34 nm DNA was comparably as effective a 
surface-to-probe bridge as smaller oligonucleotides.   
To verify that the charge was passing through the DNA, we also measured the 
electrochemistry of well matched DNA duplexes against duplexes that contained a single 
mismatched base pair (CA) on the same chip (Figure 3.3a).  Mismatched bases have been 
shown to attenuate DNA CT through perturbations of the π-stack (24, 25, 34, 39).  
Comparing well matched and mismatched DNA monolayers on the same chip ensured 
that both were subjected to the same processing conditions.  As seen, the mismatch 
clearly attenuates the CT signal, as the average CV peak area was significantly lower, 
measuring only 0.8 ± 0.1 nC and 1.8 ± 0.2 nC for the cathodic and anodic peaks, 
respectively.  This is a factor of two or more lower than that of the well matched 
monolayer in each case.  The mismatched peaks exhibit slightly larger splitting, although 
this difference does not hold at higher scan rates.  This effect is independent of mismatch 
position; placement of the mismatch at positions that differed by up to 20 base pairs in 
the 100-mer, through single base changes in the central 36-mer segment, resulted in 
similar signal attenuation (data not shown).  The mismatch inhibited the transport 
capability of the DNA bridge regardless of its position in the 100-mer.   
To establish the reproducibility of mismatch attenuation, we tested DNA CT of 
well-matched and mismatched 100-mer monolayers side-by-side across six chips, which 
represented over 40 electrodes of each type of monolayer (configuration as illustrated in 
Figure 3.3a).  We found that the ratios of the cathodic CV peak areas of well-matched to 
mismatched monolayers were 2.3 ± 0.4.  A t-test of this ratio distribution in comparison 
to the null ratio of 1 had a p-value of 0.0005.  By comparison, this well matched to 
74 
 
mismatched ratio is 1.9 to 3.5 for various intercalating redox probes in 15-mer DNA (24) 
and 2.7–2.8 for 17-mer DNA with a Nile Blue redox probe (34).  The consistency of this 
measured attenuation for mismatches with prior measurements of mismatched 
monolayers demonstrates that charge flow depends on the integrity of the DNA π-stack, a 
strong argument that transport occurs through the 100-mer DNA.  Furthermore, that a 
single defect in a 100-mer produced an effect similar to one in much shorter DNA is 
remarkable given the substantial length disparity.   
 
Kinetics of DNA CT Through 100-mer Monolayers 
Electron transfer kinetics were estimated by measuring the scan-rate dependence 
of the peak splitting between the anodic and cathodic Nile Blue CV peaks of these DNA 
monolayers.  At high scan rates (> 1 Vs
-1
), the voltammetry enters the totally irreversible 
reaction regime and the peak splitting becomes linear with scan rate.  By applying 
Laviron analysis (40) in this regime, the electron transfer rate k can be estimated.  
Interestingly, the electron transfer kinetics of well matched and mismatched 100-mer 
DNA monolayers were virtually identical, as with prior measurements of 17-mers (Figure 
3.4) (34).  For the well-matched 100-mer, k100 = 39 s
-1
, and similarly the mismatched 
100-mer yielded k100 = 40 s
-1
.   
Although slow, these transfer rates are significantly faster than those expected for 
tunnelling across 34 nm from the electrode directly to the redox probe (41–43).  These 
figures are also indistinguishable (given the analysis) from those obtained from the 17-
mer monolayer on the same chip, for which k17 = 25 s
-1
, consistent with our previous 
studies of DNA of similar lengths (34, 44–47).  Thus, the electron transfer rates of these  
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Figure 3.4 Kinetics of CT through 100-mer and 17-mer monolayers. a, The chip layout 
for testing electron transfer kinetics. b, CV peak splitting versus scan rate for well 
matched (WM) and mismatched (MM) 100-mer DNA monolayers along with well 
matched 17-mer monolayers as averaged over four devices on a single chip.  Data were 
obtained in Tris buffer (10 mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2 and 4 mM 
spermidine, pH 7). By applying Laviron analysis in this linear regime, the electron 
transfer coefficient and electron transfer rate were obtained. Values are α = 0.6 and k = 
30–40 s-1 for well matched 100-mer, mismatched 100-mer, and well matched 17-mer 
monolayers. 
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monolayers exhibit essentially no variation with length over this regime.  Previous 
transfer-kinetic studies of DNA monolayers with 16-mer sequences showed an 
exponential dependence of the electron transfer rate with linker length with a coefficient 
for the electronic coupling, β = 1 Å-1, consistent with values expected for tunnelling 
through a saturated carbon linker (47); the extrapolated transfer rate through the 16-mer 
DNA in the absence of the linker was ~10
8
 s
-1
.  It appears that the rate-limiting step is not 
CT through the DNA duplex, but rather transport through the alkanethiol linker.  Thus, 
the estimated rates are also fully consistent with rapid transfer through the 100-mer DNA 
assembly.   
To provide further evidence that CT in the 100-mer is DNA-mediated and does 
not involve direct interaction of the Nile Blue probe with the surface, we prepared a chip 
with the well matched 100-mer, a well matched 17-mer, the 100-mer assembly without 
the central 36-mer single-stranded segment, and the single-stranded, Nile Blue-modified 
25-mer (ssNB 25-mer) alone without complement (Figure 3.5). The ssNB 25-mer was 
included as a clear control for direct contact of the redox probe with the surface.  Since 
this single-stranded segment of DNA lacks a thiol, the only mode by which it may adhere 
to the electrode is by adsorption onto the gold through direct interactions of the bases and 
redox probe with the surface.  Thus, probe reduction must necessarily be due to direct 
surface contact and not DNA CT.   
Consistent with this, it is evident in Figure 3.5 that the CV of the 100-mer differs 
significantly from that of the adsorbed ssNB 25-mer, not only with respect to the signal 
intensity and peak shape, but also with respect to peak splitting and midpoint potential.  
The CV of the 100-mer instead resembles that of the 17-mer, for which CT is DNA- 
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Figure 3.5 Electrochemistry and enzymatic activity on fully and partially assembled 
DNA films.  a, The chip layout used to measure the electrochemical characteristics and 
RsaI activity with four DNA films (from top left to bottom right) including the well 
matched 100-mer which contains the RsaI binding site, a well matched 17-mer that does 
not contain the RsaI binding site, the single stranded 25-mer modified with Nile Blue 
(ssNB), and the 100-mer without the central 36-mer segment.  As illustrated, the ssNB 
25-mer and 100-mer without the central 36-mer are expected to be reduced through direct 
surface adsorption and contact.  Figure (a) also illustrates restriction of the well matched 
100-mer DNA films upon addition of RsaI and Mg
2+
.  b, CV scans of the four DNA films 
before (blue) and after (red) the addition of RsaI.  The enzyme reaction was carried out in 
Tris buffer (10 mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2, 4 mM spermidine, pH 7.9).  
Scans were taken before and after the enzyme reaction in phosphate buffer (5 mM 
phosphate, 50 mM NaCl, 4 mM MgCl2, 4 mM spermidine, 10% glycerol, pH 7).  CV 
scans were measured versus Ag/AgCl at a scan rate of 100 mV s-1.  For the 100-mer, 17-
mer and single stranded 25-mer, respectively, the peak splittings are 80 mV, 60 mV, and 
15mV, the midpoint potentials are -180 mV, -180mV, and -170mV, and k100 = k17 = 1/39 
kss25. Values could not be determined accurately for the 100-mer without the 36-mer 
segment. 
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mediated.  Moreover, although direct surface reduction of the Nile Blue probe on the 
ssNB 25-mer yields a sharp CV peak that shows only minor splitting at fast scan rates, 
DNA-mediated reduction of the Nile Blue probe through the well matched 100-mer and 
17-mer yield a broad peak that is split significantly and further broadened at fast scan 
rates. These pronounced, visible differences in the electrochemistry can be attributed to 
the greater kinetic barrier associated with charge transfer through the DNA as compared 
to direct contact and reduction at the electrode surface.  This kinetic difference is 
highlighted further by the measured CT rates for these samples: surface reduction of the 
Nile Blue probe on the ssNB 25-mer occurs at a nearly 40-fold faster rate than charge 
transfer through the 100-mer and 17-mer DNA, based on Laviron analysis for these 
chips. Although kinetic comparisons can be made between these assemblies, signal 
intensities are hard to compare because of the substantial differences in mode of 
adherence to the surface and the resultant packing densities.   
Also shown in Figure 3.5, omission of the central 36-mer to create a duplex with a 
central single-stranded segment that can easily bend and sway also yields drastic 
electrochemical changes.  Not only is its redox peak significantly smaller than that of the 
fully assembled 100-mer (cathodic peak size of 0.7 nC versus 2 nC, respectively), the 
decreased peak splitting and sharper peak shape much more closely resemble those of the 
ssNB 25-mer.  Thus, the Nile Blue redox signal of the 100-mer DNA missing the 36-mer 
segment is probably caused by direct contact of the probe with the surface, just as for the 
single-stranded 25-mer.  Interestingly, the signal for this disordered jumble of DNA on 
the surface is much smaller than the signal from either the ssNB 25-mer or the fully 
assembled, well matched 100-mer.   
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RsaI Restriction Activity on 100-mer Monolayers  
Restriction enzyme activity on these 100-mer-modified electrodes provided 
another probe of the DNA-mediated reaction.  To facilitate restriction, the restriction site 
must be accessible for protein binding and in a biologically recognizable conformation.  
If the restriction site is below the Nile Blue redox probe and if the duplex is upright and 
does not contact the surface, successful cutting releases the probe into solution.  This 
activity on a DNA-modified electrode destroys the pathway of DNA CT to the probe to 
yield significant loss of the redox signal.   
To test for restriction-enzyme activity, chips with partial assemblies as shown in 
Figure 3.5 were exposed to the restriction enzyme RsaI, which cuts the sequence 5′-
GTAC-3′ with high specificity and leaves blunt ends on the resulting DNA segments.  
For these chips, the 100-mer is the only DNA assembly with a viable RsaI restriction site.  
After incubation of the enzyme with 10 mM Mg
2+
 for 15 minutes on the chip, substantial 
signal attenuation (90% by the cathodic peak area of the CV) is observed for the 100-mer, 
while the other quadrants remain essentially unchanged.  This result demonstrates clearly 
that the DNA in these 100-mer monolayers is accessible to the protein and in a 
biologically recognizable conformation.  Moreover, in the 100-mer, CT is necessarily 
DNA-mediated.  For the quadrant containing the ssNB 25-mer which directly contacts 
the surface, exposure to RsaI caused no change in the signal.  For the quadrant containing 
the 100-mer without the central 36-mer segment, the minimal signal loss (10% by the 
cathodic peak of the CV) is probably due to the instability of this assembly to the 
electrode rinsing and buffer-exchange steps required for this experiment.  For the 17-mer 
duplex, there is no restriction site and therefore no expectation of signal attenuation.  For 
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the 100-mer, then, the attenuation we observed must reflect that CT to the Nile Blue 
probe is DNA-mediated; if the Nile Blue redox probe of the 100-mer were directly 
adsorbed to the surface, no response to RsaI treatment would be expected.   
Restriction-enzyme activity was also monitored as a function of time in the well 
matched 100-mer alongside other DNA duplexes that contain the RsaI binding site 
(Figure 3.6).  These included a well matched 17-mer (with a different sequence than that 
which was used in the partial assembly experiment) and the 100-mer with a single base-
pair mismatch (not at the restriction site).  As these three types of DNA all contain the 
RsaI binding site, successful cutting will result in detachment of the Nile Blue redox 
probe and attenuation of the electrochemical signal.  As a negative control, one well of 
the chip was modified with the well matched 100-mer, but was not treated with RsaI.  
Initially, before the enzyme was added, the signals from all the monolayers were stable in 
the buffer solution.  Subsequently, RsaI was added to the quadrants that contained the 
well matched 100-mer, well matched 17-mer, and mismatched 100-mer.  The fourth 
quadrant, which was modified with the well matched 100-mer, was isolated in a separate 
well maintained free of enzyme.  While activation of the enzyme with Mg
2+
 triggers a 
rapid decrease in integrated charge on the RsaI-exposed quadrants, the signal from the 
quadrant not treated with enzyme increases slightly.  The loss of Nile Blue signal for the 
three RsaI-treated quadrants is consistent with RsaI cleavage activated by divalent 
cations.  In the isolated quadrant where the DNA is intact, Mg
2+
 enhances the signal.  The 
observation of enzymatic activity in these monolayers demonstrates that the DNA is in its 
native conformation and is biologically accessible and active. 
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Figure 3.6 Enzymatic activity on 100-mer monolayers as a function of time.  Integrated 
cathodic CV peak area versus time for various DNA monolayers exposed to RsaI (red) 
and 100-mer DNA in the absence of enzyme (blue).  The types of DNA tested include the 
well matched (WM) 100-mer, a well matched (WM) 17-mer, and the mismatched (MM) 
100-mer, all of which contain the RsaI binding site.  The charge was obtained by 
integrating the cathodic Nile Blue CV peaks obtained at a 100 mV s
-1
 scan rate.  
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Summary and Conclusions 
DNA-mediated electrochemistry through 100-mer monolayers revealed large 
signals for well matched duplexes, comparable to those observed with shorter duplexes. 
This result indicates that CT through DNA is robust in these long DNA films.  
Nonetheless, attenuation by single base mismatches illustrates the delicacy of this process 
and strongly argues that the integrity of the base pair π-stack is crucial.  That a single 
mismatch within a 100-mer of otherwise well matched bases causes signal attenuation 
equal to that seen in mismatched DNA that is ~20% of the length establishes a new point 
of reference for the sensitivity of DNA CT to minor perturbations.  Cutting with the RsaI 
restriction endonuclease demonstrates the biological integrity of the monolayers and also 
illustrates the utility of these longer DNA assemblies for sensing DNA-binding protein 
reactions.  The ability to construct these CT-active assemblies using smaller 
oligonucleotides may be particularly useful for associated nanoelectronics applications.  
All of these results document that DNA can efficiently facilitate CT over 100 base pairs, 
or 34 nm, close to the persistence length of duplex DNA in solution.  This remarkable 
distance for CT surpasses those in other reports of long-range transport through 
conjugated molecular wires (8, 9), and is among the longest distances reported for a 
molecular monolayer (4, 5, 7, 48).   
From our estimates of electron transfer rates, which are essentially the same for 
the 100-mer and 17-mer, the rate-limiting step must still be tunneling through the 
alkanethiol linker.  This puts a lower bound on the rate of electron transfer through the 
100-mer DNA itself.  In our previous studies of a 16-mer, in which we saw significant 
variations in rate caused by linker length, we could extrapolate that the rate of electron 
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transfer through the 16-mer must be > 10
8
 s
-1
.  Given our lower bound for the 100-mer, 
k100 = 10
2
 s
-1
, that is no faster than that through the linker, we obtain an estimate for β of 
0.05 Å
-1
 through the DNA.  This conservative estimate is in the range of conventional 
conjugated molecular wires (0.001-0.2 Å
-1
) (2-9).  Simply put, even for this 34 nm DNA 
wire, the small alkanethiol linker is still rate-limiting.   
The full mechanism associated with this DNA-mediated electrochemistry is still 
elusive, and this study highlights several observations that are difficult to reconcile.  
Despite a wide range of redox potentials, various redox probes are compatible with DNA 
electrochemistry as long as the probes are electronically well coupled to the DNA base-
pair stack (28).  For all of these probes we found that they are reduced at potentials near 
their free redox potentials.  However, the reduction potentials of the individual bases 
were all significantly higher than the redox potentials of the probes.  In this study, the 
reduction potential of Nile Blue (-250 mV versus Ag/AgCl) is substantially more positive 
than that of any of the free bases (less than -1 V versus Ag/AgCl) (49).  To date, direct 
reduction of DNA has not been observed at the potentials of these redox probes, nor 
would it be consistent with the parameters involved.  This conundrum could be 
reconciled if the stacked DNA duplex forms a delocalized band structure, different from 
individual bases, that has a low-lying lowest unoccupied molecular orbital from the 
overlapping π-orbitals of the bases.  Although such a band structure is plausible, to date 
an equilibrium band structure has not been observed experimentally.  Our group thus 
postulated that DNACT is conformationally gated and that the CT-active state or states 
are transient, nonequilibrium states (50).  Experimental evidence suggests that in solution 
these states, which we consider to be delocalized domains of the π-stacked bases, extend 
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over about four base pairs (50).  Whether these domains are more extended or less 
transient within the DNA film versus within solution is unclear.  Unlike conventional 
molecular wires, which exhibit inherent rigidity, DNA undergoes motions on time scales 
of picoseconds to milliseconds.  The fleeting alignment of the bases creates a delicate π-
network with CT states that are active only transiently.  The observation that a single 
mismatch in a 100-mer is resolved with the same degree of signal attenuation as seen in 
much shorter DNA further underscores how remarkably small perturbations in this 
system profoundly influence the global orbital network.  A poorly stacked single base-
pair mismatch may block the formation of the potential band structure.   
Is DNA a molecular wire? In this experiment, clearly it bridged the electrode and 
redox probe over 34 nm.  DNA not only fulfils many of the requirements of molecular 
wires, but also it surpasses conventional wires in its ease of synthesis and flexibility of 
design.  However, this is a transient and fragile wire, as it must be maintained in buffered 
solution, and effective conduction over its length is extraordinarily sensitive to subtle 
structural variations.  Indeed, the DNA bridge may be considered instead as an extension 
of the gold electrode, a sensor 34 nm long to detect solution-borne targets.  Although the 
sensitivity to base stacking presents a challenge for the use of DNA as a molecular wire 
for integrated circuits, the ability to make long, well coupled DNA assemblies in circuits 
is a clear benefit.  On the other hand, this exquisite electronic sensitivity to structural 
perturbations actually makes the DNA wire ideal for biosensing under physiological 
conditions. 
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DNA Charge Transport in Single Molecules:  
Length Dependence Measurements and  
Detection of Methyltransferase Binding and Activity 
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conductivity data.  N.B. Muren synthesized DNA and assisted with data analysis and 
interpretation.   
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Introduction 
Carbon nanotube (CNT)-based devices, in which single molecules span an 
oxidatively cut gap in the CNT, provide a versatile platform with well defined electrical 
contacts that has previously been used to measure the electrical properties of a variety of 
small molecule bridges (1–9).  Importantly, these measurements can be carried out in 
aqueous solution, making them useful for measurements involving biomolecules.  
Previously, this platform was shown to be highly effective for single molecule 
measurements of DNA-mediated charge transport (DNA CT) through DNA duplexes that 
covalently bridge the CNT gap (Figure 4.1) (9).  In these studies, the path of CT through 
the device was confirmed to be DNA-mediated because of the dramatic loss of current 
flow induced by single base mismatches in the bridging duplex, a result that is consistent 
with measurements of DNA CT in ensemble electrochemical studies (10–13).  
Additionally the single DNA duplex that is wired into the device was shown to be readily 
bound and cut by a restriction endonuclease, indicating that it is maintained in a 
biologically recognizable and accessible conformation (9).   
This previous work suggests that CNT-DNA devices may be utilized for other 
measurements and applications of DNA CT that have previously been limited to bulk 
solution and electrochemical studies.  Though challenging, single molecule 
measurements provide more direct information about the fundamental electronic 
properties of a molecule than do ensemble measurements (14).  Additionally, the inherent 
responsiveness of single molecule platforms and the extreme sensitivity of DNA CT to 
structural perturbations enhance each other when combined for biosensing applications.  
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Figure 4.1 Electronic integration of DNA into a CNT device.  Oxidative cutting of the 
CNT creates a gap with carboxylic acid point contacts on the cut ends.  Amine-modified 
DNA is then covalently attached to these point contacts by peptide coupling to form an 
electronic bridge across the gap.  The resulting DNA-mediated path for current flow 
through the device is sensitive to structural perturbations that disrupt DNA CT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
91 
 
Here, we show work to extend this single molecule, CNT-DNA platform to 
measurements of the distance dependence of DNA CT and to electrical detection of 
methyltransferase binding and activity. 
The characterization of long-range CT in DNA is an important goal not only for 
our fundamental understanding of this process but also to determine how this property 
might be exploited for nanoelectronics and biotechnology applications.  Additionally, 
basic rate and distance dependence measurements will be key for the interpretation of 
growing evidence that DNA CT may be utilized in living organisms for long-range 
signaling toward the coordination of complex cellular activities (15).  Previous 
measurements in solution and with surface electrochemical platforms indicate that the 
distance dependence of DNA CT is very shallow and puts DNA within the conductive 
range of other molecular wires (16–19).   
In electrochemical, ground state measurements of DNA CT over 34 nm (100 bp), 
for example, CT was limited not by the DNA length but by the C6 alkanethiol linker used 
to attach the DNA to the electrode surface (19).  Although this limit prevents the direct 
calculation of β—a parameter that describes the distance dependence of the CT rate—the 
dominance of the linker, even over 34 nm, provides compelling support for a shallow 
distance dependence.  An estimated β value of 0.05 Å-1 from these measurements agrees 
with previous work in solution (16, 17), putting DNA among the longest molecular wires 
reported to date (19).  Here we investigate this distance dependence further with ground 
state, single molecule measurements of DNA CT.  We fabricate and characterize CNT-
DNA devices with DNA bridges of varying length (up to 34 nm) and also investigate the 
effect of linker length (C3 vs. C6) on these measurements. 
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In general for the detection of biomolecules, CNTs and nanowires incorporated 
into field-effect transistors offer valuable electrical detection platforms because their 
conductivity is modulated by binding of analytes (20–24).  One drawback of these 
devices is that the conductivity changes are not specific and depend upon the 
characteristics of the analyte and its mode of interaction with the CNT (25, 26).  
Interference caused by nonspecific binding of analytes presents a significant challenge 
for specific detection, particularly in single molecule measurements.  The electronic 
integration of DNA into these devices, with its dual function as recognition element and 
transducer, helps to overcome this challenge, especially for the detection of DNA-binding 
proteins.  The programmable sequence of DNA imparts specific recognition by protein 
targets, and the structural sensitivity of DNA CT facilitates the direct conversion of 
protein binding into an electrical signal.   
The use of DNA CT for the sensitive and specific detection of proteins has 
already been demonstrated on electrochemical platforms (27, 28).  Proteins that distort 
the structure of the DNA π-stack upon binding, such as methyltransferases which bind 
DNA and flip a base completely out of the duplex (29, 30), have been shown 
electrochemically to cause a sharp attenuation of DNA CT (27).  In this study, we use the 
CNT-DNA platform to detect single molecule binding and activity by the 
methyltransferase SssI which binds the sequence 5ʹ-CG-3ʹ and, with the methyl donor S-
adenosyl methionine (SAM), methylates the cytosine base (31).  This methyltransferase 
is considered the bacterial analog to human methyltransferases, which also recognize and 
methylate the same site (31).  We show that CNT-DNA devices can be used to detect 
binding and base flipping by single molecules of SssI based on the resulting disruption of 
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DNA CT and thus current flow through the device.  Additionally, methylation of the 
devices by SssI alters the binding potential of the bridging DNA substrate and this effect 
may be monitored electrically.  
 
Materials and Methods 
Materials 
All standard and modified phosphoramidites were purchased from Glen Research.  
All other chemicals for the preparation of DNA, buffers, and CNT-DNA devices were 
purchased from Sigma-Aldrich and used as recieved.  The methyltransferase SssI and 
BSA were purchased from New England Biolabs, stored at -20°C, and used as received.   
 
DNA Sequences 
For distance dependence studies, the 15-mer, 40-mer, 60-mer, 80-mer, and 100-
mer were designed such that one strand in each duplex carried a C3 amine linker at each 
end and the complementary strand was unmodified.  For the 15-mer, the sequence was: 
5'-H2N-(CH2)3-GAC AGT CGA CAT GTC-(CH2)3-NH2-3'.  For the 100-mer, the 
sequence was: 5'-H2N-(CH2)3-AGT ACT GCA GTA TCG ACG TCA TAG GAC ATT 
GGA GCG CTC CAG CTG TGA CAT ATA AAA GTA GTG AGT CAA TCG TGT 
ACT GTA GTC CAT GTA TAC TGC ACT A-(CH2)3-N2H-3'.  For the 40-mer, 60-mer, 
and 80-mer the sequences were identical to the 100-mer but with 30, 20, and 10 bases, 
respectively, removed from each end.   
 For SssI binding and activity studies, 15-mers with one or more SssI binding sites 
(5ʹ-CG-3ʹ, shown underlined) were used including: H2N-(CH2)3-5ʹ-GAC AGT CG ACA 
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TGT C-3ʹ-(CH2)3-NH2 and H2N-(CH2)3-5ʹ-CG GCC CG GC CG CG CG-3ʹ-(CH2)3-NH2.  
A 15-mer without the SssI binding site was also used: H2N-(CH2)3-5ʹ- 
ATTAAATTAATATAT-3ʹ-(CH2)3-NH2. 
 
DNA Synthesis and Purification 
Oligonucleotides were synthesized on an Applied Biosystems 3400 DNA 
Synthesizer using standard reagents.  The amine-modified strands were synthesized with 
3'-PT-amino-modifier C3 CPG beads to modify the 3' end and a 5'-amino-modifier C3-
TFA phosphoramidite to modify the 5' end.  The unmodified complement was 
synthesized using standard reagents and procedures.  Both amine-modified and 
unmodified DNA were cleaved from the solid support and deprotected by treating with 
concentrated ammonium hydroxide for 8 hrs. at 60 °C.  All DNA was purified by high-
performance liquid chromatography (HPLC) on a polymeric PLRP-S column (Agilent) 
with a 50 mM ammonium acetate buffer/acetonitrile gradient.  For the 40-mer, 60-mer, 
80-mer, and 100-mer strands, the column was heated to 60 °C to discourage the 
formation of secondary structures.  At least two rounds of HPLC were performed on each 
DNA type to achieve highly pure samples.  After purification, samples were 
characterized by matrix-assisted laser desorption/ionization time of flight mass 
spectrometry.  DNA stocks were then desalted, resuspended in phosphate buffer (5 mM 
phosphate, 50 mM NaCl, pH 7), and quantified by UV/Vis absorption at 260 nm 
according to their extinction coefficients (IDT Oligo Analyzer).  Equimolar amounts (50 
µM) of complementary strands were combined and thermally annealed.  
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CNT-DNA Device Preparation  
Devices with electronically wired CNT point contacts were prepared as described 
previously (4–9, 32, 33).  Briefly, chemical vapor deposition was used to grow sparse 
single walled CNTs on a doped silicon wafer containing 300 nm of native oxide on its 
surface.  The surface was then coated with PMMA photoresist (Microchem) and 
conventional photolithography was used to pattern gold source and drain electrodes over 
the CNTs with a grid shadow mask (SPI Supplies).  For each device, electron beam 
lithography was then used to remove the PMMA coating from a section of the nanotube.  
The exposed portion was then cut with an oxidative plasma etch, leaving carboxylic acids 
on the two termini of the cut nanotube.  Importantly, the size of the gap cut in the 
nanotube was adjusted to fit precisely the length of a given DNA bridge.  To prepare the 
devices for reconnection with DNA, the nanotubes were treated with a 2-(N-morpholino) 
ethansulfonic acid (MES) buffer solution (0.1 M) with EDCI (5 mM) and Sulfo-NHS (10 
mM) overnight to activate the carboxylic acid termini inside the CNT gap.  Following 
this, the devices were rinsed with MES buffer, dried, and treated with 5 μM DNA in 
phosphate buffer to reconnect the devices with DNA.  
 
Electrical Measurements of DNA Length Dependence and SssI Binding 
Electrical measurements for all devices were performed under ambient, buffered 
conditions with the silicon wafer serving as a global back gate.  A mechanical probe 
station was used to make electrical contact to each device and a semiconductor device 
analyzer (Agilent) was used to collect and process electrical data.  For DNA length 
dependence studies, the resistance of devices connected with various lengths of DNA was 
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measured over a rage of gating voltages (-3 V to 1 V).  The highest resistance measured 
over this range was taken as the resistance of the device and a plot of resistance vs. DNA 
length was compiled.  From this plot, the distance dependence parameter β was 
extrapolated by fitting the plot with the exponential shown in equation 1: 
      R = R0e
βL
                         (1) 
where R is the device resistance, R0 is the y-intercept, and L is the DNA bridge length.   
For measurements of SssI binding, reconnected devices with or without the 
recognition site were treated with 6 nM SssI and 300 μM SAM in SssI reaction buffer (10 
mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2, 1 mM Dithiothreitol, pH 7.9).  The 
conductance of each device was measured over a range of gating voltages (-3 V to 1 V), 
before and after SssI treatment as well as after rinsing away the bound protein.  The 
highest conductance measured in this range for a given condition was taken to represent 
the device conductance for that condition, and all conductance values for a device were 
normalized with respect to the overall highest conductance measured for the device. 
 
Results and Discussion 
Single Molecule Length Dependence Measurements of DNA CT  
 For DNA length dependence measurements, CNT-DNA devices were prepared 
with bridging DNA segments of varying length including a 15-mer (5 nm), 40-mer (14 
nm), 60-mer (20 nm), 80-mer (27 nm), and 100-mer (34 nm), all with C3 amine linkers.  
For each DNA length, the resistance of 3–5 different reconnected devices was measured 
These data were plotted (Figure 4.2) and fit to equation 1.  The line of best fit for these 
data gives a β value of 0.01 Å-1.  This shallow distance dependence is in agreement with     
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Figure 4.2.  Resistance of DNA spanning a carbon nanotube gap as a function of DNA 
length.  Data shown are for DNA attached to the CNT device by a C3 linker.  The highest 
resistance measured over a rage of gating voltages (-3 V to 1 V) for each device was 
taken as the resistance of the device.  Measurements from multiple devices are shown for 
each DNA length.  The data are fit to equation 1 to give a β value of 0.01 Å-1.     
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previous ensemble measurements on DNA-modified electrode surfaces in which a 
conservative estimate of β was made at 0.05 Å-1 (19).   
In contrast to ensemble electrochemistry measurements in which the C6 
alkanethiol linker, not the DNA length, limits the rate of DNA CT over 34 nm, it appears 
here that the C3 linker may not be limiting.  If the C3 linker limited DNA CT in this case, 
the same resistance value—the resistance contribution of the two C3 linkers—would be 
expected for each DNA length.  Although the variation in the measured resistance for 
each progressively longer DNA segment does overlap and thus makes it difficult to rule 
out a contribution from the linker, there is a clear trend toward increased resistance with 
increased DNA length.  In particular, the average resistance for the 100-mer DNA bridge 
is statistically greater than the average resistance for the 15-mer.  As a control, and to 
gain more information about the contribution of the alkane linker to these measurements, 
DNA duplexes of the various DNA lengths with C6 amine linkers are currently being 
studied.  
  
Single Molecule Detection of SssI Methyltransferase 
The scheme for a typical SssI binding experiment on a DNA-bridged device is 
given in Figure 4.3, and the corresponding conductance-voltage characteristics are given 
in Figure 4.4.  For these initial experiments, a DNA bridge with more than one 5ʹ-CG-3ʹ 
SssI binding site was used.  However, given the footprint of SssI, which spans at least 6 
base pairs on each side of the binding site (34), the 15-mer DNA segment is likely to only 
accommodate binding by a single SssI protein at a central site.  For devices reconnected 
with this DNA (3 devices), an average conductance of 1.4 ± 0.8 μS was observed (Figure 
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Figure 4.3 Electrical detection of SssI binding at a DNA-bridged CNT device.  All DNA 
for these experiments is attached to the CNT device by a C3 linker.   (1) Duplex DNA 
containing the SssI binding site (with target base to be methylated shown in purple) forms 
a conductive bridge between the two ends of a gap cut in a CNT device.  (2) Upon 
addition of SssI and SAM cofactor (represented by the blue hexagon), the 
methyltransferase binds the DNA at its recognition site, and flips the base to be 
methylated out of the DNA π-stack, thereby cutting off DNA CT.  SssI remains bound 
with the base flipped even after the methylation reaction is complete.  (3) Upon rinsing, 
SssI dissociates from the DNA; the methylated base re-inserts into the DNA π-stack and 
restores CT through the device.   
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Figure 4.4 Sequence-specific, SssI-DNA binding and disruption of DNA CT through the 
CNT device.  Left column: SssI binding at a DNA-bridged device containing the SssI 
recognition site.  The DNA sequence was H2N-(CH2)3-5ʹ-CGGCCCGGCCGCGCG-3ʹ-
(CH2)3-NH2.  Right column: lack of SssI binding at a DNA-bridged device that does not 
contain the SssI recognition site.  The DNA sequence was H2N-(CH2)3-5ʹ- 
ATTAAATTAATATAT-3ʹ-(CH2)3-NH2.  Typical normalized conductance curves (top 
row) and average relative conductance values (bottom row) are shown for the respective 
DNA-bridged devices.  For each, the numbered points correspond to measurements at the 
numbered steps illustrated in Figure 4.3: (1) buffer before addition of SssI, (2) buffer with 
SssI and SAM, and (3) buffer after SssI has been rinsed away.  The buffer conditions 
were 10 mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2, 1 mM Dithiothreitol, pH 7.9.  The 
conductance of each device was normalized with respect to the highest conductance 
value. 
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4.4, left column).  Upon incubation of these devices with 6 nM SssI and 300 μM of the 
requisite SAM cofactor, a 91% ± 15% reduction in the conductance was observed.  
Notably, the SssI concentration utilized for our experiments is just below the binding 
affinity of this enzyme (Kd = 11 nM) (35).  The crystal structure of the similar 
methyltransferase HhaI bound to methylated DNA shows that base flipping occurs even 
when the protein is bound to this substrate (30), although the binding affinity is reduced 
(36–38).  In these single molecule devices, it is apparent that the protein remains bound 
with the base flipped out, even after the methylation reaction is complete.  Washing these 
devices with buffer is necessary to dissociate the enzyme and recover the conductance to 
close to the initial value. 
 
Sequence Specificity and SAM Dependence of SssI Detection 
 To test for sequence-specific binding of SssI, the nanotube gap was bridged with a 
sequence that lacks the SssI binding site (Figure 4.4, right column).  Before treatment 
with the methyltransferase, the devices showed an average conductance of 1.5 ± 0.4 μS.   
Even after extended incubation (>1 h) of these devices with SssI and the SAM cofactor, 
no changes in the conductance of these devices was observed.  Clearly, the specific 
recognition sequence is necessary for SssI binding and subsequent base flipping that shuts 
off current flow through the device.   
The cofactor SAM is required for methyltransferase activity, because it is the 
source of the electrophilic methyl group and is necessary for the specific binding of the 
enzyme to the substrate (31).  Thus, to further confirm that the decrease in conductance is 
due to the specific binding and methyltransferase activity of SssI, we investigated the 
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SAM-dependence of this decrease (Figure 4.5).  To simplify the analysis, devices that 
were reconnected with DNA containing only one, centrally located 5ʹ-CG-3ʹ binding site 
for SssI were utilized.  When these DNA-bridged devices were incubated with SssI in the 
absence of the SAM cofactor, only a slight attenuation in conductance was observed.  
This may be due to the introduction of more scattering sites in the channel of the device 
upon nonspecific protein binding (5).  However, when the same devices were 
subsequently incubated with SssI in the presence of the SAM cofactor, a >90% 
attenuation of their conductance was observed.  In turn, the conductance of the devices 
could be recovered to their original value with a buffer wash.   
 
SssI-catalyzed Device Methylation  
Finally, the effect of methylation of the SssI binding site on the measurement of 
subsequent activity by SssI was investigated.  To address this question, devices with a 
single SssI binding site were again utilized.  The devices were first exposed to SssI and 
SAM in order to catalyze methylation of the DNA bridge.  Similar to the experiments 
described above, a large decrease in the current flow through the device is observed, but 
the original conductivity is nearly recovered when the protein is washed away (Figure 
4.5, steps 1–4).  If this, now methylated, device is then re-subjected to SssI and SAM 
treatment, no change in the conductance is observed (Figure 4.5, steps 5–7).  This result 
reflects the reduced affinity of SssI for methylated DNA.  Initially, the 6 nM 
concentration of SssI is high enough for binding and base flipping to occur at the non-
methylated substrate.  With the protein washed away, the added methyl group itself does  
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Figure 4.5 SssI-catalyzed DNA methylation alters the protein-binding affinity of the 
device.  A device containing a single SssI binding site was taken through the illustrated 
and numbered steps (left) and the corresponding relative conductances (right) were 
measured in (1) buffer containing 10 nM BSA before addition of SssI, (2) buffer and SssI 
without SAM, (3) buffer and SssI with SAM (represented by the blue hexagon), and (4) 
buffer after SssI has been rinsed away. Note that current attenuation is only observed for 
step (3).  After device methylation, the device was taken through the same sequence of 
steps 5-8 with no current attenuation observed.  The sequence was H2N-(CH2)3-5ʹ-
GACAGTCGACATGTC-3ʹ-(CH2)3-NH2, with the single 5ʹ-CG-3ʹ site located at the 
center of the duplex.  The buffer conditions were 10 mM Tris-HCl, 50 mM NaCl, 10 mM 
MgCl2, 1 mM Dithiothreitol, pH 7.9. 
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not inhibit DNA CT as this modification does not perturb the π-stack.  When the device is 
re-subjected to 6 nM SssI, however, this concentration is no longer high enough to initiate 
binding to the now methylated DNA.  These changes in the binding potential of the DNA 
are sensitively translated here from the single molecule level as an electrical output; 
chemical modification of the DNA wire by the protein alters subsequent protein binding 
and the resulting electrical response. 
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Summary and Conclusions 
The experiments described here demonstrate the versatility of applications for 
which CNT-DNA devices may be used to measure DNA CT at the single molecule level.  
Using this platform, the distance dependence of DNA CT was investigated by preparing 
devices with DNA bridges of varying length and measuring current flow through these 
devices.  For data collected at five different bridge lengths (15-mer, 40-mer, 60-mer, 80-
mer, and 100-mer) a β value of 0.01 Å-1 was derived.  This shallow distance dependence 
measurement agrees strongly with the conservative estimate of β for DNA CT derived 
from ensemble measurements on DNA-modified electrode surfaces (β = 0.05 Å-1) (19).  
Unlike previous ensemble measurements where β could not be measured directly, these 
data suggest that CNT-DNA devices allow for the direct measurement of the distance 
dependence of DNA CT.  Continued work to support the characterization of this 
fundamental property of DNA is currently underway.  In order to understand the 
contribution of the alkane linker to these measurements, DNA duplexes with C6 amine 
linkers, in addition to C3 amine linkers, are being studied at the various DNA lengths.   
 Work to detect DNA binding and DNA methylation by the methyltransferase SssI 
with CNT-DNA devices represents the first report of an electrical strategy to monitor 
these activities on the single molecule level.  These experiments demonstrate that DNA in 
these devices, which forms a covalently wired bridge, is simultaneously a sensitive 
recognition element and transducer of methyltransferase binding.  Base flipping by SssI 
at its specific recognition sequence disrupts CT through the DNA bridge and causes 
nearly complete attenuation of the device conductance.  These devices can be used to 
sensitively distinguish DNA that lacks the 5ʹ-CG-3ʹ binding site, as SssI does not induce 
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base flipping and the disruption of DNA CT at DNA without this site.  These studies 
represent the next step up in complexity from previous work in which these devices were 
used to detect DNA cutting by a restriction enzyme (9).  Unlike these previous studies, in 
which detection was achieved by irreversible destruction of the device, here the 
sequence-specific binding and activity of SssI is detected in a way that leaves the device 
intact, yet reports on the enzymatic reaction.  Methylation of the DNA bridge by SssI is 
readily observed because this activity alters the subsequent protein binding affinity of the 
device, but not its conductivity.   
Thus, this work generalizes the CNT-DNA platform for fundamental, single 
molecule measurements of DNA CT as well as for the detection of proteins that bind 
DNA and disrupt DNA CT.  Completed investigations of the distance dependence of 
DNA CT with this platform will provide, for the first time, a direct measure of this 
property.  This information will help to inform nanoelectronic applications that utilize 
DNA CT as well as provide insight about how DNA CT may be used for long-distance 
signaling in living organisms.  The specific, electrical monitoring of single molecule 
protein-DNA interactions with CNT-DNA devices may be extended to the wide variety 
of other proteins that disrupt DNT CT upon DNA binding.  This strategy shows promise 
by providing a unique perspective from which to detect and characterize protein-DNA 
interactions, and allowing these activities to be sensitively monitored at the single 
molecule level. 
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Introduction 
 
Binding interactions between proteins and DNA are critical to many cellular 
processes including transcriptional regulation, replication, DNA modification, and DNA 
repair.  As such, significant efforts have been made towards the development of effective 
assays to characterize protein-DNA interactions as well as towards exploiting these 
events for disease detection and drug targeting.  Of particular interest is DNA binding by 
transcription factors and methyltransferases—two different classes of proteins that can 
significantly influence gene expression.  While transcription factors directly regulate 
gene expression by binding DNA (1), methyltransferases alter methylation patterns in the 
genome, upon DNA binding, that epigenetically direct gene expression (2).  
Overexpression and aberrant activity of transcription factors and methyltransferases can 
lead to abnormal gene expression and thus many of these proteins have been identified as 
primary indicators of cancer and other disease processes (3-7).   
Unfortunately, current technologies for the detection of these proteins are not 
amenable for use in the clinic due to cost, complexity, lengthy analysis times, or lack of 
portable equipment, all of which impede their use as diagnostic markers for disease (8, 
9).  Several prominent techniques for protein detection and the study of protein-DNA 
interactions include western blotting, chromatin immunoprecipitation on microarrays 
(ChIP-chip) (10, 11),
 
protein binding microarrays (11), Dam methylase fusion proteins 
(DamID) (12), and molecular beacons (13).  As these techniques rely on fluorescence, 
they are prone to the errors and sensitivity limitations inherent with this platform (14, 15).  
In addition, they often involve multiple labeling steps, protein-specific antibodies, 
expensive reagents, bulky detection instrumentation, and complex data analysis, and thus 
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are not feasible for routine clinical use (14, 15). 
Electrochemistry offers an appealing alternative to fluorescence-based detection 
schemes as this transduction method is inherently inexpensive, requires minimal sample 
preparation, involves straightforward data analysis, may utilize portable equipment, and 
has the potential for multiplexing (15–17).  Electrochemical assays which rely on the 
sensitivity of DNA-mediated charge transport (DNA CT) chemistry show particular 
promise for rapid and facile biosensing (16, 18).  As DNA CT is mediated through the 
base pair π-stack formed by the double helix, this chemistry has unmatched structural 
sensitivity to perturbations of the π-stack (19, 20).  The DNA-modified electrode 
platform has been used to readily detect all base mismatches (21, 22), and a variety of 
base lesions (23) and DNA-binding proteins (24, 25) that structurally distort the DNA.   
In this detection scheme, thiol-modified DNA duplexes bearing a covalent redox 
probe are assembled on a gold electrode surface (21, 22).  When a potential is applied to 
the electrode, DNA CT facilitates reduction of the probe, producing an electrochemical 
signal.  DNA with a structural distortion to the π-stack shows an attenuated signal, 
relative to unperturbed DNA, thereby allowing for sensitive detection of the structural 
distortion.  As most DNA-binding proteins bind specific DNA sequences, this property 
may be exploited to specifically detect a protein of interest.  Electrodes can easily be 
modified with customized DNA containing binding sites aimed at the specific detection 
of target proteins (Figure 5.1).  Thus DNA may be utilized in these electrochemical 
sensors of protein-DNA interactions as both the recognition element and the transducer. 
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Figure 5.1 Detection of protein binding on DNA-modified gold electrodes.  DNA 
bearing a covalent redox probe (blue oval) and thiol linker (wavy line) is assembled on a 
gold electrode surface.  Top row: for DNA containing the TBP binding site, treatment of 
the electrode with TBP results in DNA binding and bending by 90°.  Bottom row: for 
DNA containing a methyltransferase binding site, treatment of the electrode with the 
methyltransferase results in DNA binding and base flipping.  Both binding events distort 
the structure of the DNA π-stack and severely impede DNA CT to the redox probe.  The 
resulting attenuation of the measured redox signal allows for the detection of protein 
binding.    
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              TATA Binding Protein (TBP)                                Methyltransferase          
 
 
Figure 5.2 Distortion of the DNA π-stack by DNA-binding proteins.  Proteins are shown 
in blue and DNA is shown in grey. (Left) Crystal structure of TBP bound to DNA (PDB 
ID: 1NH2) (30).  TBP binds the recognition site 5´-TATAAAG-3´ and kinks the DNA 
90° upon binding.  (Right) Crystal structure of HhaI methyltransferase bound to DNA 
(PDB ID: 1FJX) (28).  HhaI binds the recognition site 5´-GCGC-3´ and flips the 
underlined cytosine out of the base stack, shown in red.     
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Proteins detected previously with this platform include DNA methyltransferases 
and the transcription factor TBP (TATA binding protein) which both significantly disrupt 
the π-stack of DNA upon binding by very different modes (Figures 5.1, 5.2).  While 
DNA methyltransferases flip a base completely out of the DNA helix in order to catalyze 
the transfer of a methyl group (26–28), TBP kinks the DNA by 90° upon binding (29, 
30).  For the detection of these proteins, DNA bearing the covalently crosslinked 
intercalator daunomycin was utilized in a single electrode format (24).  Though effective, 
this redox reporter has several significant drawbacks, including instability and sequence 
restrictions, which limit its versatility and prospects for use in a simple diagnostic assay.  
Beyond the probe, a more effective detection scheme also requires the switch to a 
multiplexed format to increase statistics, decrease assay time and labor, and allow for the 
side-by-side measurement of multiple samples and controls on the same device.   
Here we describe work to improve this DNA CT-based platform for the rapid, 
electrochemical detection of DNA-binding proteins.  This work centers specifically on 
the need for large, consistent signals from a stable, DNA-mediated redox reporter, in a 
multiplexed electrode format.  Using TBP and the bacterial methyltransferase SssI as 
targets, properties of the covalent redox probes Nile Blue and Methylene Blue (Figure 
5.3) were investigated on multiplexed chips.  The effects of protein buffer components on 
signal size and shape were evaluated as well as the response to protein binding.  Upon 
establishing optimal buffer conditions and determining that the Methylene Blue probe is 
more responsive to protein binding, SssI binding was examined in greater detail.  This 
work provides insight on the parameters that must be considered for the continued 
development of DNA CT-based electrochemical strategies for protein detection.  
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Materials and Methods 
Materials 
All standard and modified phosphoramidites were purchased from Glen Research.  
Nile Blue perchlorate (laser grade) for coupling was purchased from Acros.  Modified 
Methylene Blue dye for coupling was synthesized as described previously (31).  
Sinefungin was purchased in dry form from Sigma-Aldrich and solutions were prepared 
in 10 mM HCl and stored at -20°C.  Lambda DNA was purchased in solution from New 
England Biolabs and used as received.  All other chemicals for the preparation of protein 
buffers and DNA-modified electrodes were purchased from Sigma-Aldrich and used as 
recieved.  Multiplexed chips were fabricated at Caltech as described previously (32). 
 
Protein Preparation 
All proteins were purchased from commercial sources and used as received.  BSA 
was purchased from New England Biolabs and stored at -20°C.  Human TBP was 
purchased from ProteinOne and aliquots were stored at -80°C.  SssI methylase was 
purchased from New England Biolabs and stored at -20°C.  
 
DNA Sequences 
All DNA sequences used in these experiments are summarized in Table 5.1.  For 
experiments on running buffer effects and TBP binding, electrodes were modified with 
the sequence 5ʹ-HS- (CH2)6 -GAGATATAAAGCACGCA-3', where the TBP binding site 
is underlined, with a Nile Blue- or Methylene Blue-modified complement.  For mismatch  
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Table 5.1 DNA sequences used for electrochemistry.  The TBP and SssI binding sites are 
indicated in red.  The site of a CA mismatch for mismatch discrimination experiments is 
bolded.  For all DNA, the Nile Blue or Methylene Blue redox probe is covalently 
attached to the terminal 5ʹ-T. 
 
 
Experiment Sequence 
Buffer effects, TBP 
binding, mismatch 
discrimination  
5ʹ-HS- (CH2)6 - GAGATATAAAGCACGCA -3' 
                         CTC TATATTTCGTGCGT 
SssI binding, 
Unmethylated 
5ʹ-HS- (CH2)6 - GACTGACCGTGGACTGA -3' 
                         CTGACTGGCACCTGACT 
SssI binding, 
Fully Methylated 
5ʹ-HS- (CH2)6 - GACTGAC
m
CGTGGACTGA -3' 
                         CTGACTGG
m
CACCTGACT 
SssI binding,  
No site 
5ʹ-HS- (CH2)6 - GACTGACTGTGGACTGA -3' 
                         CTGACTGACACCTGACT 
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discrimination experiments a CA mismatch was inserted into this sequence at the 
italicized C base.  For experiments to measure SssI binding, the sequence 5ʹ-HS-(CH2)6-
GACTGACCGTGGACTGA-3' was used with either an unmethylated or methylated SssI 
binding site (underlined).  A Methylene Blue-modified complement, with an 
unmethylated or methylated site, was employed to form duplexes with an unmethylated 
or fully methylated SssI binding site, respectively.   A sequence in which a T replaces the 
5ʹ-C in the SssI binding site was also utilized to measure binding on a nonspecific DNA 
substrate: 5ʹ-HS-(CH2)6-GACTGACTGTGGACTGA-3ʹ.  
 
DNA Synthesis 
All DNA was synthesized on an Applied Biosystems 3400 DNA Synthesizer.  
Thiolated strands were prepared with a C6-S-S phosphoramidite at the 5ʹ terminus.  
Strands containing methylated cytosine were synthesized with a 5-methyl dC-CE 
phosphoramidite.  DNA for Nile Blue coupling was prepared with ultramild 
phosphoramidites and a NHS-carboxy dT phosphoramidite at the 5ʹ terminus.  DNA for 
Methylene Blue coupling was prepared with regular phosphoramidites and an amino-C6-
dT phosphoramidite at the 5ʹ terminus.  All DNA was purified by reverse-phase HPLC 
with a polymeric PLRP-S column (Agilent) and characterized by mass spectrometry.  All 
DNA stocks were desalted, resuspended in phosphate buffer (5 mM phosphate, 50 mM 
NaCl, pH 7), and quantified by UV/Vis absorption at 260 nm.  Equimolar amounts (50 
µM) of complementary strands were combined and thermally annealed.   
For Nile Blue-modified DNA, coupling was carried out on the solid support as 
described previously (25).  Briefly, a saturated solution of Nile Blue perchlorate (10 
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mg/mL) in 10% DIEA in dichloromethane was applied to the DNA by syringe (1mL per 
column) and allowed to shake overnight (18 hours) at room temperature.  The DNA was 
then washed with dichloromethane, methanol, and acetonitrile, dried, deprotected and 
cleaved from the solid support (50 mM potassium carbonate in methanol overnight at 
room temperature), and purified by reverse-phase HPLC.  For Methylene Blue-modified 
DNA, coupling was carried out in solution as described previously (31).  Briefly, DNA 
that had been purified by reverse-phase HPLC with the dimethoxy trityl group removed 
was suspended in 0.1 M NaHCO3 and combined with an equimolar amount of modified 
Methylene Blue dye in DMSO.  The mixture was allowed to shake overnight at room 
temperature.  The coupled DNA was then purified from the free dye using a Nap-5 size 
exclusion column (GE Healthcare) before further purification by HPLC.  The final 
structures of Methylene Blue- and Nile Blue-modified DNA are illustrated in Figure 5.3.  
For thiolated DNA, after initial HPLC purification, the disulfide was reduced to the free 
thiol in 100 mM dithiothreitol in 100 mM Tris-HCl buffer pH 8.3 at room temperature for 
45 minutes, purified on a Nap-5 column, and further purified by HPLC.   
 
Multiplexed Chip Preparation and Assembly 
Prior to application of DNA solutions, chips were cleaned with acetone and 
isopropanol, dried, and further cleaned by exposure to UV ozone for 5 minutes.  The 
chips were then assembled with a rubber gasket and clamp, and a solution of 25 µM 
DNA in phosphate buffer was immediately applied to each quadrant of the chip (25 µL 
DNA per quadrant).  The DNA was allowed to assemble on the chip overnight in a 
humidified environment at room temperature. 
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Figure 5.3 Covalent redox probes for the detection of protein binding.  Structures of Nile 
Blue (top) and Methylene Blue (bottom) redox probes covalently attached to DNA.    
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Electrochemistry 
All electrochemistry was carried out with a standard potentiostat and multiplexer 
console (CH Instruments).  A three-electrode system was employed including a Pt wire 
auxiliary electrode and Ag/AgCl reference electrode (Cypress Systems).  Chips were first 
backfilled with 1 mM mercaptohexanol in phosphate buffer with 5% glycerol for 45 
minutes at room temperature.  For all electrochemistry, cyclic voltammetry (CV) scans 
were performed at a 100 mV/s scan rate over the potential window of 0 mV to -500 mV.  
Squarewave voltammetry (SWV) was performed at 15 Hz over the same potential range.  
Signal size was measured as the CV cathodic peak area or the SWV peak area, as 
indicated.  For experiments to determine the effects of different buffer components, after 
backfilling and thorough rinsing by buffer exchange, scans were performed in a variety of 
buffers.  These include phosphate buffer, TBP-binding buffer (5 mM phosphate, 50 mM 
NaCl, 4 mM MgCl2, 4 mM spermidine, 50 µM EDTA, 10% glycerol, pH 7) and 
variations that isolate different components.   
For all protein binding experiments, after backfilling with mercaptohexanol, 
electrodes were backfilled with 3 μM BSA in phosphate buffer for 45 minutes at room 
temperature.  After thorough rinsing by buffer exchange, background scans were 
performed in the specific binding buffer for the protein of interest.  TBP-binding buffer 
was used for TBP while SssI-binding buffer (10 mM Tris-HCl, 50 mM NaCl, 10 mM 
MgCl2, pH 7.9) was used for SssI.  After removing this blank buffer from the common 
well over the electrodes, a solution of the target protein in binding buffer was then added 
(200 µL total volume).   
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For experiments with SssI, the inactive cofactor analog sinefungin (160 µM) was 
added to the reaction solution.  Scans were performed in this solution at various time 
points to measure binding over time.  For protein titrations, the reaction solution was 
serially exchanged for solutions of increasing protein concentration and binding was 
allowed to occur for 30 minutes before scanning.  To measure the effect of competitor 
DNA, scans were taken after complete binding of the protein (30 minutes).  A solution of 
Lambda DNA in protein-binding buffer was then added directly into the protein solution 
on the electrode, mixed thoroughly, and scans were performed over time.  To investigate 
the importance of the cofactor for SssI binding, electrodes were treated with 50 nM SssI 
without any cofactor, allowed to incubate for 45 minutes, and then scanned.  Chips were 
then rinsed thoroughly, exposed to a new solution of 50 nM SssI with 160 µM sinefungin, 
allowed to incubate for 45 minutes, and then scanned.  To evaluate SssI binding on DNA 
with a fully methylated binding site or without a binding site, chips were modified on one 
half with the DNA substrate for specific binding (unmethylated with 5ʹ-CG-3ʹ site) and 
on the other half with the DNA substrate for nonspecific binding (fully methylated or 
with the sequence 5ʹ-TG-3ʹ).  SssI binding to these substrates was then performed side-
by-side on the same surface.       
 
Results and Discussion 
Effect of Running Buffer on Signal Size and Shape 
In this electrochemical protein detection scheme, the protein binding buffer is also 
the electrochemical running buffer.  Thus, it is critical to establish how various buffer 
components affect the electrochemical signal in order to both ensure conditions that allow 
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for protein binding and maximize signal size.  Drastic differences in signal size and peak 
sharpness were observed for DNA-modified electrodes scanned in phosphate buffer 
followed by TBP-binding buffer (Figure 5.4).  For these electrodes, there is an 
approximately 10-fold increase in the CV cathodic peak size when scanned in TBP-
binding buffer as compared to phosphate buffer.  Upon this buffer change, the redox 
peaks also change from extremely broad and split to sharp with reduced splitting.  This 
effect is reversible with buffer exchange and was observed for the same 17-mer DNA 
sequence with either the covalent Nile Blue or Methylene Blue redox probe.   
As the main difference between phosphate buffer and TBP-binding buffer is the 
presence of spermidine and MgCl2 in the TBP-binding buffer, the individual effect of 
these buffer components was investigated.  Electrodes modified with 17-mer Nile Blue 
were scanned in phosphate buffer followed by phosphate buffer with added 4 mM 
spermidine or 4 mM MgCl2.  Scans were taken in phosphate buffer between each 
exchange to ensure complete signal reversal back to the baseline (Figure 5.5).  From this 
experiment, it is clear that both magnesium and spermidine contribute to the signal 
enhancement, with spermidine contributing most significantly.  Indeed, the combined 
signals from phosphate buffer with spermidine or MgCl2 alone nearly approximate the 
signal size and shape when the electrode is scanned in TBP-binding buffer. 
It is important to determine if the enhanced signals caused by spermidine and 
MgCl2 in the running buffer are DNA-mediated or if these buffer components induce an 
alternate mode of probe reduction.  To do this, a single CA mismatch was incorporated 
into the 17-mer Nile Blue DNA and the well matched and mismatched duplexes were 
assembled side-by-side on the same chip.  Scans of the chip in TBP-binding buffer show  
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Figure 5.4.  Running buffer conditions influence the signal size and shape from 
multiplexed, DNA-modified electrodes.  Electrodes were modified with (left) Nile Blue- 
and (right) Methylene Blue-modified 17-mer DNA of the same sequence.  CVs from the 
electrodes scanned first in phosphate buffer (5 mM phosphate, 50 mM NaCl, pH 7) (red 
trace), followed by TBP-binding buffer (5 mM phosphate, 50 mM NaCl, 4 mM MgCl2, 4 
mM spermidine, 50 µM EDTA, 10% glycerol, pH 7) (blue trace) are shown for 
representative electrodes.  Scans were performed at a 100 mV/s scan rate with an 
Ag/AgCl reference electrode.  
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Figure 5.5 Spermidine and MgCl2 in running buffer cause signal enhancement.  The well 
matched Nile Blue-modified 17-mer was assembled on multiplexed chips and scanned in 
a variety of buffers including phosphate buffer (5 mM phosphate, 50 mM NaCl, pH 7) 
(blue trace), phosphate buffer with 4 mM MgCl2 added (green trace), phosphate buffer 
with 4 mM spermidine added (orange trace), and TBP-binding buffer (5 mM phosphate, 
50 mM NaCl, 4 mM MgCl2, 4 mM spermidine, 50 µM EDTA, 10% glycerol, pH 7) (red 
trace).  Scans were taken in phosphate buffer between each new solution to ensure that 
the signal reversed completely back to the initial phosphate buffer baseline scan.  CVs for 
a representative electrode are shown overlaid.  Scans were performed at a 100 mV/s scan 
rate with an Ag/AgCl reference electrode.  
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clear mismatch discrimination with a mismatched: well matched CV cathodic peak size 
ratio of 0.2 ± 0.1 across 20 electrodes for each DNA type (3 chips) (Figure 5.6).  This 
result is consistent with previous measurements of DNA-mediated electrochemical signal 
attenuation in the presence of a CA mismatch (21, 22), confirming that the buffer-
enhanced signals are still DNA-mediated.       
Mg
2+
 and spermidine have previously been shown to facilitate DNA packing as 
their positive charge helps to neutralize the negatively charged phosphate backbone of 
DNA and decrease interstrand repulsions (33–35).  The increased peak sharpness in TBP-
binding buffer indicates a greater degree of organization and uniformity in the film, and 
the increased peak size indicates that the film reorganization induced by Mg
2+
 and 
spermidine facilitates more efficient reduction of the redox probe.  Since gathering these 
initial results, the signal enhancing effects of Mg
2+
 and spermidine have been used for a 
wide range of DNA sequences and lengths on DNA-modified electrodes (31, 36, 37). 
 
Response to TBP-Binding by Nile Blue- vs. Methylene Blue-Modified DNA 
In addition to the identification of buffer conditions that both allow for protein 
binding and promote strong electrochemical signals, the selection of a covalent probe that 
responds sensitively to protein binding is also critical.  Toward this end, the response to 
TBP binding of two consistent and well characterized redox probes for DNA-mediated 
electrochemistry were compared.  Nile Blue- and Methylene Blue-modified 17-mers 
containing the TBP binding site (5´-TATAAAG-3´) were assembled side by side on 
multiplexed chips and the binding of 200 nM human TBP was electrochemically 
monitored over time (Figure 5.7).   
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Figure 5.6 Mismatch discrimination is retained in signal-enhancing buffer conditions.  
The well matched (red trace) and mismatched (blue trace) Nile Blue-modified 17-mers 
(17-mer-NB) were assembled side by side on multiplexed chips and scanned in TBP-
binding buffer.  CVs for representative electrodes are shown overlaid.  Scans were 
performed at a 100 mV/s scan rate with an Ag/AgCl reference electrode.  
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Figure 5.7  Response of Nile Blue- and Methylene Blue-modified DNA to TBP binding 
over time.  Electrodes were modified with (left) Nile Blue- and (right) Methylene Blue-
modified 17-mers containing the TBP binding site side by side on multiplexed chips.  
After addition of 200 nM TBP in TBP-binding buffer, the electrodes were scanned over 
time.  CVs of representative electrodes for each DNA type are shown with traces at 
progressive time points overlaid: background scan (red); 200 nM TBP, initial, 20 min., 40 
min., and 100 min. (light blue to dark blue).  All scans were performed in the TBP-
containing solution.  Scans were performed at a 100 mV/s scan rate with an Ag/AgCl 
reference electrode.  
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  In general, the Methylene Blue-modified 17-mer yielded larger initial signals (3 
nC ± 0.2 nC for the CV cathodic peak) in TBP-binding buffer than the Nile Blue-
modified 17-mer (1 nC ± 0.2 nC) across 16–24 electrodes tested for each DNA type (3 
chips).  This result—a generally larger signal size for methylene Blue-modified DNA—
has has been consistently observed across different sequences of DNA modified with this 
probe (31).  In monitoring the signal change over time with TBP binding, the Methylene 
Blue-modified DNA also showed a greater response.  At the final time point (100 
minutes), the Methylene Blue-modified DNA yielded a 40% ± 5% signal decrease by CV 
cathodic peak while the Nile Blue-modified DNA yielded a 20% ± 4% signal decrease.   
 The larger signal decrease for Methylene Blue-modified DNA is likely related to 
its overall larger signal size; with a larger initial signal there is simply more signal to lose 
upon TBP binding and greater potential for a signal change that may be fully measured.  
Signal size is also important for the dynamic range of the electrochemical sensor.  A 
larger initial signal creates a wider range over which subtle changes in signal may be 
meaningfully interpreted.  In DNA CT-based protein sensing this may, for example, 
allow for the accurate electrochemical determination of protein concentration or for the 
monitoring of conformational changes in protein-DNA binding that occur under changing 
conditions.         
 
Time and Concentration Dependence of SssI Binding 
 As Methylene Blue-modified DNA was shown to consistently produce large 
signals and respond sensitively to protein binding, this probe was used for the detection 
of SssI methyltransferase.  SssI, which binds the site 5ʹ-CG-3ʹ and methylates the C-5 
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position of the target cytosine, was selected for study because it is considered the 
bacterial analog to human methyltransferases, which bind and methylate the same 
sequence (38).  Additionally, SssI belongs to the same, highly conserved C-5-cytosine 
methyltransferase family as HhaI methyltransferase, the most thoroughly characterized 
DNA methyltransferase.  Biochemical and structural analyses indicate that the 
characteristics of binding and activity by HhaI, which recognizes the site 5ʹ-GCGC-3ʹ 
and methylates the C-5 position of the first cytosine, may be generalized across this 
family, with particular similarity to SssI (39, 40).  Thus, although a crystal structure for 
SssI has not yet been solved, the DNA binding and base flipping of the target cytosine 
observed in the crystal structure of HhaI is considered closely homologous between these 
two methyltransferases (28).    
For electrochemical SssI detection experiments, the manufacturer-recommended 
buffer for SssI binding was confirmed to produce sizable signals on multiplexed chips 
modified with Methylene Blue-modified DNA due to the high MgCl2 content (10 mM).  
For these experiments, sinefungin, an inactive analog of the S-adenosyl-L-methionine 
(SAM) cofactor, was used.  This cofactor analog is commonly used in methyltransferase-
DNA binding experiments to prevent DNA methylation and protein dissociation and to 
trap SssI in the bound state.   
 To characterize the binding activity, the electrochemical response of Methylene 
Blue-modified DNA to SssI binding was first measured over time (Figure 5.8).  To reach 
the maximum signal response, a high concentration of SssI (100 nM) was tested.  These 
timecourse experiments show that the majority of the signal loss (22% ± 4% by CV 
cathodic peak) occurs in the first 20 minutes, with the maximum response (32% ± 4%)  
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Figure 5.8  Time dependent response to SssI binding.  Electrodes were modified with the 
Methylene Blue-modified 17-mer containing the SssI binding site.  After addition of 100 
nM SssI with 160 μM sinefungin in SssI-binding buffer, the electrodes were scanned over 
time.  CV scans for a representative electrode are shown with traces at progressive time 
points overlaid: background scan (red); 100 nM SssI, initial, 20 min., 50 min., and 80 
min. (light blue to dark blue).  All scans were performed in the SssI-containing solution.  
CV scans were performed at a 100 mV/s scan rate with an Ag/AgCl reference electrode.  
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reached by 50 minutes.  In addition to signal loss, there is significant peak broadening 
associated with SssI binding, a result also observed for TBP binding.  This is likely due to 
increased disorder and heterogeneity in the DNA film upon protein binding that decreases 
the uniformity of probe reduction.  Because this peak broadening translates directly into 
decreased peak size as measured by SWV, this technique may be used to more sensitively 
report changes in the electrochemical signal from protein binding.   In this case, analysis 
of the SWV data shows a signal loss of 48% ± 3% by the first 20 minutes and a 
maximum signal loss of 60% ± 1% by 50 minutes.   
After the timescale of SssI binding had been established, the concentration 
dependence of the electrochemical response was measured (Figure 5.9).  SssI 
concentrations from 15 nM to 100 nM were measured by titration.  Since it was 
determined that the maximum response to binding is reached between 20-45 minutes 
after treatment, protein binding was allowed to proceed for 30 minutes before scanning.   
From these titration experiments, it is clear that the electrochemical response to SssI 
binding is concentration dependent over the tested range.  Consistent with the result 
measured from the time dependence study, a maximum signal loss of 62% ± 1% (by 
SWV peak area) was observed for 100 nM SssI.   
By compiling data from two separate titration experiments in which different SssI 
concentrations were measured, a binding curve can be approximated (Figure 5.10).  This 
curve suggests that half of the total signal loss from binding occurs between 40-50 nM 
SssI.  This concentration range cannot be directly compared to the reported Kd for SssI 
bound to DNA in solution (11 nM) (41) for several reasons: SssI binding in this system is 
likely not at equilibrium, not all DNA strands in the film are equally accessible, and the  
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Figure 5.9  Concentration dependent response to SssI binding.  Electrodes were modified 
with the Methylene Blue-modified 17-mer containing the SssI binding site.  SssI was 
titrated into SssI-binding buffer with 160 μM sinefungin, starting at 15 nM.  Each 
increasing SssI concentration was allowed to bind on the electrode for 30 min. before 
scanning.  CV scans for a representative electrode are shown with traces at increasing 
concentrations of SssI overlaid: background scan (red), 15 nM SssI (orange), 50 nM SssI 
(green), and 100 nM SssI (purple).  All scans were performed in the SssI-containing 
titration solution.  CV scans were performed at a 100 mV/s scan rate with an Ag/AgCl 
reference electrode.  
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Figure 5.10  Binding curve for SssI from electrochemical titration experiments.  Data 
shown are a compilation of two separate titration experiments, corresponding to the filled 
square or X marker shapes.  Electrodes were modified with the Methylene Blue-modified 
17-mer containing the SssI binding site.  SssI was titrated into a solution of SssI-binding 
buffer with 160 μM sinefungin, starting at 15 nM.  Each increasing SssI concentration 
was allowed to bind on the electrode for 30 min. before scanning.  Calculation of % 
signal remaining was made from quantified SWV peak areas.  Error bars represent the 
standard deviation across 8 electrodes measured for each point.  SWV traces for an 
example electrode in the filled square data series are shown overlaid (inset).  The circled 
points in the binding curve correspond to the SWV traces of the same color including 
background scan (red), 15 nM SssI (orange), 50 nM SssI (green), and 100 nM SssI 
(purple).  All SWV scans were performed in the SssI-containing titration solution at 15 
Hz with an Ag/AgCl reference electrode.    
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general loss of dynamic freedom at surfaces complicates the kinetics of protein binding 
on DNA-modified electrodes.  However, it is clear that DNA binding in solution and on 
surfaces both occur on the same nanomolar concentration scale.  Additionally, since these 
differences between solution and surface systems generally make DNA-binding at 
surfaces more difficult, it is reasonable that an SssI concentration higher than the Kd is 
required to see a binding response.  Thus, the SssI concentration range that elicits an 
electrochemical response is realistic and consistent with active DNA binding by SssI.  
 
Reversibility and Cofactor Dependence of SssI Binding 
In order to confirm that the observed signal decrease is due to DNA-binding by 
SssI, the dissociation of bound SssI by competitor DNA was measured.  Electrodes were 
bound with 100 nM SssI with 160 µM sinefungin for 45 minutes to cause a maximum 
initial signal decrease (Figure 5.11).  Consistent with previous concentration dependence 
experiments, a signal loss of 35% ± 5% (by the CV cathodic peak area) was observed for 
binding by 100 nM SssI.  Lambda DNA was then used as a competitor substrate in 
solution to dissociate SssI.  Although rinsing SssI-bound electrodes with buffer alone 
does not restore the signal, incubation with 5 µg/mL lambda DNA for 20 minutes results 
in near complete signal restoration (96% ± 2% of original signal, by CV cathodic peak 
area).  This result indicates that signal loss is due to direct binding of the protein to the 
DNA of the DNA-modified electrode and that this binding is fully reversible by the 
introduction of an alternative DNA substrate in solution.  
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Figure 5.11  Competitor DNA restores electrochemical signal loss from SssI binding.  
Electrodes were modified with the Methylene Blue-modified 17-mer containing the SssI 
binding site.  After a background scan (red trace), binding of 100 nM SssI with 160 µM 
sinefungin was first allowed to go to completion for 45 min. (blue trace).  Lambda DNA 
(5 µg/mL) was then titrated directly into the SssI-containing solution and allowed to 
incubate on the electrodes for 20 min.  (brown trace).  CV scans of a representative 
electrode are shown overlaid.  All scans were performed directly in the test solutions 
(SssI-binding buffer alone, buffer with SssI and sinefungin, buffer with SssI, sinefungin, 
and Lambda DNA).  CV scans were performed at a 100 mV/s scan rate with an Ag/AgCl 
reference electrode.  
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As another control to confirm that signal decreases are a result of the active 
binding of SssI to DNA, the importance of the sinefungin cofactor in the observed signal 
loss was evaluated.  Biochemical studies of C-5-cytosine DNA methyltransferases have 
shown that the affinity of these proteins for DNA is significantly increased by the 
presence of their cofactor (42, 43); HhaI, for example, shows a 500-fold increase in 
affinity for DNA binding with the addition of cofactor (42).  While only a 1% ± 1% 
signal decrease (by CV cathodic peak area) was observed upon addition of 50 nM SssI 
without the sinefungin cofactor, a 20% ± 3% signal decrease was observed when 50 nM 
SssI with 160 µM sinefungin was added (Figure 5.12).  This decrease is consistent with 
what was previously observed for 50 nM SssI in concentration dependence experiments.   
Importantly, treatment of DNA-modified electrodes with sinefungin alone does not result 
in any measurable signal decrease.  The dependence of the electrochemical signal loss on 
the presence of both SssI and cofactor provides further support that this signal loss is due 
to the active, biologically relevant binding of SssI specifically to the DNA of the DNA-
modified electrode.  
 
Effect of DNA Methylation and Sequence on SssI Binding  
The nature of SssI binding on DNA-modified electrodes was further investigated 
by using substrate DNA that contains a fully methylated SssI binding site.  By assembling 
unmethylated DNA and fully methylated DNA side by side on the same chip, SssI 
binding was examined in terms of the variables described previously (time dependence, 
concentration dependence, reversibility, and cofactor dependence).  In order to pick out 
subtle differences in response, changes in signal were analyzed from SWV data.   
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Figure 5.12  Signal loss by SssI is cofactor-dependent.  Electrodes were modified with 
the Methylene Blue-modified 17-mer containing the SssI binding site.  After a 
background scan (red trace), 50 nM SssI alone was allowed to incubate on the electrodes 
for 45 min. (brown trace).  Following this, the electrode was rinsed and 50 nM SssI with 
160 µM sinefungin was allowed to incubate for 45 min. (blue trace).  CV scans for a 
representative electrode are shown overlaid.  All scans were performed directly in the test 
solutions (SssI-binding buffer alone, buffer with SssI alone, and buffer with SssI and 
sinefungin).  CV scans were performed at a 100 mV/s scan rate with an Ag/AgCl 
reference electrode.  
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Importantly, the average SWV signal size was the same (within error) for DNA with an 
unmethylated binding site (7.9 nC ± 0.5 nC) and DNA with a fully methylated binding 
site (8.8 ± 0.4 nC).   
For all variables tested, the binding response was identical for both DNA types; 
DNA with the fully methylated binding site showed the same time dependence, cofactor 
dependence, and reversibility as the unmethylated DNA.  The percent change in SWV 
signal was also the same (within error) for the two DNA types across the range of SssI 
concentrations tested (15 nM–100 nM).  Responses to 50 nM and 100 nM SssI are 
quantified in Figure 5.13 (50 nM: 45% ± 2% signal loss for unmethylated DNA and 43% 
± 2% for fully methylated DNA; 100 nM: 62% ± 1% signal loss for unmethylated DNA 
and 60% ± 2% for fully methylated DNA ).  C-5-cytosine DNA methyltransferases have 
previously been shown to have reduced affinity (~10-fold) for DNA with a fully 
methylated binding site (43, 44).  However, a crystal structure of HhaI methylase bound 
to fully methylated DNA shows that base flipping of the methylated cytosine still occurs 
with this bound complex (45).  Clearly, any reduced affinity for the fully methylated 
substrate is not electrochemically resolved with the DNA-modified electrodes tested here.  
The data indicate that SssI binding and base flipping occurs on both substrates at the SssI 
concentrations that are required for detection with this platform.  
Next, nonspecific binding by SssI to DNA without the binding site was evaluated.  
A 17-mer without the SssI binding site was designed by maintaining a sequence identical 
to the 17-mer with the 5ʹ-CG-3ʹ binding site but changing the 5ʹ-C to a T.  SssI binding to 
these substrates was examined side by side on multiplexed chips.  As in the previous 
substrate comparison, the SWV signal size was the same (within error) for these two  
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Figure 5.13 Effect of SssI binding on nonspecific substrates.  Comparative SssI binding 
is shown in terms of binding site methylation (reds) and DNA sequence (blues).  Binding 
on the nonspecific substrates—DNA with a fully methylated binding site (light red) and 
DNA without a binding site (light blue)—is compared to binding on the specific, 
unmethylated substrate that contains the SssI binding site (dark red and dark blue).  
Binding comparisons on specific and nonspecific substrates for each variable 
(methylation status or sequence) were performed side by side on the same chip and at 
least two chips were analyzed for each variable and SssI concentration.  The percentage 
signal remaining was calculated from quantified SW data and averaged across the 
replicates.  The error bars show the standard deviation across all electrodes tested for a 
given DNA substrate and SssI concentration.    
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substrates across four chips (4.9 nC ± 0.3 nC for DNA with the binding site and 4.5 nC ± 
0.4 nC for DNA without the binding site).  Binding by 50 nM and 100 nM SssI was 
measured separately on two chips for each concentration.  After calculating the 
percentage change in signal from SssI binding for both DNA types, the difference in 
percentage change between DNA types averaged across the replicates.   
Overall, the DNA substrate with the SssI binding site showed approximately 10% 
more signal loss than the substrate without the binding site.  This result was observed for 
both 50 nM and 100 nM SssI binding and is shown in Figure 5.13 (50 nM: 11% ± 2% 
greater change in the DNA substrate with the SssI binding site; 100 nM: 9% ± 2% greater 
change in the DNA substrate with the SssI binding site).  Although this difference is 
small, it is likely significant; the identical initial signal size given by the two types of 
DNA provides a solid foundation for legitimate comparisons and this effect was 
consistently observed across multiple replicates.  Additionally, the previous comparison 
of binding on two distinct DNA substrates that yielded no measurable difference (DNA 
with an unmethylated or fully methylated binding site), gives precedence for a negative 
result and supports the significance of a measured difference in this system.   
Previous biochemical studies of C-5-cytosine DNA methyltransferases provide 
information for the interpretation of this result.  For HhaI, which recognizes the site 5ʹ-
GCGC-3ʹ, a single base change to this site causes a 60–300-fold decrease in its binding 
affinity (as determined by gel shift), depending on the base that is changed (46).  
Although a similar study has not been performed for SssI, it is unlikely that the shift in Kd 
for nonspecific binding by SssI would be as dramatic as what is observed for HhaI; SssI 
already binds DNA 55-fold less tightly than HhaI (Kd = 11 nM vs. 0.2 nM, respectively) 
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and recognizes a shorter, inherently less specific sequence (39, 46).  However, a clear 
decrease in binding is observed by gel shift upon substitution of the 5ʹ-C for T within the 
binding site (47).  The mode of SssI action is also important to consider; while other C-5-
cytosine DNA methyltransferases such as HhaI bind their specific DNA site and then 
dissociate, SssI has been found to bind DNA nonspecifically and methylate DNA 
processively (48).  Although SssI catalyzes methylation completely and exclusively at 5ʹ-
CG-3ʹ sites (38), it binds duplex DNA regardless of the presence of this site (48). 
Additionally, it should be noted that for the low density films that are necessary to 
accommodate protein binding in this assay, there may be some contribution to the 
Methylene Blue redox signal from direct contact of the probe with the electrode surface, 
in addition to reduction that occurs by DNA CT (31).  It is unclear how specific and 
nonspecific binding by SssI affects these two reduction modes.  However, it is possible 
that the combination of these reduction modes decreases the capacity of the assay to 
distinguish sequence-specific binding because it provides more opportunities for 
nonspecific SssI binding to interfere with probe reduction.  Nonspecific binding of SssI 
may either distort the structure of the DNA π-stack and shut off DNA CT or prevent 
direct reduction of the Methylene Blue probe at the surface.  Both actions would decrease 
the sequence specificity reported by this assay.   
Thus, for SssI on DNA-modified electrodes, nonspecific binding likely occurs for 
both DNA types, whether or not they contain the 5ʹ-CG-3ʹ binding site.  This nonspecific 
binding clearly causes a significant decrease in the electrochemical signal in this system.  
Like binding experiments on DNA with a fully methylated binding site, any difference in 
the affinity of SssI for the nonspecific and specific DNA substrates may not be resolved 
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on this platform.  For DNA that does contain the 5ʹ-CG-3ʹ binding site, SssI can flip the 
5ʹ-C base out of the DNA π-stack, an interaction that is known to attenuate DNA CT.  
Since the inactive cofactor sinefungin is used for these experiments, once SssI binds and 
flips this base it should largely stay bound in this position.  This additional interaction, in 
combination with any resolvable difference in the affinity of SssI for the two substrates, 
may account for the added 10% decrease in signal observed for DNA that contains the 
SssI binding site.  Because nonspecific and specific, base-flipping protein-DNA 
interactions may occur simultaneously, it is not possible to distinguish what mode of 
interaction accounts for what portion of signal loss for the two different DNA substrates.  
Despite this, these results indicate that SssI interacts with the two DNA substrates 
differently and that this difference may be measured electrochemically. 
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Summary and Conclusions 
 The work described here outlines efforts toward the development of an 
electrochemical assay to monitor protein-DNA binding interactions.  This assay utilizes 
DNA-modified electrodes and relies on the sensitivity of DNA CT to structural 
perturbations of the π-stack to report protein binding.  Improvements were made upon 
previous work with this assay by the incorporation of covalent redox probes—Nile Blue 
and Methylene Blue—that are versatile and robust, and the extension of this detection 
scheme to a multiplexed chip format that allows for more complex experiments and side-
by-side comparisons.  The effect of common protein buffer components on the 
electrochemical signal was evaluated.  Positively charged components, including 
spermidine and MgCl2, were found to significantly enhance electrochemical signal size 
while retaining mismatch discrimination.   
 Binding by SssI Methylase on multiplexed, DNA-modified electrodes was 
evaluated with Methylene Blue-modified DNA substrates.  Signal loss and significant CV 
peak broadening was observed upon electrode treatment with SssI and the measured time 
dependence, concentration dependence, cofactor dependence, and reversibility of this 
signal loss all indicate that it is due to direct SssI-DNA binding.  In general, significant 
substrate specificities for this binding could not be distinguished with this 
electrochemical assay; the same response was measured for unmethylated and fully 
methylated DNA substrates and only 10% more signal loss was observed for DNA with 
the specific SssI binding site over DNA that does not contain the SssI binding site.  In 
terms of methylation status, this lack of measurable substrate specificity indicates that the 
decrease in affinity for the fully methylated binding site cannot be resolved with this 
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assay and active binding and base flipping of the already methylated target base occurs.  
In terms of sequence, the very subtle difference in substrate specificity is likely due to the 
nonspecific, processive mode of SssI-DNA binding that clearly impacts the 
electrochemical signal in this system. 
 This work illustrates the challenges that still exist for the development of sensitive 
electrochemical assays for the detection of protein-DNA interactions. For detection 
schemes that rely on electrochemical decreases from protein binding, like the assay 
developed here, future work must focus on the optimization of redox probes and DNA-
modified electrode film morphologies that more sensitively report and distinguish 
specific protein binding.  Until improvements are made in this area, such assays may be 
best suited to evaluate binding in controlled, purified samples in which conditions that 
assure specific binding have already been identified in solution and may be translated to 
the surface.   
Even considering this current limitation, this multiplexed assay that easily, 
rapidly, and inexpensively provides an electrical readout of protein-DNA interactions 
promises to be useful in a variety of research applications.  Alongside work to improve 
the specificity of this assay, the current assay may be used in combination with solution 
experiments to improve our understanding of how protein-DNA binding in solution 
compares to binding at surfaces.  More detailed analysis of the differences between 
solution and surface binding will help with the development of more effective detection 
schemes, devices, and data interpretation as detection strategies shift toward surface 
platforms and the inherent advantages that they carry.  Additionally, given that the most 
dramatic differential in this assay is observed for the comparison of situations in which 
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protein is bound or unbound (such as in the case of cofactor dependence and reversibility 
experiments, regardless of whether that binding is a specific or nonspecific mode), this 
assay would be well suited for applications that require this binary report.  Examples of 
such applications include screening for drugs that inhibit protein-DNA binding, analysis 
of how cofactors or changes in buffer conditions affect protein binding, and observation 
of complex processes that involve protein-DNA interactions in real-time.  Here, by 
evaluating the current limitations of this assay as well as demonstrating its most positive 
and useful attributes, we can focus future work on improving its capacity to report 
substrate specificity and exploiting it in applications for which its capacity to report 
protein binding is best suited. 
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Introduction  
 In mammals, DNA methylation is the most prominent form of epigenetic gene 
regulation and is a critical long-term gene silencing mechanism (1, 2).  This covalent 
addition of a methyl group to the carbon-5 position of cytosine at predominantly 5ʹ-CG-3ʹ 
sites is catalyzed by enzymes called DNA methyltransferases which use the cofactor S-
adenosyl-L-methionine (SAM) as a methyl donor.  DNA methylation is central to many 
normal cellular processes including development, X chromosome inactivation, control of 
gene expression by repression, and silencing of transposons, among others (2, 3). 
However, aberrant DNA methylation has been associated with multiple disease states (4) 
including developmental abnormalities such as IFC syndrome (5) and Rett syndrome (6), 
autoimmune diseases such as lupus (7), and many types of cancer (8–10).   
The link between abnormal DNA methylation and cancer has recently become an 
area of intense, widespread research and both excessive methylation (hypermethylation) 
and deficient methylation (hypomethylation) have been identified in diverse tumor types 
(9, 11).  While hypermethylation can contribute to oncogenesis by the silencing of tumor 
suppressor genes (10), hypomethylation may activate oncogenes or latent 
retrotransposons, or cause chromosome instability (9).  In many cases, these harmful 
methylation states have been linked to the abnormal expression and activity of 
methyltransferases (10, 12–17). 
 Mammalian DNA methyltransferases include Dnmt1, Dnmt3a, and Dnmt3b and 
while all three catalyze the same reaction, they play different roles in establishing 
methylation patterns in the genome.  Dnmt1 transmits methylation patterns across cell 
divisions by completing methylation on newly replicated strands at 5ʹ-CG-3ʹ sites that 
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carry methylation on the template strand (3).  Thus Dnmt1 is called a “maintenance” 
methyltransferase and displays a significant preference for hemimethylated DNA 
substrates (18, 19).  Dnmt3a and Dnmt3b, in contrast, have been identified as “de novo” 
methyltransferases because of their activity at unmethylated 5ʹ-CG-3ʹ sites, primarily 
during embryogenesis when the genome is largely unmethylated and methylation patterns 
must be set (3, 20).  Studies that link these methyltransferases to a variety of cancers 
make it clear that their inherently different functions carry over to unique roles in these 
maladies.  Furthermore, the interaction and cooperation between these methyltransferases 
(21–23) adds an additional layer of complexity to their regulation in healthy cells and 
their disregulation that is now being identified in a growing number of cancers.   
 In this multifaceted and newly developing field, much is still not understood 
about the role of methyltransferases in cancer initiation and progression.  Gaining this 
understanding is an attractive goal as abnormalilties in methylation activity usually occur 
far before other signs of malignancy and could thus be used as indicators for early 
detection of cancer (9, 10).  Additionally, identification of cancers with a certain 
methylation phenotype (hypermethylation or hypomethylation) can help specify an 
effective course of treatment (9, 24).  Perhaps the most enticing motivation though, is that 
like other epigenetic modifications methylation is reversible; the correction of harmful 
methylation states reveals healthy, functional DNA that was there all along.  This great 
potential for reversal makes methyltransferases an especially attractive therapeutic target 
(9, 10).    As we move toward a more complete understanding of methylation in cancer, 
effective and accessible assays for methyltransferase activity will be critical at every step 
along the way.  From fundamental studies of methyltransferase activity in cancer cells, to 
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the identification of anti-methylation drug therapies, to the screening of patients for early 
diagnosis of methylation-related cancers, our ability to quickly and accurately measure 
methyltransferase activity will dictate how well we can expand our understanding at the 
interface of epigenetics and cancer, and make practical use of this information for 
diagnostics and therapeutics.  
 Toward this purpose, a variety of methods have been developed for the 
measurement of DNA methylation and methyltransferase activity (25).  While the most 
common current strategies involve radioactive labeling with [methyl-
3
H]-SAM (26–28), 
other methods include PCR-based bisulfite conversion (29, 30), HPLC (31), and 
fluorescence and colorometric assays (32–34).  Another subset of methylation assays are 
based on digestion of DNA by methylation-sensitive restriction enzymes from bacterial 
restriction/modification systems.  In these assays, methylation of a specific DNA 
sequence confers protection from digestion by the corresponding restriction enzyme and 
results are typically visualized by electrophoresis and southern blot (35, 36) or 
fluorescence (37–42).  Although the desire to avoid radioactive substrates has motivated 
the development of these diverse non-radioactive methods, such alternatives carry their 
own significant drawbacks.  These include time-consuming sample preparation and 
analysis, costly detection equipment, expensive antibodies and fluorescently labeled 
substrates, an inability to expand to high throughput analysis of multiple samples, and 
detection schemes that are incompatible with human methyltransferases.  
 Electrochemical platforms overcome many of these drawbacks, providing low-
cost, portable sensors that have great potential for multiplexing and use in clinical 
settings (43–45).  Despite these advantages and the clear benefits of electrochemistry as a 
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non-radioactive method, relatively little work has been done to develop electrochemical 
platforms for the detection of methyltransferase activity.  The electrochemical methods 
that have been reported include the direct electrocatalytic oxidation of individual DNA 
bases as a means to detect 5-methylcytosine (46) and several strategies that use 
methylation-sensitive restriction enzymes.  These strategies include include restriction-
based signal modulation with DNA-functionalized gold nanoparticles (47); restriction-
facilitated binding of redox-active moieties, such as carbon nantubes (48), probe-
modified DNA (49), and redox-active enzymes (50); and DNA monolayers with 
methylation-sensitive restriction sites that bear either electrochemical (51–54) or 
photoelectrochemical (55) reporters.  Though diverse, these previous electrochemical 
approaches are very limited in that they are either demonstrated with synthetic 5-
methylcytosine alone and not enzymatic methylation or they are only applicable for the 
detection of bacterial methyltransferase activity.  Because human methyltransferase 
activity depends on the methylation state of the DNA target (hemimethylated or 
unmethylated), assays for the detection and study of human methyltransferases must 
allow for the use of both substrates. 
 Here we describe a new electrochemical assay for the detection of 
methyltransferase activity in which either a hemimethylated or unmethylated substrate 
may be used for the sensitive detection of both bacterial and human methyltransferase 
activity.  In this assay, DNA-modified electrodes bearing a covalent redox probe are 
combined with a methylation-sensitive restriction enzyme to convert methylation into an 
electrical signal (Figure 6.1).  By utilizing a covalent redox probe that is reduced by 
DNA-mediated charge transport (DNA CT), we take advantage of this robust, exquisitely 
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Figure 6.1 Assay for the electrochemical detection of methyltransferase activity.  DNA-
modified electrodes with the overlapping recognition site of a methyltransferase and 
restriction enzyme (green section in DNA) are prepared.  In the presence of active 
methylases (top left), the DNA-modified electrodes become methylated and protected 
from cutting during subsequent treatment with a restriction enzyme.  Thus by cyclic 
voltammetry (top right), the covalent redox probe exhibits a “signal ON” result both 
before (blue) and after (red) restriction enzyme treatment.  In the absence of active 
methyltransferases (bottom left), the DNA remains unmethylated and is readily cut by the 
restriction enzyme.  This “signal OFF” result is reported through cyclic voltammetry 
(bottom right) by signal attenuation upon restriction enzyme treatment.   
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sensitive, and well characterized chemistry (56, 57).  Such DNA-modified electrodes 
have been used previously to detect mismatches (58-61), lesions (62), and protein binding 
(63, 64) or restriction activity (60, 61, 65).  Here, electrodes are modified with DNA that 
contains the human methylation site (5ʹ-CG-3ʹ) within the recognition site of a 
methylation-sensitive restriction enzyme.  Upon treatment of the electrodes with active 
methyltransferases, these sites become methylated, protecting the DNA from restriction 
during subsequent restriction enzyme treatment.  With the DNA intact, the redox signal 
from the probe is retained (“signal ON”) and indicates the presence of active methylases.  
If the electrode is not treated with active methyltransferases, the DNA remains 
unmethylated and is readily cut, causing the nearly complete disappearance of the redox 
signal (“signal OFF”).   
This assay is demonstrated with either the BstUI or BssHII endonuclease 
restriction site (5ʹ- CGCG - 3ʹ or 5ʹ-GCGCGC-3ʹ, respectively).  For BstUI, methylation 
of any of the cytosines within the recognition site protects the DNA from restriction.  For 
BssHII, full methylation of either of the two 5ʹ-CG-3ʹ sites within its recognition 
sequence is required to block restriction.  Importantly, this means that a hemimethylated 
substrate (5ʹ-G
m
CGCGC-3ʹ) may be used with BssHII for this assay as this DNA is still 
readily cut if it is not further methylated  This substrate versatility is critical for studies 
that involve the primary human methytransferase Dnmt1 which has a strong preference 
for hemimethylated 5ʹ-
m
CG-3ʹ sites.  This work is the first reported electrochemical 
strategy that facilitates detection of human methyltransferase activity.  We demonstrate 
this assay for the detection of bacterial and human samples in a multiplexed, low cost 
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format that may easily be applied to high throughput studies or utilized in research and 
clinical laboratories.   
 
Materials and Methods 
Materials 
All standard and modified phosphoramidites were purchased from Glen Research.  
Modified Methylene Blue dye for coupling was synthesized as described previously (66).  
S-adenosyl-L-methionine (SAM) and Lambda DNA were purchased in solution from 
New England Biolabs and aliquots were stored at -20°C.  Tritiated SAM (
3
H-SAM) was 
purchased from Perkin Elmer and aliquots were stored at -20°C.  All other chemicals for 
the preparation of protein buffers and DNA-modified electrodes, and for use in 
radioactive methyltransferase activity experiments were purchased from Sigma-Aldrich 
and used as recieved.  Multiplexed chips were fabricated at Caltech as described 
previously (60).  Reagents for cell culture were purchased from Invitrogen and used as 
received. 
 
Protein Preparation 
All proteins were purchased from commercial sources.  SssI methyltransferase, 
BstUI restriction endonuclease, BssHII restriction endonuclease, RsaI restriction 
endonuclease, and BSA were purchased from New England Biolabs, stored at -20°C, and 
used as received unless otherwise indicated.  Protease from Streptomyces griseus was 
purchased as a dry powder from Sigma-Aldrich and stored as a 250 μM solution in 40% 
glycerol in phosphate buffer without salt (5 mM phosphate, pH 7) at -20ºC.  Human 
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Dnmt1 was purchased from BPS Bioscience and aliquots were stored at -80°C.  As 
Dnmt1 and BssHII require a 37°C heated incubation to show activity, these proteins were 
purified by size exclusion spin column (10 kDa cutoff, Amicon) prior to electrochemistry 
experiments to remove dithiothreitol (DTT) which disrupts DNA-modified electrodes 
upon heating.  This step also functioned to desalt Dnmt1 whose activity is inhibited by 
NaCl and Mg
2+
.  The purification was performed according to manufacturer instructions 
at 4°C and Dnmt1 was exchanged into the Dnmt1 reaction buffer (50 mM Tris-HCl, 1 
mM EDTA, 5% Glycerol, pH 7.8), while BssHII was exchanged into the general 
methylation/restriction (M/R) activity buffer (10 mM Tris-HCl, 50 mM NaCl, 10 mM 
MgCl2, pH 7.9) .  This step was not required for the preparation of SssI, BstUI, or RsaI as 
DTT in unheated solution was not found to disrupt DNA-modified electrodes.  
 
Nuclear Lysate Preparation 
 HCT116 cell lines, including parent and DNMT1
-/-
 lines, were acquired from the 
Vogelstein group at Johns Hopkins and cultured as described previously (23, 27).  
Briefly, cells were cultured in McCoy’s 5A modified medium supplemented with 10% 
fetal bovine serum and 1% penicillin/streptomycin.  To prepare nuclear lysates, cells 
were harvested, counted, and aliquoted appropriately to ensure an equal number of cells 
for each sample (~10
7
 cells per sample).  Nuclear extraction was performed using the NE-
PER Nuclear and Cytoplasmic Extraction Reagents Kit (Pierce), according to the 
manufacturer’s protocol.  Nuclear lysates were aliquoted and stored at -80°C.   
The protein concentration of nuclear lysates was measured by BCA Protein Assay 
(Pierce).  Expression of Dnmt1 was analyzed by western blot based on work described 
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previously (23, 27).  Briefly, an equivalent amount of total nuclear protein (200 μg) for 
each lysate sample was resolved on a 4-20% Tris-HCl gel (75 minutes at 200 V) before 
transfer to a polyvinylidene fluoride membrane (Millipore).  Membranes were blocked 
with 5% nonfat milk in TBST buffer.  Incubation with a rabbit polyclonal primary 
antibody for Dnmt1 (New England Biolabs, M0231S; 1:2000 dilution) and rabbit 
polyclonal primary antibody for Lamin A (Santa Cruz Biotechnology, sc-20680; 1:1000 
dilution) was carried out for 18 hours at 4°C with shaking.  An Alexa Fluor-conjugated 
goat anti-rabbit secondary antibody (Invitrogen, A-21076; 1:10,000 dilution) was then 
used to detect the immunocomplexes by scanning at 680 nm with an Odyssey IR Imaging 
System (LI-COR).   
 
DNA Sequences 
All DNA sequences used in these experiments are summarized in Table 6.1.  For 
the detection of methyltransferase activity with BstUI, electrodes were modified with the 
sequence 5ʹ-HS- (CH2)6 - GACTGAGTACTCGCGACT GA -3' with a Methylene Blue-
modified complement.  The unmethylated BstUI restriction site (5ʹ- CGCG - 3ʹ) is 
underlined.  As a control, this sequence also contains the RsaI restriction site (5ʹ-GTAC-
3') which is italicized.  For control experiments with synthetically methylated DNA, the 
BstUI restriction site in the above sequence was replaced with a fully methylated 
restriction site (5ʹ- 
m
CG
m
CG -3') and a Methylene Blue-modified complement that also 
contains the fully methylated restriction site was used.   
For the detection of methyltransferase activity with BssHII, electrodes were 
modified with the sequence 5ʹ-HS- (CH2)6 - GACTGAGTACTGCGCGCACTGA -3'  
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Table 6.1 DNA sequences used for electrochemical detection of methyltransferase 
activity.  The BstUI or BssHII restriction site is indicated in red.  The RsaI restriction site 
is indicated by bold type.  For all DNA, the Methylene Blue redox probe is covalently 
attached to the terminal 5ʹ-T. 
 
 
DNA Substrate Sequence 
BstUI, 
Unmethylated 
5ʹ-HS- (CH2)6 - GACTGAGTACTCGCGACTGA-3' 
                         CTGACTCATGAGCGCTGACT 
BstUI, 
Fully Methylated 
5ʹ-HS- (CH2)6 - GACTGAGTACT
m
CG
m
CGACTGA-3' 
                         CTGACTCATGAG
m
CG
m
CTGACT 
BssHII, 
Unmethylated 
5ʹ-HS- (CH2)6 - GACTGAGTACTGCGCGCACTGA-3' 
                         CTGACTCATGACGCGCGTGACT 
BssHII, 
Hemimethylated 
5ʹ-HS- (CH2)6 - GACTGAGTACTG
m
CGCGCACTGA-3' 
                         CTGACTCATGACGCGCGTGACT 
BssHII, 
Fully Methylated 
5ʹ-HS- (CH2)6 - GACTGAGTACTG
m
CGCGCACTGA-3' 
                         CTGACTCATGACG
m
CGCGTGACT 
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with a Methylene Blue-modified complement.  The unmethylated BssHII restriction site 
(5ʹ- GCGCGC - 3ʹ) is underlined.  A hemimethylated DNA substrate was prepared by 
replacing the unmethylated BssHII restriction site with a hemimethylated restriction site 
(5ʹ- G
m
CGCGC -3') and utilizing an unmethylated Methylene Blue-modified 
complement.  DNA with full methylation of one of the 5ʹ- GC - 3ʹ pairs in this sequence 
was prepared using the same hemimethylated restriction site but using a methylated 
Methylene Blue-modified complement (5ʹ- GCG
m
CGC -3').  As an additional control, 
DNA with the unmethylated BstUI restriction site was used to measure BssHII activity on 
DNA without a BssHII restriction site.   
 
DNA Synthesis 
All DNA was synthesized on an Applied Biosystems 3400 DNA synthesizer.  
Thiolated strands were prepared with a C6-S-S phosphoramidite at the 5ʹ terminus.  
Strands containing methylated cytosine were synthesized with a 5-methyl dC-CE 
phosphoramidite.  DNA for Methylene Blue coupling was prepared with regular 
phosphoramidites and an amino-C6-dT phosphoramidite at the 5ʹ terminus.  All DNA 
was purified by reverse-phase HPLC with a polymeric PLRP-S column (Agilent) and 
characterized by mass spectrometry.  All DNA stocks were desalted, resuspended in 
phosphate buffer (5 mM phosphate, 50 mM NaCl, pH 7), and quantified by UV/Vis 
absorption at 260 nm.  Equimolar amounts (50 µM) of complementary strands were 
combined and thermally annealed.  
For Methylene Blue-modified DNA, coupling was carried out in solution as 
described previously (66) and the structure of the final product is shown in figure 6.2.   
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Figure 6.2 Structure of covalent Methylene Blue redox probe used for the detection of 
methyltransferase activity.  The probe is attached to the terminal 5ʹ-T at the end of the 
DNA opposite the alkanethiol linker.      
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Briefly, DNA that had been purified by reverse-phase HPLC with the dimethoxy trityl 
group removed was suspended in 0.1 M NaHCO3 and combined with an equimolar 
amount of modified Methylene Blue dye in DMSO.  The mixture was allowed to shake 
overnight at room temperature.  The coupled DNA was then purified from the free dye 
using a Nap-5 size exclusion column (GE Healthcare) before further purification by 
HPLC.  For thiolated DNA, after initial HPLC purification, the disulfide was reduced to 
the free thiol in 100 mM dithiothreitol in 100 mM Tris-HCl buffer pH 8.3 at room 
temperature for 45 minutes, purified on a Nap-5 column, and further purified by HPLC.   
 
Multiplexed Chip Preparation and Assembly 
Prior to application of DNA solutions, chips were cleaned with acetone and 
isopropanol, dried, and further cleaned by exposure to UV ozone for 5 minutes.  The 
chips were then assembled with a rubber gasket and clamp, and a solution of 25 µM 
DNA in phosphate buffer was immediately applied to each quadrant of the chip (25 µL 
DNA per quadrant).  The DNA was allowed to assemble on the chip overnight in a 
humidified environment at room temperature. 
 
Electrochemistry 
All electrochemistry was carried out with a standard potentiostat and multiplexer 
console (CH Instruments).  A three-electrode system was employed including a Pt wire 
auxiliary electrode and Ag/AgCl reference electrode (Cypress Systems).  Chips were first 
backfilled with 1 mM mercaptohexanol in phosphate buffer with 5% glycerol for 45 
minutes at room temperature.  For all electrochemistry, cyclic voltammetry (CV) scans 
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were performed at a 100 mV/s scan rate over the potential window of 0 mV to -500 mV.  
Scans were taken in 200 μL of the specified buffer in the common well of the chip.  
Signal size was measured as the CV cathodic peak area.   
For the detection of SssI activity, after thorough rinsing of the mercaptohexanol 
backfilling solution, background scans were performed in the M/R activity buffer.  
Individual quadrants of the chip were then treated with SssI in M/R activity buffer with 
160 μM SAM cofactor.  A reaction volume of 10 μL was used for each quadrant.  The 
SssI solution was allowed to incubate on the chip at room temperature for 2 hours.  At 
that time, the solution was removed, the chip was rinsed in M/R activity buffer, and a 
solution of 10 μg/mL Lambda DNA in M/R activity buffer was applied and allowed to 
incubate on the chip for 45 minutes at room temperature to force the dissociation of any 
protein still bound to the DNA-modified electrode.  Following this, a rinse with 500 mM 
NaCl in M/R activity buffer was performed to ensure complete protein dissociation.  The 
chip was rinsed with M/R activity buffer to remove residual salt and a background scan 
was taken.  Next, 1,000 units/mL of BstUI in M/R activity buffer was applied to the chip 
and allowed to incubate at room temperature for 2 hours before a final scan.  As a 
control, after completion of the assay, chips were treated with 1,000 units/mL RsaI in 
M/R activity buffer at room temperature for 30 minutes and then scanned for signal loss.     
A similar procedure was followed for the detection of purified Dnmt1 activity on 
a hemimethylated substrate.  Dnmt1 activity buffer is not optimal for electrochemistry 
because it lacks salts (such as NaCl and MgCl2, which are known to inhibit Dnmt1) (67) 
and spermidine (which may also interfere with Dnmt1 activity because of its positive 
charge), both buffer components that are known to enhance the signal size of DNA-
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modified electrodes.  Because of this, after the methylation reaction had been allowed to 
proceed in Dnmt1 activity buffer, an optimized scanning buffer (5 mM phosphate, 50 
mM NaCl, 4 mM MgCl2, 4 mM spermidine, 50 µM EDTA, 10% glycerol, pH 7) was 
used for all electrochemical scans of activity by Dnmt1.  As both Dnmt1 and BssHII 
show decreased activity in this scanning buffer, chips were thoroughly rinsed in the 
appropriate buffer for the subsequent step before proceeding.  After a background scan, 
chips were treated with Dnmt1 in Dnmt1 activity buffer with 100 μg/mL BSA and 160 
μM SAM.  A reaction volume of 10 μL was used for each quadrant.  The chip was heated 
at 37°C in an incubator for 2 hours.  During this incubation, the chip was stored in a 
humidified container in order to prevent evaporation.   The chip was then treated with 
Lambda DNA at room temperature followed by a NaCl rinse, as described previously.  
After a background scan in the scanning buffer, 1,500 units/mL of BssHII was applied to 
the chip and allowed to incubate at 37°C for 1 hour.  A final scan was then taken.   
For electrochemical detection of methyltransferase activity in cell lysates, the 
same procedure used for purified Dnmt1 was employed; a reaction volume of 10 μL with 
25 mg/mL lysate and 160 μM SAM was used to treat each quadrant at 37°C for 2 hours.  
Then, specifically for lysate samples, the lysate solution was removed and chips were 
treated with a 1 μM protease solution in phosphate buffer (5 mM phosphate, 50 mM 
NaCl, pH 7) for 90 min at 37ºC.  Chips were then rinsed thoroughly with scanning buffer 
to remove any residual protease.  A background scan in scanning buffer was then taken, 
followed by BssHII treatment and a final scan, as described previously.    
 
 
166 
 
3
H-SAM Methylase Activity Assay 
The methyltransferase activity of purified protein samples and nuclear lysates was 
determined by a conventional 
3
H-SAM methylase activity assay, with a procedure based 
partially on previous work (23, 27).  Briefly, 20 μL reactions were prepared with 20 μM 
DNA, 0.5 μCi 3H-SAM (~3 μM), and the sample of interest in its appropriate activity 
buffer (15 nM Dnmt1 or 12 mg/mL nuclear lysate).  For reactions with Dnmt1, 100 
μg/mL BSA was also included.  For the DNA substrate, the same BssHII unmethylated 
and hemimethylated 22-mer sequence that had been used for the electrochemical assay 
with BssHII restriction was employed (Table 6.1) but without any probe or thiol 
modifications.  For each experiment, positive (15 nM SssI) and negative (no protein) 
controls were included as points of reference.  To prepare a heat-inactivated nuclear 
lysate control, the mixed sample was heated at 65°C for 35 min. before processing with 
the other samples.  Reactions were mixed thoroughly and allowed to incubate at 37°C for 
2 hours.  The reactions were then stopped with 30 μL of a 10 % TCA solution, spotted 
onto DE81 filter paper (Whatman), and allowed to air dry for 15 minutes.  The filter 
papers were then soaked separately in 10 mL of 50 mM Na2HPO4 for 15 min., followed 
by individual rinsing with 50 mM Na2HPO4 and 95% cold ethanol.  The filter papers 
were then dried at 37°C for 30 min. before measurement by liquid scintillation counting.   
 
Results and Discussion 
Detection of SAM-dependent SssI Methyltransferase Activity 
Initial work on this assay was performed with SssI methyltransferase, which binds 
the site 5ʹ-CG-3ʹ and methylates the C-5 position of the target cytosine (68).  SssI was 
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selected because it is considered the bacterial analog to human methyltransferases, which 
bind and methylate the same sequence (68).  For the development of this assay, it was 
first important to confirm that any protection of the DNA from restriction after 
methyltransferase treatment is due exclusively to DNA methylation.  To do this, the 
dependence of SssI-mediated protection on the SAM cofactor was evaluated.  As SAM is 
the methyl donor in the methylation reaction, it is required for DNA methylation.  
Multiplexed chips were modified in three quadrants with the unmethylated BstUI 20-mer 
and treated side-by-side with 15 nM SssI with SAM, 15 nM SssI alone, or SAM alone.  
As a control, the fourth quadrant was modified with the synthetically methylated BstUI 
20-mer and left untreated.  Chips were then treated with BstUI to visualize the DNA 
protection that had occurred (Figure 6.3).   
After SssI-treatment of the electrodes, large electrochemical signals are observed 
from the Methylene Blue-modified DNA film.  Importantly, the electrodes are treated 
with competitor DNA and thoroughly rinsed in order to remove bound SssI which can 
attenuate the electrochemical signal (63) and interfere with the assay.  It should be noted 
that for the low density films that are necessary to accommodate protein binding in this 
assay, there is some contribution to the Methylene Blue redox signal from direct contact 
of the probe with the electrode surface, in addition to reduction that occurs by DNA CT 
(66).  However, as this is a restriction-based assay in which both surface and DNA-
mediated reduction are equally shut off by cutting, this combination of reduction modes 
does not affect the performance of the assay.  
Clearly, from these data, signal protection is dependent on the combined 
treatment of SssI and SAM.  While the electrodes treated with SssI and SAM show near  
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Figure 6.3 SssI protection from BstUI restriction is dependent on the SAM cofactor.  
Chips were modified in three quadrants with the unmethylated BstUI 20-mer (top row 
and bottom right) and in one quadrant with the synthetically methylated BstUI 20-mer 
(bottom left).  DNA protection was evaluated side by side on the same chip: the 
unmethylated DNA quadrants were treated with 20 nM SssI + SAM (160 μM) (top left), 
20 nM SssI alone (top right), or SAM alone (160 μM) (bottom right), while the 
synthetically methylated quadrant was left untreated (blue traces).  The chip was then 
treated in all quadrants with BstUI (1,000 units/mL) (red traces).  Finally, the chip was 
treated in all quadrants with RsaI (1,000 units/mL) (black trace).  All scans were 
performed in M/R activity buffer.  CV scans were performed at a 100 mV/s scan rate 
with an Ag/AgCl reference electrode.  
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complete signal protection (98% ± 2%), SssI alone or SAM alone show the same, 
minimal signal protection (12% ± 1% and 13% ± 1%, respectively).  As expected, the 
synthetically methylated DNA shows complete protection (no measurable signal 
decrease).  The SAM-dependence of SssI-mediated signal protection as well as the same 
lack of protection by either moiety alone provides strong evidence that the observed 
signal protection is an effective report of DNA methylation. 
To further rule out other possible modes of DNA protection, such as SssI-DNA 
binding or nonspecific protein aggregation that physically blocks the BstUI restriction 
site, chips were then treated with a second restriction enzyme, RsaI.  Importantly, SssI 
does not have the capacity to methylate and protect the RsaI recognition site against 
restriction and thus any observed protection would necessarily be due to an alternative 
mode.  With this treatment, the remaining redox signals for all DNA types are reduced to 
the same, near complete level of attenuation (4% ± 1% signal remaining for all).  In this 
DNA substrate, the RsaI recognition site is located just one base away from the SssI 
recognition site and is therefore well within the binding footprint of SssI, which covers at 
least 7 nucleotides on each side of the binding site (69).  Thus, if SssI-DNA binding or 
nonspecific aggregation of SssI were preventing the access of BstUI to the DNA this 
physical block would also prevent the access of RsaI.  This result indicates that all DNA 
on the electrode is readily accessible to cleavage by a restriction enzyme, even after 
treatment with SssI and/or SAM.  Thus the observed SssI-mediated signal protection is 
due specifically and exclusively to DNA methylation catalyzed by this methyltransferase.  
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Concentration Dependence of SssI Methyltransferase Activity 
Next, the concentration range over which SssI methyltransferase activity may be 
detected with this assay was evaluated.  Multiplexed chips modified with the BstUI 
unmethylated 20-mer were treated with a range of SssI concentrations (0–16 nM) 
including up to four different concentrations on the same chip surface (Figure 6.4, inset).  
An activity curve, based on the percent signal protected from BstUI restriction at each 
concentration of SssI, was compiled from 4 chips with 4-8 electrodes measured at each 
concentration (Figure 6.4).  Near complete signal protection is observed with SssI 
concentrations of 8 nM and higher (96 % ± 3% at 8 nM; 99% ± 1% at 16 nM).  Between 
the narrow SssI concentration range of 4 nM and 2 nM there is a sharp loss of signal 
protection (91% ± 5% at 4 nM; 21% ± 5% at 2 nM).  Below 2 nM SssI, signal protection 
is not distinguished from the baseline signal that remains when electrodes are left 
untreated (7% ± 1%).   
The sharp change from almost no protection to near complete protection that 
occurs between 2–4 nM SssI is a detection limit that likely reflects the binding affinity of 
SssI (11 nM) (70), the specific activity of the sample, and the morphological accessibility 
of the DNA film.  The narrow dynamic range of this assay indicates that it may be used 
to distinguish very small relative differences in the concentration and/or activity of 
methyltransferase samples within this range.  Additionally, such dramatic switching 
behavior suggests that this assay may be best employed in its current form for ON/OFF 
detection of methyltransferase activity rather than quantification: although the specific 
concentration of methyltransferase solutions that fall within the dynamic range may be 
determined, discrete concentrations above and below this range cannot be distinguished.   
171 
 
 
 
 
 
Figure 6.4  DNA protection by SssI methylation is concentration-dependent.  Chips were 
modified in all quadrants with the unmethylated BstUI 20-mer.  DNA protection by 
various concentrations of SssI was evaluated side by side on the same chip, and CV 
signals from representative electrodes of an example chip are shown (inset).  Overlaid 
CV traces include the initial signal before BstUI treatment (black, dashed), 8 nM SssI 
(red), 4 nM SssI (orange), 2 nM SssI (green), and untreated (purple).  Quantification of 
the observed signal protection across 4 separate chips is displayed as an SssI activity 
curve where the circled points correspond to the concentrations tested on the example 
chip.  Error bars represent the standard deviation among 4–8 electrodes for each point.  
All scans were performed in M/R activity buffer.  CV scans were performed at a 100 
mV/s scan rate with an Ag/AgCl reference electrode.  
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Nevertheless, given the small sample volume required (10 μL), these results demonstrate 
that this assay may be used to readily detect SssI methyltransferase activity down to 20 
fmoles of protein.   
The sensitivity and dynamic range of this assay for the measurement of SssI 
activity may be compared to other strategies for the detection of methyltransferase 
activity.  Although specific assay characterization data for SssI are not available for 
fluorescence and colorimetric methods in solution, the assay described here is superior in 
terms of the sample volume required; only 10 μL of methyltransferase sample is required 
for this assay while at least 75–115 μL is typically required for these solution methods 
(32, 38).  Additionally, these more conventional solution methods require costly 
antibodies, reagents, and scanning equipment that are not necessary for the 
electrochemical approach described here.  
Several electrochemical assays, employing a variety of redox reporters, have been 
described for the detection of SssI activity based on SssI-catalyzed methylation protection 
of DNA films from cutting by the HpaII restriction enzyme (51–54).  Because different 
batches of SssI can show different levels of enzymatic activity, SssI concentrations in 
these reports are given in terms of units of activity, where one unit is defined as the 
amount of SssI required to protect 1 μg of Lambda DNA in a total reaction volume of 20 
μl in 1 hour at 37°C against cleavage by a restriction enzyme (71).  Based on 
measurements of the specific batch of protein used for these experiments, the dynamic 
range of 2-8 nM for the assay presented here converts to a range of 30-60 units/mL.  In 
general, other assays in the literature report wider dynamic ranges (0.5-355 units/mL 
(51), 0.1-450 units/mL (52), 0.1-40 units/mL (53), and 0.5-50 units/mL (54)) and lower 
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detection limits (0.1 units/mL (51), 0.05 units/mL (52), 0.04 units/mL (53), and 0.1 
units/mL (54)).  However, these experiments were all conducted with a single electrode 
format and the sample volumes required for analysis are not reported, so the total protein 
required for detection may not be compared.  Notably, the amount of SssI required for 
full protection of the DNA-modified electrode and the largest “signal ON” response in 
the assay described here is the same or lower than these other assays.  This characteristic 
is advantageous for applications that require a simple ON/OFF report.   Additionally, the 
previously described assays do not present a format that allows for the detection of 
human methyltransferase activity.  As development of such a format was a central goal of 
work described here, effort has not yet been directed at pushing toward lower detection 
limits or expanding the dynamic range of this assay, and thus substantial improvements 
are still possible in these areas.   
Not surprisingly, points within the dynamic range (2–8 nM) show the greatest 
variability in signal protection.  This variability can be considered in terms of two 
separate sources.  First, a small degree of variability in signal protection is observed 
between electrodes in the same quadrant, on the same chip.  For example, at 4 nM SssI, 
the standard deviation for percent protection among electrodes in the same quandrant is ~ 
± 3% while for 0 nM or 16 nM it is ~ ± 1%.  This variability likely reflects subtle 
morphological differences or defects in DNA film formation that either facilitate or 
inhibit DNA methylation.  The impact of these slight physical differences between DNA-
modified electrodes is amplified and only apparent within this narrow concentration 
range in which SssI activity may be measured.   
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A second source of variability in this dynamic region arises from measurements 
between different chips for which different SssI serial dilutions were prepared.  For 
example, at 4 nM SssI, the standard deviation for percent protection between electrodes 
on different chips treated with separately prepared SssI solutions increases from ± 3% to 
± 5% while for 0 nM or 16 nM it remains at ± 1%.  It is possible that some of this 
increased variability may come from greater morphological differences between DNA-
modified electrodes on different chips, but this is not expected to be a significant 
contribution; batch processing of multiplexed chips ensures uniform gold electrode 
surfaces (60) and the consistent signal size measured across chips modified with this 
target DNA (5.7 nC ± 0.4 nC across 5 chips, 76 electrodes) confirms this electrode 
uniformity.  Instead, the increased variability between separately performed experiments 
in this region is likely due to the inherent lack of accuracy associated with manually 
preparing consistent protein solutions at discrete concentrations between 2–8 nM.  The 
fact that this assay reflects this variability is further support for its use in distinguishing 
subtle concentration and activity differences between samples.  Importantly, this source 
of variability is eliminated when a consistent set of serial dilutions is analyzed side by 
side on the same chip.  Thus, the most meaningful comparisons with this assay are those 
made on the same chip surface with samples that share as much of the same preparation 
as possible. 
 
A Hemimethylated Substrate for the Detection of Dnmt1 Methyltransferase Activity 
For this assay to be relevant for the detection of human disease states that involve 
aberrant methyltransferase activity, it must have the capability to detect the activity of 
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human methyltransferases.  Specifically, to detect the most abundant human 
methyltransferase, Dnmt1, this assay must accommodate the strong preference of Dnmt1 
for activity at hemimethylated 5ʹ-
m
CG-3ʹ sites.  Although use of the BstUI restriction 
endonuclease in this assay, shown here, is clearly effective for the detection of 
methyltransferase activity on unmethylated substrates, this particular methylation-
protection system cannot be used to detect activity on hemimethylated substrates; 
hemimethylation alone protects DNA from BstUI restriction, making any further 
methylation indistinguishable with this assay.  Because of this, a new restriction 
endonuclease, BssHII, which recognizes the site 5ʹ-GCGCGC-3ʹ, was incorporated into 
the assay.  Importantly, BssHII requires full methylation of either 5ʹ-CG-3ʹ site within its 
recognition sequence to prevent DNA restriction.  Thus, both hemimethylated and 
unmethylated DNA substrates may be used with BssHII in this assay for the detection of 
human methyltransferase activity.   
 In order to make accurate comparisons of Dnmt1 activity on hemimethylated and 
unmethylated substrates, it was first important to establish that BssHII recognizes and 
cuts the two substrates equally.  Multiplexed chips were modified in separate quadrants 
with the BssHII unmethylated and hemimethylated 22-mers.  As controls, the BssHII 
fully methylated 22-mer and DNA that does not contain the BssHII restriction site (BstUI 
unmethylated 20-mer) were also included in separate quadrants.  The results are shown in 
Figure 6.5.  Importantly, the initial signal size is the same (within error) for the BssHII 
unmethylated (6.4 nC ± 0.3 nC) and hemimethylated (5.7 nC ± 0.4 nC) 22-mers.  Upon 
treatment with BssHII, the same, near complete signal loss was observed for both DNA 
substrates (unmethylated: 88% ± 0.4% ; hemimethylated: 89% ± 0.8%).  In contrast, only  
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Figure 6.5. Unmethylated and hemimethylated DNA substrates are cleaved equally by 
BssHII.  The chip was modified in each of four quadrants with the BssHII unmethylated 
22-mer (top left), the BssHII hemimethylated 22-mer (top right), the BssHII fully 
methylated 22-mer (bottom left), and the BstUI unmethylated 20-mer (bottom right).  
Initial scans (blue traces) and scans after treatment with 1,500 units/mL BssHII (red 
traces) are shown overlaid for each DNA type.  All electrochemistry was measured in the 
optimized scanning buffer.  CV scans were performed at a 100 mV/s scan rate with an 
Ag/AgCl reference electrode.  
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small signal decreases were observed for the fully methylated DNA substrate (14% ± 
2%) and DNA substrate without the BssHII recognition site (17% ± 2%).  This degree of 
nonspecific signal loss, which is not due to BssHII restriction, was consistently observed 
for chips that are subjected to heating at 37°C.  These results confirm that unmethylated 
and hemimethylated substrates may be used for the measurement and comparison of 
methyltransferase activity in this assay.   
 
Detection of Dnmt1 Methyltransferase Activity  
 With the demonstrated capacity to utilize a hemimethylated substrate, this assay 
was next applied to the detection of purified Dnmt1.  As a first step, the activity and 
hemimethylated substrate preference of the purchased Dnmt1 stock was validated by a 
conventional 
3
H-SAM activity assay.  In order to establish the best comparison between 
these results and the electrochemical assay, the same sequences used for electrochemistry 
(BssHII unmethylated and hemimethylated 22-mers) were employed without redox probe 
or thiol modifications.  As anticipated, SssI shows the same activity on both the 
unmethylated and hemimethylated 22-mers, while Dnmt1 shows substantially more 
activity on the hemimethylated 22-mer than on the unmethylated 22-mer (more than 12-
fold greater activity) (Figure 6.6).  The magnitude of this preference for the 
hemimethylated 22-mer over the unmethylated 22-mer is in agreement with previous 
reports for Dnmt1 (18).  The lack of substrate specificity by SssI also contributes to its 
significantly greater overall activity as compared to Dnmt1.   
 Upon verification of the Dnmt1 stock, the activity of this methyltransferase was 
next measured with the electrochemical assay.  Multiplexed chips were modified in  
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Figure 6.6 Substrate specificity of SssI and Dnmt1 by 
3
H-SAM activity assay.  The 
methylation activity of SssI (left) and Dnmt1 (right) on the BssHII unmethylated (green) 
and hemimethylated (lavender) 22-mer was evaluated with the 
3
H-SAM activity assay.  
The counts per minute (CPM) by liquid scintillation counting are shown.  This data for 
SssI and Dnmt1 was collected within the same experiment, using the same 
3
H-SAM stock 
and thus CPM values may be directly compared.  Error bars are the standard deviation 
derived from three replicates within the same experiment.  Although it is not pictured in 
the graph, the negative control in this experiment (not treated with any methyltransferase) 
was measured as 0.2 x 10
3
 CPM.  
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separate quadrants with the BssHII unmethylated and hemimethylated 22-mers, and DNA 
protection by 90 nM Dnmt1 (1 pmol total Dnmt1) was evaluated for each substrate side 
by side on the same chip (Figure 6.7).  Just as in the 
3
H-SAM activity assay, Dnmt1 
catalyzes significantly more methylation, and thus DNA protection, on electrodes 
modified with the hemimethylated 22-mer (53% ± 3% signal protected) than on 
electrodes modified with the unmethylated 22-mer (14% ± 3% signal protected).  On 
another set of chips, this Dnmt1 activity was also found to be dependent on the SAM 
cofactor (Figure 6.8).  While signal protection was observed for the hemimethylated 22-
mer treated with 90 nM Dnmt1 and SAM (39% ± 8% signal protected), significantly less 
signal protection was observed when this substrate was treated with Dnmt1 alone (17% ± 
4% signal protected).  In fact, this low level of signal protection was similar to what was 
observed on the same chip for the unmethylated 22-mer with or without SAM (18% ± 3% 
and 16% ± 1% signal protected, respectively).   
Although full characterization of the dynamic range and detection limit of this 
assay for Dnmt1 has not yet been completed, these initial results may be used to make 
general comparisons with other methods to detect Dnmt1.  No electrochemical assays for 
Dnmt1 have been reported, but several fluorescence-based solution methods have been 
described (34, 38).  In these assays a 50–75 μL sample volume of Dnmt1 is required and 
approximately 1 pmol of Dnmt1 represents a lower limit of what may be consistently 
detected.  Here, a 10 μL sample of Dnmt1 is required and 1 pmol of Dnmt1 is strongly 
detected.  Future work will aim to determine an actual detection limit for Dnmt1 in this 
assay, as well as push this limit lower, but even this initial work suggests a favorable 
comparison between this assay and current methods for the detection of Dnmt1.   
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Figure 6.7. Dnmt1 preferentially protects hemimethylated DNA over unmethylated 
DNA.  The chip was modified with the BssHII unmethylated 22-mer (left) and the BssHII 
hemimethylated 22-mer (right).  DNA protection by 90 nM Dnmt1 was evaluated for 
each substrate side-by-side on the same chip.  Scans after Dnmt1 treatment (blue traces) 
and scans after treatment with 1,500 units/mL BssHII (red traces) are shown overlaid for 
representative electrodes of each DNA type.  All electrochemistry was measured in the 
optimized scanning buffer.  CV scans were performed at a 100 mV/s scan rate with an 
Ag/AgCl reference electrode.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
181 
 
 
 
 
 
Figure 6.8 DNA protection is SAM-dependent.  The illustrated quadrants of the chip 
were modified with the BssHII hemimethylated 22-mer.  DNA protection was evaluated 
side-by-side on the same chip for quadrants treated with 90 nM Dnmt1 alone (left) or 90 
nM Dnmt1 + SAM (160 μM) (right).  Scans after Dnmt1 treatment (blue traces) and 
scans after treatment with 1,500 units/mL BssHII (red traces) are shown overlaid for 
representative electrodes of each treatment.  All electrochemistry was measured in the 
optimized scanning buffer.  CV scans were performed at a 100 mV/s scan rate with an 
Ag/AgCl reference electrode.  
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Taken together, the substrate specificity and clear SAM dependence of Dnmt1-
facilitated DNA protection in this assay provide strong confirmation that this protection is 
the result of Dnmt1-catalyzed DNA methylation.  Further, these results demonstrate that 
this assay is highly effective for the sensitive electrochemical detection of human 
methyltransferase activity; the assay is not restricted by the substrate preferences of these 
proteins, which are so crucial in guiding their diverse regulatory roles in living 
organisms.  In fact, because of its substrate flexibility, this assay may be particularly 
suited for studies on the substrate-specific activities and cooperative interactions of the 
different human methyltransferases.  Additionally, the amount of Dnmt1 that is required 
for detection by this assay is competitive with fluorescence-based solution assays that are 
currently used for detection of Dnmt1 activity.   
 
Toward Detection of Methyltransferase Activity from Human Cancer Cell Lysates  
 One application of this assay is for the detection of human methyltransferase 
activity directly from the complex mixture of a cellular sample.  This capability is 
attractive for the rapid analysis of clinical diagnostic and laboratory research samples 
with minimal sample preparation.  Toward this goal, the human colorectal carcinoma cell 
line, HCT116, was used as a model sample source.  Importantly, HCT116 cells are 
known to show gene silencing through promoter hypermethylation (72, 73) and the 
activity of Dnmts has been studied extensively in this cell line (23, 27, 74, 75).  HCT116 
variants described previously (23, 27), including the parent cell line and a Dnmt1 
knockout (Dnmt1
-/-
), were selected to ensure samples with inherently different levels of 
methyltransferase activity. 
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 Nuclear lysates were first characterized by western blotting for the expression of 
Dnmt1 (Figure 6.9, inset).  The presence of strong Dnmt1 expression in the parent cell 
line and complete absence of this methyltransferase in the Dnmt1
-/-
 cell line confirms the 
genetic identities of the cells that should translate into differential methyltransferase 
activity.  Following this confirmation, a conventional 
3
H-SAM activity assay was used to 
measure the methyltransferase activity of these nuclear lysates.  Again, to enable the most 
direct comparison to the electrochemical assay, the BssHII unmethylated and 
hemimethylated 22-mers were used as the DNA substrates.  Importantly, nuclear lysate 
activity data (Figure 6.9) was collected within the same 
3
H-SAM experiment as SssI and 
Dnmt1 activity data (Figure 6.6) and thus CPM values may be compared directly.   
 Results from these experiments help to confirm the expected activity of the 
nuclear lysate samples in several ways.  First, both parent and Dnmt1
-/-
 lystates show 
clear methyltransferase activity (1900 ± 90 and 1100 ± 70 CPM, respectively, on the 
unmethylated 22-mer; 3400 ± 200 CPM and 1200 ± 200 CPM, respectively, on the 
hemimethylated 22-mer) that is significantly greater than an untreated control or sample 
treated with a heat-inactivated lysate (both ~200 CPM).  Second, the lysate from the 
parent cell line shows greater activity on both DNA substrates than the lysate from the 
Dnmt1
-/-
 cell line (nearly two-fold greater activity on the unmethylated 22-mer and nearly 
three-fold greater activity on the hemimethylated 22-mer).  This result is anticipated 
because of the lack of Dnmt1 activity in the knockout cell line; the presence of some 
remaining methyltransferase activity is likely due to Dnmt3a and Dnmt3b which are still 
active in this cell line.  Finally, the nuclear lysate from the parent cell line shows a nearly 
two-fold preference for the hemimethylated 22-mer while the Dnmt1
-/-
 exhibits no  
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Figure 6.9 Characterization of HCT116 nuclear lysates by 
3
H-SAM activity assay and 
western blot.  The methylation activity of the parent and Dnmt1
-/-
 nuclear lysates on the 
BssHII unmethylated (green) and hemimethylated (lavender) 22-mer was evaluated with 
the 
3
H-SAM activity assay.  The counts per minute (CPM) from liquid scintillation 
counting are shown.  This data was collected within the same experiment, using the same 
3
H-SAM stock as that for SssI and Dnmt1 (Figure 6.6) and thus CPM values may be 
directly compared.  Error bars are the standard deviation derived from three replicates 
within the same experiment.  Although it is not pictured, a negative control (not treated 
with any methyltransferase) and a heat-inactivated nuclear lysate (parent) were both 
measured as 0.2 x 10
3
 CPM.  Inset: western blot of the parent and Dnmt1
-/-
 nuclear 
lysates for Dnmt1 and Lamin A (loading control).    
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significant preference.  Again, the methyltransferase composition of these two cell lines 
may be used to explain this result; while the most prominent methyltransferase in the 
parent cell line, Dnmt1, is most active on hemimethylated DNA, the methyltransferases 
present in the Dnmt1
-/-
 cell line, Dnmt3a and Dnmt3b, both have no substrate preference.    
 After confirming the specific activities of the nuclear lysates, these samples were 
next analyzed by the electrochemical assay.  In contrast to purified protein samples, 
cellular lysates are composed of a complex mixture of proteins, DNA, metabolites, and 
other cellular debris, and carry significant challenges for specific detection on surface 
platforms.  In particular for this assay, it is necessary to manage the DNA-binding 
proteins that are present in the sample which can nonspecifically bind the DNA on the 
electrode and block restriction activity and/or cause unwanted signal decreases.  Upon the 
addition of nuclear lysates to electrodes modified with the BssHII 22-mers, a substantial 
signal decrease and peak broadening is observed (Figure 6.10).  Along with this 
decreased signal, electrodes can no longer be cut by restriction enzymes.  Several 
observations made it clear that this decrease is due to the active binding of various 
proteins to the DNA of the electrode and not digestion of the DNA by nucleases or 
nonspecific adsorption of biomolecules to the electrode surface: (i) the decrease occurs 
rapidly (within 15 minutes) and does not continue past this time and (ii) heat inactivation 
of the nuclear lysate completely prevents this signal decrease.   
As treatment with competitor DNA was found to be ineffective at reversing this 
signal loss, a protease treatment step was developed.  For the BssHII hemimethylated 22-
mer treated with the parent nuclear lysate, substantial recovery of the signal is achieved 
after protease treatment (Figure 6.10).  This result confirms that the signal decrease is due  
186 
 
 
 
 
 
Figure 6.10 Progress toward the electrochemical detection of methyltransferase activity 
from HCT116 nuclear lysates.  Left: protease treatment reverses signal loss caused by the 
nuclear lysate.  The chip was modified with the BssHII hemimethylated 22-mer and 
treated with 25 mg/mL parent nuclear lysate with 160 μM SAM.  The chip was then 
treated with 1 μM protease solution.  Shown overlaid are the initial scan before lysate 
treatment (black trace), the scan after lysate treatment (brown trace), and the scan after 
protease treatment (blue trace), for a representative electrode.  Right: BssHII is active 
after protease treatment.  The chip was rinsed thoroughly and then treated with 1,500 
units/mL BssHII.  Shown overlaid are the initial scan after protease treatment (blue trace) 
and the scan after BssHII treatment (red trace).  All electrochemistry was measured in the 
optimized scanning buffer.  CV scans were performed at a 100 mV/s scan rate with an 
Ag/AgCl reference electrode. 
187 
 
to the extensive binding of multiple proteins in solution to the DNA of the electrode.  
Importantly, after protease treatment, the DNA is readily cut by BssHII.  This indicates 
that, after digestion of the bound proteins, the DNA is now accessible for restriction.  
Although no protective activity by the nuclear lysate is observed, this protease treatment 
overcomes a significant obstacle that has hindered progress with cellular lysates and may 
be an important step toward the successful detection of methyltransferase activity in these 
complex samples. 
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Summary and Conclusions 
Described here is a new assay for the electrochemical detection of 
methyltransferase activity that allows for the use of unmethylated and hemimethylated 
DNA substrates to detect activity from both bacterial and human samples.  This assay 
utilizes DNA-modified electrodes with a methylation-sensitive restriction site that 
overlaps with the active site of a DNA methyltransferase.  Upon treatment with active 
methyltransferases, methylation of this site protects the DNA-modified electrodes from 
subsequent cutting by a restriction enzyme, resulting in “signal ON” detection.  This 
response was shown to depend on the presence of the methyl donor, SAM, confirming 
that DNA protection in this assay is indeed conferred by methylation.  Additionally, it 
was demonstrated that methyltransferase-treated electrodes are still readily cut by a 
restriction enzyme that is not inhibited by methylation, indicating that DNA protection is 
not due to physical blocking of the DNA by bound proteins. 
Characterization of the concentration dependence of this methylation-based signal 
protection for bacterial SssI methyltransferase revealed sharp switching behavior for this 
assay with a narrow dynamic range of 2–8 nM SssI.  Thus for SssI, the assay in its current 
form is best suited for applications that require an ON/OFF report of methyltransferase 
activity, rather than an accurate quantification of unknown samples.  Notably, because of 
the small sample volumes that are required for this assay (10 μL) and the sensitive “signal 
ON” detection scheme, SssI activity can be observed for samples as small as just 20 
fmoles of protein.  Although several other electrochemical assays report lower detection 
limits and wider dynamic ranges for SssI (51–54), the lower concentration of SssI 
required in this assay to produce the full “signal ON” response, is actually an advantage 
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for ON/OFF applications.  The small required sample volume, multiplexed format, and 
substrate flexibility that allows for the study of human methyltransferases are additional 
benefits of this assay over those reported previously.  Also, efforts have not yet been 
focused on lowering the detection limit or modulating the dynamic range of this assay 
and these aims represent a promising area of future work.   
The narrow 2–8 nM dynamic range, which falls just below the binding constant of 
SssI, is likely a strong reflection of this binding limit; once a concentration is reached for 
which DNA binding is favorable, all DNA on the electrode is rapidly methylated and 
protected.  Additional factors that likely influence this dynamic range include the activity 
(turnover) of the methyltransferase sample and the film morphology of the DNA on the 
surface.  Of these contributions, the morphological accessibility of the DNA film is the 
factor that may be modulated in future work to possibly expand this dynamic range.  
Different film morphologies (e.g. fully accessible duplexes spaced evenly across the 
surface or dense island patches of DNA for which only outer duplexes are accessible to 
protein activity), may present more or less challenging landscapes for a given 
methyltransferase to fully protect from restriction.  By creating DNA film morphologies 
that are more difficult to fully protect, it may be possible to accurately quantify samples 
of unknown methyltransferase concentration over a wider range.  It is also important to 
consider that, due to vast differences in binding constant, size, turnover rate, optimal 
reaction temperature, and substrate preference of different methyltransferases, the 
concentration-dependent response, including the size of the dynamic range, for this assay 
will likely be highly methyltransferase-specific.  It will be necessary to evaluate this for 
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each methyltransferase of interest in order to determine how this assay may be applied to 
work with a particular methyltransferase.         
Detection of activity by Dnmt1, the most prominent human methyltransferase, 
was also demonstrated here with this assay.  Importantly, the use of a restriction enzyme 
(BssHII) that requires full methylation of a 5ʹ-CG-3ʹ site within its recognition site 
allowed for the incorporation of a hemimethylated DNA substrate.  The strong preference 
of Dnmt1 to methylate hemimethylated DNA was first confirmed by a conventional 
3
H-
SAM activity assay on the same DNA substrates used for electrochemistry.  This 
preference was then reflected electrochemically by substantially more protection of 
electrodes modified with hemimethylated DNA as compared to those modified with 
unmethylated DNA.  Dnmt1 activity was also shown electrochemically to be dependent 
on the methyl donor, SAM, confirming methylation as the mode of protection.  Though a 
lower detection limit has not yet been determined for this assay, strong detection of 1 
pmol of Dnmt1 indicates that this assay is already competitive with current fluorescence-
based solution methods for Dnmt1 detection (34, 38).  Although differential 
methyltransferase expression and activity was confirmed for a human colorectal 
carcinoma cell line (HCT116) model system by western blot and 
3
H-SAM activity assay, 
activity directly from nuclear lysates has not yet been measured electrochemically.  
However, progress with the development of a protease treatment to reverse the 
detrimental effects of nonspecific binding by the nuclear lysate makes continued work 
toward this goal promising.  
These results represent the first reported detection of human methyltransferase 
activity by an electrochemical method.  Not only does the ability to use both an 
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unmethylated and hemimethylated substrate in this assay enable, for the first time, the 
electrochemical measurement of activity by human Dnmt1, this flexibility will be 
valuable for studies on how substrate specificities influence methylation activities.  
Importantly, the electrochemical format of this assay requires minimal equipment, is low 
cost, and allows for multiplexing and extension to high throughput studies.  Side-by-side 
activity experiments on unmethylated vs. hemimethylated substrates would allow for the 
rapid analysis of the substrate-specific methylation activity of a given sample.  This type 
of experiment could be applied to a range of basic research, diagnostic, and therapeutic 
work with human methyltransferases including the study of cooperative activities 
between methyltransferases, the investigation into how “maintenance” and “de novo” 
activities contribute to cancer initiation, the characterization of cancer methylation 
phenotype, and the development and screening of methyltransferase-specific drug 
therapies.   
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 DNA-mediated charge transport (DNA CT) is a unique chemical phenomenon 
that arises from the physical structure and dynamics of DNA.  Extensive work, from 
diverse experimental vantage points, in solution, on surfaces, and with single molecule 
techniques has established a solid foundation to understand this chemistry (1).  Like 
graphite and other materials with extensive π-orbital networks, the π-stacked array of 
heterocyclic aromatic base pairs that forms the core of the linear DNA molecule creates a 
conductive path that can transmit charge over long distances (2, 3).  In contrast to other π-
stacked solids, though, the structure of DNA in solution is dynamic, with constant 
fluctuations in the physical alignment, and resulting π-orbital overlap, of neighboring 
base pairs.  These dynamical changes in orientation determine the timescale of DNA CT 
(picoseconds to millisecond) and influence the mechanism; the transient formation of 
electronically aligned, multi-base domains over which charge can delocalize is what 
makes DNA CT an energetically favorable process and actually gates the flow of charge 
through this molecule (1, 4).  Given the critical role of structure in this chemistry, it is not 
surprising that DNA CT is exquisitely sensitive to physical disruptions of the base pair π-
stack.  Mismatched or damaged bases (5, 6) as well as protein binding and restriction 
activity (7) have all been shown to attenuate DNA CT.  
 In this thesis work, we have built up and out from this foundation in several new 
directions including work to address the following questions: “How does DNA CT vary 
over regimes of increasing distance?” and “How may we exploit this sensitive chemistry 
for the multiplexed, electrochemical detection of proteins?”  In order to investigate these 
questions with our DNA-modified electrodes, which allow for ground state, 
electrochemical measurements, it was first necessary to expand this platform to a 
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multiplexed chip format (8).  We designed and fabricated silicon chips with sixteen 
individually addressable gold electrodes that may be modified with up to four different 
types of DNA, and verified that this platform supports DNA-mediated electrochemistry.  
This improved electrochemical format allows for side-by-side controls and provides 
greater consistency and reproducibility than single electrodes.  As such, this multiplexed 
platform opens the door for the complex experiments that are necessary to measure the 
distance dependence of DNA CT and apply this chemistry to biosensing.   
Although previous work in solution suggested that the distance dependence of 
DNA CT is very shallow (9), DNA CT over long distances in the ground state had not yet 
been measured.  An understanding of this fundamental property is critical as we consider 
how we might use DNA as a molecular wire in nanoelectronics as well as how nature 
may already use DNA CT for long distance signaling and the coordination of cellular 
processes (10).  Using DNA-modified electrodes on multiplexed chips, we measured 
DNA CT over 34 nm (100 bp), the longest distance over which this chemistry has been 
measured to date (3).  Remarkably, the signal size and attenuation from the incorporation 
of a single base mismatch is the same for the 100-mer as for much shorter, 17-mer DNA.  
Also like the 17-mer, the rate of DNA CT through the 100-mer is limited by the C6 
alkanethiol linker that anchors the DNA to the electrode.  Thus, over 34 nm of DNA, the 
distance dependence of DNA CT is too shallow to be resolved above the limits of the 
platform used to make the measurement.  Though a β value for DNA could not be 
directly calculated, we made a conservative estimate of β as 0.05 Å-1 for DNA.  This 
shallow distance dependence agrees with previous excited state solution measurements, 
and indicates that DNA is competitive with the longest and most conductive molecular 
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wires reported.  Ongoing work to measure the distance dependence of DNA CT in single 
DNA molecules with the carbon nanotube-DNA (CNT-DNA) platform suggests that the 
actual distance dependence of DNA CT may be even shallower: a preliminary β value of 
0.01 Å
-1
 was extrapolated from conductivity measurements across three DNA lengths.   
 DNA CT was also used for the detection of DNA methyltransferases by both 
single molecule and multiplexed, electrochemical platforms.  These proteins are attractive 
targets as their aberrant expression and activity has been identified as an early indicator 
of multiple types of cancer (11).  The DNA-binding action of methyltransferases, which 
includes flipping a base out of the π-stack in order to add a methyl group, was previously 
shown by electrochemistry to disrupt DNA CT (7).  With CNT-DNA devices, we used 
this property for the single molecule detection of binding by SssI methyltransferase, the 
bacterial analog to human methyltransferases (12).  In addition to binding, we showed 
that these devices can also be used to detect methylation, as this chemical modification 
alters the subsequent protein binding affinity of the device. 
 Multiplexed, electrochemical detection of methyltransferase binding and activity 
was explored by two different strategies.  First, we worked to detect SssI by the same 
approach used with the CNT-DNA devices; binding and base flipping by SssI on the 
DNA-modified electrode causes a disruption of DNA CT that may be measured 
electrochemically.  In this way we monitored binding by SssI that is concentration- and 
cofactor-dependent as well as reversible with competitor DNA.  Importantly, this assay is 
general and may be easily extended to the detection of other proteins that distort the DNA 
π-stack upon binding.  However, we determined that this “signal OFF” approach is 
susceptible to signal attenuation caused by nonspecific protein binding, a problematic 
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issue that would be amplified in more complex samples, such as cell lysates, that contain 
a host of interfering proteins.  Thus, this strategy may be best used in its current form to 
detect protein binding from controlled samples (such as for anti-methylation drug 
screening) as well as characterize protein-DNA interactions and improve our 
understanding of how protein-DNA binding at surfaces may be compared to binding in 
solution. 
 In a second line of work, we developed a new electrochemical assay for the 
detection of methyltransferase activity.  In this assay, methylation of the DNA-modified 
electrode confers protection from cutting during subsequent treatment with a restriction 
enzyme.  With the methylated DNA intact, the redox signal from the probe is retained, 
and thus indicates the presence of active methyltransferases in the sample.  We showed 
that this assay is effective for the sensitive, rapid detection of both bacterial and human 
methyltransferase activity in small sample volumes (10 μL).  Uniquely, the design of this 
assay allows for the use of both hemimethylated and unmethylated DNA, a feature that is 
important for work with human methyltransferases which show differing preferences for 
these substrates.  This capacity to use a hemimethylated substrate allowed, for the first 
time, the electrochemical detection of Dnmt1, the most prominent human 
methyltransferase.  We used this assay to demonstrate the cofactor dependence and 
substrate specificity of Dnmt1 activity.  The “signal ON” nature of this assay makes it 
more resistant to the problems associated with nonspecific binding from complex 
samples and thus ongoing work to detect methyltransferase activity directly from human 
cancer cell lysates is promising.  Importantly, the electrochemical format of this assay 
requires minimal equipment, is low cost, and could be easily applied to high throughput 
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studies, making it an accessible option for a variety of research and clinical settings.  The 
capacity to accommodate human samples and the substrate flexibility of this assay will 
allow it to be used for diverse applications.  A notable example is its use to assess the 
substrate-specific methylation activity of a sample, a key factor in cancer pathogenesis, 
which is important for work on both diagnostic and therapeutic approaches to 
methylation-related cancers. 
 Highlighted by this thesis work are two of the most fascinating, defining 
characteristics of DNA CT: the capacity to proceed over very long distances and the 
exquisite sensitivity to subtle structural perturbations.  When considered generally, 
removed from the traditional context for DNA, these characteristics describe a process 
that may be used for long-distance sensing and signaling, a mechanism for transmitting 
information between spatially separated locations.  When considered back in the context 
that has been established for DNA, this process is facilitated by a material that may be 
easily synthesized and manipulated in the laboratory, and that, at this moment, is being 
replicated by the mile inside every living organism on the planet.  Consideration of both 
contexts in combination results in a flowering of possibilities that are at once challenging 
and exciting to imagine.  We have systematically built a solid foundation for 
understanding how these defining characteristics of DNA CT arise from the structure of 
DNA itself.  With this, we are well equipped to explore how this mechanism for long-
distance sensing and signaling plays out in living organisms and envision how we might 
also utilize it to sensitively transmit information on the nanoscale.  This work represents 
several fresh steps toward illuminating the wide reach of this chemistry, but clearly there 
is still much left to understand and to create.   
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